- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株1-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID #15310-LN
AC CVCL_E548
SY 15310-LN; TER461
DR dbMHC; 48439
DR ECACC; 94050311
DR IHW; IHW9326
DR IMGT/HLA; 10074
WW http://bioinformatics.hsanmartino.it/ecbr/cl326.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID #490
AC CVCL_B375
SY Mab 7; Mab7
DR CLO; CLO_0001018
DR ATCC; HB-12029
RX Patent=US5616470;
CC Monoclonal antibody target: Cronartium ribicola antigens.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID #822
AC CVCL_X345
SY Mab 13; Mab13
DR ATCC; HB-12030
RX Patent=US5616470;
CC Monoclonal antibody target: Cronartium ribicola antigens.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID #W7079
AC CVCL_E549
SY #W7079 REM; REMUS; W7079
DR dbMHC; 48440
DR ECACC; 94022552
DR IHW; IHW9223
DR IMGT/HLA; 11548
WW http://bioinformatics.hsanmartino.it/ecbr/cl223.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID (BF1) 8A3.31
AC CVCL_G217
DR CLO; CLO_0001019
DR ATCC; HB-9283
RX Patent=US4845026;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID +/+ (A)
AC CVCL_6479
DR CLO; CLO_0001020
DR ATCC; CRL-6470
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6470; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Finite cell line
//
ID +/+ (B)
AC CVCL_6480
DR CLO; CLO_0001021
DR ATCC; CRL-6471
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6471; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Finite cell line
//
ID +/+ (C)
AC CVCL_S361
DR ATCC; CRL-6472
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6472; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Finite cell line
//
ID +/+ Li
AC CVCL_4977
DR CLO; CLO_0001022
DR ATCC; CRL-6467
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-340.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6467; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Finite cell line
//
ID +/+ MGT
AC CVCL_3627
DR CLO; CLO_0001023
DR ATCC; CRL-6468
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID +/+ SCT
AC CVCL_3628
DR CLO; CLO_0001024
DR ATCC; CRL-6469
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Cancer cell line
//
ID [AD]FiPSAG07645-4F-17
AC CVCL_V152
SY ESi035-A
DR hPSCreg; ESi035-A
DR ISCR; 2260
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Lineas_ADFiPSAG07645-4F-17.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V148 ! AG07645
SX Female
CA Induced pluripotent stem cell
//
ID [CRTRd]FiPS3067-4F-9
AC CVCL_V153
SY ESi036-A
DR hPSCreg; ESi036-A
DR ISCR; 2261
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/solicitud_deposito-CRTRd-FiPS3067-4F-9.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125665; X-linked creatine transporter deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID [CRTRd]FiPS3819-4F-2
AC CVCL_V154
SY ESi003-A
DR BioSamples; SAMEA3303029
DR hPSCreg; ESi003-A
DR ISCR; 2262
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/solicitud_deposito_Lineas_CRTRd-FiPS3819-4F-2.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C125665; X-linked creatine transporter deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID [ctrl.PD]FiPS005-4F-9
AC CVCL_9S10
SY [Ctrl.PD] FiPS005-4F-9; ESi043-A
DR hPSCreg; ESi043-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_2015/Documento_Deposito_FiPS005-4F-9.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID [GA]FiPS4F
AC CVCL_C792
SY GA-FiPS4F; ESi030-A
DR hPSCreg; ESi030-A
DR ISCR; 2263
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/GA_FiPS4F.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C99101; Glutaric acidemia type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID [GD]FiPS-4F-21c
AC CVCL_V156
SY ESi004-A
DR BioSamples; SAMEA3303117
DR hPSCreg; ESi004-A
DR ISCR; 2264
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Linea_GD_FiPS-4F-21c.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID [PD]FiPS006-4F-11
AC CVCL_9S09
SY [PD] FiPS006-4F-11; ESi040-A
DR hPSCreg; ESi040-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_2015/Documento_Deposito_FiPS006-4F-11.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID [PD]FiPS022-V4F-15
AC CVCL_V157
DR ISCR; 2265
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Deposito-Linea-PDFiPS022-V4F-15.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID [PD]FiPS031-4F-1
AC CVCL_9S12
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_2015/Documento_Deposito_FiPS031-4F-1.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID [TSD]FiPS-4F-3-1
AC CVCL_9S11
SY [TSD] FiPS-4F-3-1; ESi042-A
DR hPSCreg; ESi042-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Linea_TSD-FiPS-4F-3-1.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U385 ! GM00527
SX Male
CA Induced pluripotent stem cell
//
ID 00136
AC CVCL_E557
SY 136
DR dbMHC; 48441
DR ECACC; 94071418
DR IHW; IHW9279
DR IMGT/HLA; 10002
WW http://bioinformatics.hsanmartino.it/ecbr/cl279.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 022HU-NSO
AC CVCL_6494
DR CLO; CLO_0001025
DR ATCC; CRL-11177
CC Discontinued: ATCC; CRL-11177; probable.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
SX Female
CA Cancer cell line
//
ID 0308
AC CVCL_IP58
SY 0308-GSC; GSC-0308
DR BTO; BTO:0006002
RX PubMed=23307328;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 031M-CUMC/INSERM
AC CVCL_IJ15
SY 031M
RX PubMed=27789403;
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 051407cb
AC CVCL_V362
SY 970615NSB
DR IMGT/HLA; 14462
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 066
AC CVCL_Y448
DR ATCC; CRL-6287
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6287; true.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Sex undetermined
CA Undefined cell line type
//
ID 066MD-CUMC/INSERM
AC CVCL_IJ16
SY 066MD
RX PubMed=27789403;
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 07-4D
AC CVCL_J077
DR ECACC; 91121239
RX PubMed=2277091;
CC Monoclonal antibody target: UniProtKB; P33545; Bovine DSC2.
CC Monoclonal antibody target: UniProtKB; Q28060; Bovine DSC3.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 07-S-0025#0100
AC CVCL_6G61
DR IMGT/HLA; 12636
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 0822
AC CVCL_IP59
SY 0822-GSC; GSC-0822
DR BTO; BTO:0006003
RX PubMed=23307328;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 090727 LQT3/BrS g1
AC CVCL_T913
DR SKIP; SKIP000214
CC Discontinued: SKIP; SKIP000214; probable.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T914 ! 090727 LQT3/BrS g2
CA Induced pluripotent stem cell
//
ID 090727 LQT3/BrS g2
AC CVCL_T914
DR SKIP; SKIP000215
CC Discontinued: SKIP; SKIP000215; probable.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T913 ! 090727 LQT3/BrS g1
CA Induced pluripotent stem cell
//
ID 1-1A4
AC CVCL_DB54
DR Ximbio; 151022
RX PubMed=9309427;
CC Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1-1D5
AC CVCL_DB55
DR Ximbio; 151023
RX PubMed=9309427;
CC Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1-1ras1000
AC CVCL_8653
DR JCRB; JCRB1355
RX PubMed=8634088;
RX PubMed=27844419;
CC Problematic cell line: Contaminated/misidentified. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419).
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J646 ! BALB/3T3 A31-1-1
CA Transformed cell line
//
ID 1-1src
AC CVCL_8654
DR JCRB; JCRB1357
RX PubMed=8634088;
RX PubMed=27844419;
CC Problematic cell line: Contaminated/misidentified. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419).
CC Transfected with: UniProtKB; P00524; Avian leukosis virus RSA v-Src.
CC Transformant: v-Src.
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J646 ! BALB/3T3 A31-1-1
CA Transformed cell line
//
ID 1-29-7
AC CVCL_Y308
DR ATCC; HB-63
CC Discontinued: ATCC; HB-63; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1-5c-4
AC CVCL_2260
SY Clone 1-5c-4; Clone 1-5c-4 WKD of Chang Conjunctiva; Wong-Kilbourne derivative of Chang conjunctiva; ChWK
DR CLO; CLO_0002500
DR CLO; CLO_0002501
DR CLDB; cl793
DR CLDB; cl794
DR CLDB; cl795
DR ATCC; CCL-20.2
DR BioSample; SAMN03151673
DR ECACC; 88021103
DR IZSLER; BS CL 93
DR KCLB; 10020.2
RX PubMed=566722;
RX PubMed=19630270;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,12
ST FGA: 18,21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID 1-7HB2
AC CVCL_2261
SY 1-7 HB2; HB2
DR ECACC; 10081201
DR Ximbio; 151445
RX PubMed=23982912;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,13
ST D5S818: 10,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8645 ! MTSV1-7
SX Female
CA Transformed cell line
//
ID 1-8
AC CVCL_T367
DR CLO; CLO_0050510
DR RCB; RCB1374
RX PubMed=8973332;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0229 ! CV-1
SX Male
CA Transformed cell line
//
ID 1-87
AC CVCL_D231
DR ChEMBL-Cells; CHEMBL3307800
DR ChEMBL-Targets; CHEMBL612272
DR Cosmic; 889083
DR Cosmic; 946049
DR Cosmic; 1066155
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1-A2
AC CVCL_9V12
RX DOI=10.1007/978-1-4684-4949-5_8;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W179 ! SBC-H20
CA Hybridoma
//
ID 1-LN
AC CVCL_L211
SY 1LN; 1-LN-PC-3-1A
DR BTO; BTO:0005352
RX PubMed=4007233;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID 1.1B4
AC CVCL_1778
DR ECACC; 00112811
DR ECACC; 10012801
RX Patent=US20040005702;
RX PubMed=21515691;
CC Characteristics: Insulin secreting.
CC Characteristics: Hybrid by electrofusion of a primary culture of human pancreatic islets with PANC-1.
CC Doubling time: ~20 hours (ECACC).
CC Discontinued: ECACC; 00112811; probable.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0480 ! PANC-1
CA Hybrid cell line
//
ID 1.1E7
AC CVCL_2257
DR ATCC; PTA-3523
DR ECACC; 10070101
RX Patent=US20040005702;
RX PubMed=21515691;
CC Characteristics: Insulin secreting.
CC Characteristics: Hybrid by electrofusion of a primary culture of human pancreatic islets with PANC-1.
CC Doubling time: ~23 hours (ECACC).
CC Discontinued: ATCC; PTA-3523; probable.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0480 ! PANC-1
CA Hybrid cell line
//
ID 1.2B4
AC CVCL_2258
DR ATCC; PTA-3524
DR ECACC; 10070103
RX Patent=US20040005702;
CC Doubling time: ~20 hours (ECACC).
CC Discontinued: ATCC; PTA-3524; probable.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 10,13
ST D5S818: 10,14
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,12
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1299 ! HuP-T3
SX Male
CA Hybrid cell line
//
ID 1.2C7
AC CVCL_AP65
DR Coriell; WC00053
RX PubMed=1530795;
CC Monoclonal antibody target: UniProtKB; P03460; Influenza B virus isolate B/Lee/1940 hemagglutinin (HA).
CC Discontinued: Coriell; WC00053; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1.4E7
AC CVCL_2259
DR ATCC; PTA-3525
DR ECACC; 10070102
RX Patent=US20040005702;
RX PubMed=21515691;
CC Characteristics: Insulin secreting.
CC Characteristics: Hybrid by electrofusion of a primary culture of human pancreatic islets with PANC-1.
CC Doubling time: ~26 hours (ECACC).
CC Discontinued: ATCC; PTA-3525; probable.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0480 ! PANC-1
CA Hybrid cell line
//
ID 1.5A9
AC CVCL_AP64
DR Coriell; WC00052
CC Monoclonal antibody target: UniProtKB; P03460; Influenza B virus isolate B/Lee/1940 hemagglutinin (HA).
CC Discontinued: Coriell; WC00052; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 10-1.D.2
AC CVCL_B376
DR CLO; CLO_0001027
DR ATCC; TIB-165
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 10-2.16
AC CVCL_B377
DR CLO; CLO_0001028
DR ATCC; TIB-93
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 10-3.6.2
AC CVCL_B378
DR CLO; CLO_0001029
DR ATCC; TIB-92
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 10.014 pRSV-T
AC CVCL_6341
SY 10.014
DR CLO; CLO_0001026
DR ATCC; CRL-11515
DR BioSample; SAMN03471338
RX Patent=US5672498;
RX PubMed=9143482;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 8,13
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6,8
ST TPOX: 8,10
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 10.84
AC CVCL_J168
SY 10.84.2
DR ATCC; HB-8387
RX Patent=US4650676;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 10/9CRC1
AC CVCL_8478
SY MPC 10/9CRC1
DR BTO; BTO:0004581
RX PubMed=15860353;
CC Breed/subspecies: 129S2/SvPas x C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID 10(AAT) Clone A
AC CVCL_U069
DR ECACC; 02043015
CC Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 100-1#16
AC CVCL_T867
SY 100-1 #16
DR SKIP; SKIP000192
RX PubMed=22848530;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T866 ! 100-1#8
SX Female
CA Induced pluripotent stem cell
//
ID 100-1#8
AC CVCL_T866
SY 100-1 #8
DR SKIP; SKIP000191
RX PubMed=22848530;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T867 ! 100-1#16
SX Female
CA Induced pluripotent stem cell
//
ID 100-2#1
AC CVCL_T868
SY 100-2 #1
DR SKIP; SKIP000193
RX PubMed=22848530;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 100-310
AC CVCL_N280
DR ATCC; HB-11028
RX Patent=US5565356;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 100213 LQT2 theta10
AC CVCL_T915
DR SKIP; SKIP000217
CC Discontinued: SKIP; SKIP000217; probable.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T916 ! 100213 LQT2 theta4
CA Induced pluripotent stem cell
//
ID 100213 LQT2 theta4
AC CVCL_T916
DR SKIP; SKIP000216
CC Discontinued: SKIP; SKIP000216; probable.
DI NCIt; C34786; Long QT syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T915 ! 100213 LQT2 theta10
CA Induced pluripotent stem cell
//
ID 10063349
AC CVCL_6G62
DR IMGT/HLA; 12650
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 1011-mel
AC CVCL_7942
SY 1011-MEL; 1011 mel; 1011mel; 1011; Mel 1011
DR CGH-DB; 9292-4
DR Cosmic; 876687
DR Cosmic; 905206
RX PubMed=8027550;
RX PubMed=8081556;
RX PubMed=15467732;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1013L
AC CVCL_4806
SY 1013-L
DR Cosmic; 721372
RX PubMed=6244232;
RX PubMed=14518029;
WW http://capcelllines.ca/details.asp?id=78
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1016T
AC CVCL_6G35
RX PubMed=748774;
RX PubMed=6244232;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 101A
AC CVCL_J815
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 103-LCL
AC CVCL_6751
DR CLO; CLO_0050492
DR BioSample; SAMN03472055
DR RCB; RCB2082
DR TKG; TKG 0614
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 9,12
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 104C1
AC CVCL_2267
DR CLO; CLO_0001030
DR ATCC; CRL-1405
DR CCRID; 3111C0002000000046
DR CCRID; 3142C0001000000091
DR ECACC; 90110524
DR JCRB; JCRB9036
OX NCBI_TaxID=10141; ! Cavia porcellus
SX Female
CA Transformed cell line
//
ID 105AJ
AC CVCL_M609
RX PubMed=8689636;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M605 ! 105KC
SX Male
CA Cancer cell line
//
ID 105AJ1.1
AC CVCL_M610
RX PubMed=8689636;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M609 ! 105AJ
SX Male
CA Cancer cell line
//
ID 105AJ3.1
AC CVCL_M611
RX PubMed=8689636;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M609 ! 105AJ
SX Male
CA Cancer cell line
//
ID 105AJ5.1
AC CVCL_M612
RX PubMed=8689636;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M609 ! 105AJ
SX Male
CA Cancer cell line
//
ID 105KC
AC CVCL_M605
SY 105 KC; KC
DR EFO; EFO_0006354
DR BioSample; SAMN03470879
RX PubMed=2045389;
RX PubMed=10906887;
RX PubMed=16039953;
RX PubMed=25485619;
CC Doubling time: 36 hours (PubMed=16039953).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Miscellaneous: STR profile established at MicroSynth from personal communication of Muff R.
ST Source(s): Microsynth; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11 (PubMed=25877200)
ST D13S317: 8 (Microsynth)
ST D16S539: 9,12,14 (PubMed=25877200)
ST D16S539: 9,14 (Microsynth)
ST D18S51: 15,19 (PubMed=25877200)
ST D18S51: 15,16 (Microsynth)
ST D21S11: 31.2,32.2
ST D3S1358: 15,17
ST D5S818: 10,11
ST D7S820: 10,13
ST D8S1179: 13,16
ST FGA: 21,23 (PubMed=25877200)
ST FGA: 23 (Microsynth)
ST Penta D: 13
ST Penta E: 5,20
ST TH01: 9
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1066
AC CVCL_E424
SY DUGE
DR dbMHC; 48442
DR ECACC; 94071403
DR IHW; IHW9340
DR IMGT/HLA; 10022
WW http://bioinformatics.hsanmartino.it/ecbr/cl340.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 1072F
AC CVCL_6G38
RX PubMed=6244232;
CC Derived from metastatic site: Brain.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1074-mel
AC CVCL_GR77
SY 1074mel; 1074MEL
DR TOKU-E; 4036
RX PubMed=8537970;
RX PubMed=15661905;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 1088-mel
AC CVCL_8029
SY 1088-MEL; 1088 Mel; 1088 mel; 1088
DR Cosmic; 876702
RX PubMed=8081556;
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 108CC15
AC CVCL_0464
SY NG108-15; NG-108-15; NG 108-15; NG10815
DR BTO; BTO:0000942
DR CLO; CLO_0008162
DR MCCL; MCC:0000361
DR CLDB; cl3691
DR ATCC; HB-12317
DR CCRID; 3111C0001CCC000017
DR CCRID; 3131C0001000600051
DR CCRID; 3142C0001000000140
DR ChEMBL-Cells; CHEMBL3308514
DR ChEMBL-Targets; CHEMBL613828
DR ECACC; 08062516
DR ECACC; 88112302
DR KCB; KCB 92029YJ
DR TKG; TKG 0726
DR TOKU-E; 2752
DR Wikidata; Q27870067
RX PubMed=16829;
RX PubMed=2985920;
WW https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=129386&lvl=3
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-214.html
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1970 ! C6-BU-1
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID 108CC5
AC CVCL_4076
SY NG108-5; NG 108-5
DR ECACC; 08062521
RX PubMed=16829;
RX PubMed=591572;
RX PubMed=2985920;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1970 ! C6-BU-1
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID 108CC5-BU
AC CVCL_4077
DR ECACC; 08062566
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5-BU-5
AC CVCL_4078
DR ECACC; 08062567
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5-BU-8
AC CVCL_4079
DR ECACC; 08062569
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5-TG-1
AC CVCL_4082
DR ECACC; 08062543
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5-TG-2
AC CVCL_4083
DR ECACC; 08062544
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5-TG-3
AC CVCL_4084
DR ECACC; 08062545
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5-TG-4
AC CVCL_4085
DR ECACC; 08062546
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5T-BU-1
AC CVCL_4080
DR ECACC; 08062570
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 108CC5T-BU-4
AC CVCL_4081
DR ECACC; 08062571
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4076 ! 108CC5
CA Hybrid cell line
//
ID 10B10
AC CVCL_6819
RX PubMed=12543551;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=10B10
CC Transfected with: UniProtKB; Q8MJS1; Pig IL12RB2.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID 10B9
AC CVCL_B379
DR CLO; CLO_0001031
DR ATCC; HB-172
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 10C4.1.3
AC CVCL_H997
DR CLO; CLO_0001032
DR ATCC; HB-11029
RX Patent=US5578704;
RX Patent=US5652110;
RX PubMed=7683273;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 10C7
AC CVCL_D146
DR CLO; CLO_0001033
DR ATCC; CRL-2430
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 10C9
AC CVCL_R704
DR ATCC; CRL-10236
RX Patent=US5108920;
CC Discontinued: ATCC; CRL-10236; probable.
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 10D2F6
AC CVCL_G563
DR CLO; CLO_0001034
DR ATCC; HB-11103
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 10E2
AC CVCL_Y303
RX PubMed=6248199;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y304 ! BLP
CA Spontaneously immortalized cell line
//
ID 10E5
AC CVCL_G016
DR CLO; CLO_0001035
DR ATCC; HB-8513
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 10F11.B2.C3
AC CVCL_IV59
DR ATCC; PTA-8333
RX Patent=US8022175;
CC Monoclonal antibody target: Newcastle disease viruses P protein.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 10F7MN
AC CVCL_G564
SY 10F7
DR CLO; CLO_0001036
DR ATCC; HB-8162
RX Patent=US4767710;
RX PubMed=6197636;
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (recognizes both M and N blood group antigens).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 10G4
AC CVCL_U285
RX Patent=US8841419;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201016.
CC Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Monoclonal antibody target: ChEBI; CHEBI:48209; Aflatoxin B2 (AFB2).
CC Monoclonal antibody target: ChEBI; CHEBI:80706; Aflatoxin G1 (AFG1).
CC Monoclonal antibody target: ChEBI; CHEBI:80705; Aflatoxin G2 (AFG2).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 10H
AC CVCL_N538
DR CLO; CLO_0050298
DR RCB; RCB0705
RX PubMed=6206890;
CC Monoclonal antibody target: ChEBI; CHEBI:61151; Poly-ADP-D-ribose (Poly(adenosine diphosphate ribose)).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 10H-2
AC CVCL_N539
DR CLO; CLO_0050283
DR RCB; RCB1142
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 10H2.12.1
AC CVCL_H998
SY 10H2
DR CLO; CLO_0001037
DR ATCC; HB-11494
RX Patent=US5440021;
CC Monoclonal antibody target: UniProtKB; P25025; Human CXCR2/IL8RB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 10P12
AC CVCL_6481
DR CLO; CLO_0001038
DR ATCC; CRL-2036
RX PubMed=2998805;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/cAn.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 10P2
AC CVCL_6482
DR CLO; CLO_0001039
DR ATCC; CRL-2034
DR BCRC; 60316
RX PubMed=2998805;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/cAn.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 10P8
AC CVCL_0E96
DR ATCC; CRL-2035
RX PubMed=2998805;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Discontinued: ATCC; CRL-2035; true.
CC Breed/subspecies: BALB/cAn.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 11-18
AC CVCL_A596
DR CGH-DB; 201-1
DR CGH-DB; 9163-4
DR Cosmic; 889084
DR Cosmic; 946048
DR Cosmic; 1066156
DR Cosmic; 1336877
DR Cosmic; 1656892
DR Cosmic; 1731372
RX PubMed=14581340;
RX PubMed=15746151;
RX PubMed=22313637;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 11-18-ER1-7
AC CVCL_D856
SY 11-18/ER1-7
DR Cosmic; 1731373
RX PubMed=22815900;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A596 ! 11-18
CA Cancer cell line
//
ID 11-18-ER2-1
AC CVCL_D857
SY 11-18/ER2-1
DR Cosmic; 1731374
RX PubMed=22815900;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A596 ! 11-18
CA Cancer cell line
//
ID 11-18-GEF10-1
AC CVCL_D776
SY 11-18/GEF10-1
DR Cosmic; 1731375
RX PubMed=22815900;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A596 ! 11-18
CA Cancer cell line
//
ID 11-18-GEF20-1
AC CVCL_D777
SY 11-18/GEF20-1
DR Cosmic; 1731376
RX PubMed=22815900;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A596 ! 11-18
CA Cancer cell line
//
ID 11-18/R
AC CVCL_S745
SY 11-18R; 11-18/ER
DR Cosmic; 1890459
RX PubMed=22773810;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A596 ! 11-18
CA Cancer cell line
//
ID 11-26c
AC CVCL_9138
DR CLO; CLO_0001043
DR ATCC; HB-250
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 11-4
AC CVCL_2819
DR ECACC; 11033102
CC Characteristics: Transfected with a firefly luciferase reporter gene under the control of the HSV-thymidine kinase promoter.
CC Characteristics: Used to evaluate the non-specific transcriptional activity of chemicals.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID 11-4.1
AC CVCL_G219
DR CLO; CLO_0001044
DR ATCC; TIB-95
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 11-5.2.1.9
AC CVCL_G189
DR CLO; CLO_0001045
DR ATCC; TIB-94
DR ECACC; 89050905
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 11-5F
AC CVCL_J078
DR ECACC; 91121236
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 11-9-1-4
AC CVCL_5948
SY 11.9.14; BT-549Gal3
DR BTO; BTO:0002603
RX PubMed=9561029;
RX PubMed=21552935;
CC Transfected with: HGNC; 6563; LGALS3.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1092 ! BT-549
SX Female
CA Cancer cell line
//
ID 11.9
AC CVCL_N790
DR ATCC; CRL-2705
CC Discontinued: ATCC; CRL-2705; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID 110-5
AC CVCL_J035
DR CLO; CLO_0001040
DR ATCC; HB-8984
RX Patent=US5180663;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1102-mel
AC CVCL_8030
SY 1102-MEL; 1102 mel; 1102mel; 1102; MEL1102
DR BTO; BTO:0002947
DR CGH-DB; 9293-4
DR Cosmic; 905207
DR Cosmic; 972280
DR GEO; GSM218054
RX PubMed=8081556;
RX PubMed=10048982;
RX PubMed=10754339;
RX PubMed=15467732;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 11028
AC CVCL_L307
RX PubMed=169374;
CC Breed/subspecies: Saint Bernard.
DI NCIt; C128195; Canine sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID 11031
AC CVCL_L308
RX PubMed=169374;
CC Breed/subspecies: Saint Bernard.
DI NCIt; C128195; Canine sarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID 1106-mel
AC CVCL_GR78
SY 1106mel; 1106MEL
DR TOKU-E; 4037
RX PubMed=8537970;
RX PubMed=15661905;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1107F-HA
AC CVCL_G344
DR TKG; TKG 0303
CC Monoclonal antibody target: Mycoplasma bovis (BCG).
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 111 BLCL
AC CVCL_E341
DR ECACC; 94031620
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 1116NS-19-9
AC CVCL_G218
SY 1116-NS-19-9
DR CLO; CLO_0001041
DR ATCC; HB-8059
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 1116NS-3d
AC CVCL_7233
DR CLO; CLO_0001042
DR ATCC; CRL-8019
DR CCRID; 3131C0001000600012
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 111A3
AC CVCL_J079
DR ECACC; 85062504
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J061 ! 53B3
CA Hybrid cell line
//
ID 1123-mel
AC CVCL_S406
SY 1123-MEL; 1123
RX PubMed=10048982;
RX PubMed=10754339;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1125
AC CVCL_E425
DR dbMHC; 48443
DR IHW; IHW9313
DR IMGT/HLA; 10032
WW http://bioinformatics.hsanmartino.it/ecbr/cl313.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 1127
AC CVCL_E426
SY FUEA
DR dbMHC; 48444
DR ECACC; 94071413
DR IHW; IHW9342
DR IMGT/HLA; 10033
WW http://bioinformatics.hsanmartino.it/ecbr/cl342.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 113F1
AC CVCL_J910
DR ATCC; HB-8490
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 114-50D4
AC CVCL_J548
DR ATCC; HB-8925
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8925; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 114-50G2
AC CVCL_J549
DR ATCC; HB-8926
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8926; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1143-mel
AC CVCL_8031
SY 1143-MEL; 1143 mel; 1143
DR Cosmic; 876688
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1156QE/8
AC CVCL_2262
SY 1156QE; 11156-Q-E; 1156Q
DR ECACC; 06072609
RX PubMed=6169654;
RX PubMed=6244232;
RX PubMed=7471097;
RX PubMed=14762065;
CC Omics: CNV analysis.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 11,14
ST D5S818: 11,12
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 116
AC CVCL_G220
SY Anti PDGF hybridoma #116
DR CLO; CLO_0001046
DR ATCC; HB-9367
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 116-13.1
AC CVCL_G221
DR CLO; CLO_0001047
DR ATCC; HB-129
CC Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 117-13
AC CVCL_T730
SY AD117m
DR CLO; CLO_0050316
DR RCB; RCB0998
RX DOI=10.1267/ahc.26.515;
CC Monoclonal antibody target: ChEBI; CHEBI:17292; Lactotetraosylceramide.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 117.1
AC CVCL_0H96
DR ATCC; PTA-4567
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1174
AC CVCL_DI59
DR GEO; GSM560316
RX PubMed=21168406;
CC Group: Cancer stem cell line.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1174-mel
AC CVCL_GR79
SY 1174mel; 1174MEL
DR TOKU-E; 4038
RX PubMed=8537970;
RX PubMed=15661905;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1180
AC CVCL_E427
SY HOEA
DR dbMHC; 48445
DR IHW; IHW9343
DR IMGT/HLA; 10034
WW http://bioinformatics.hsanmartino.it/ecbr/cl343.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 1180-mel
AC CVCL_GR80
SY 1180mel; 1180MEL
DR TOKU-E; 4039
RX PubMed=8537970;
RX PubMed=15661905;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 1181
AC CVCL_E428
SY HOVI
DR dbMHC; 48446
DR ECACC; 94071414
DR IHW; IHW9345
DR IMGT/HLA; 10035
WW http://bioinformatics.hsanmartino.it/ecbr/cl345.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 1181N1
AC CVCL_D317
SY 118MG-1181N1
RX PubMed=4337530;
CC Problematic cell line: Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0633 ! U-118MG
SX Male
CA Cancer cell line
//
ID 1182-1
AC CVCL_Z895
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=2515901;
RX PubMed=6421610;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 1182-4H
AC CVCL_Z708
SY 1182-4; 1182-4D
DR EFO; EFO_0005648
DR DGRC; 177
DR ENCODE; ENCBS601OHH
DR GEO; GSM409470
DR GEO; GSM409471
DR GEO; GSM409472
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=98714;
RX PubMed=2515901;
RX PubMed=3084259;
RX PubMed=6421610;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 1182-5
AC CVCL_Z896
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=2515901;
RX PubMed=6421610;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 1182-6
AC CVCL_Z897
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=2515901;
RX PubMed=6421610;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 1182-7b
AC CVCL_Z898
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=2515901;
RX PubMed=6421610;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 1182-mel
AC CVCL_8032
SY 1182-MEL; 1182 mel; 1182
DR BTO; BTO:0002964
DR GEO; GSM218058
DR GEO; GSM1092562
RX PubMed=10048982;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1183
AC CVCL_E429
SY HODO
DR dbMHC; 48447
DR IHW; IHW9344
DR IMGT/HLA; 10036
WW http://bioinformatics.hsanmartino.it/ecbr/cl344.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 1184
AC CVCL_2263
DR CLO; CLO_0001048
DR CLDB; cl2
DR ECACC; 90011883
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E260 ! MRC-5 CV1
SX Male
CA Transformed cell line
//
ID 1195-mel
AC CVCL_8033
SY 1195-MEL; 1195 mel; 1195
DR Cosmic; 876689
DR GEO; GSM218057
RX PubMed=8027550;
RX PubMed=10048982;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1199-mel
AC CVCL_8034
SY 1199-MEL; 1199 mel; 1199
DR Cosmic; 876690
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 11a
AC CVCL_8987
SY iPS-11a; hiPS-11a; IPS cell line 11a; iPS11a
DR EFO; EFO_0007099
DR ENCODE; ENCBS549SAW
DR ENCODE; ENCBS620GSG
DR GEO; GSM537693
DR GEO; GSM537694
DR GEO; GSM621719
DR ISCR; 1621
RX PubMed=21293464;
RX PubMed=21368825;
CC From: Harvard University; Boston; USA.
CC Omics: Deep exome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8988 ! 11b
OI CVCL_8989 ! 11c
SX Male
CA Induced pluripotent stem cell
//
ID 11B
AC CVCL_S151
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 11b
AC CVCL_8988
SY iPS-11b; hiPS-11b; iPS11b
DR EFO; EFO_0007100
DR ENCODE; ENCBS473MEX
DR GEO; GSM621715
DR ISCR; 1622
RX PubMed=21293464;
RX PubMed=21368825;
WW http://harvard.eagle-i.net/i/00000144-087d-f216-0803-96bd80000000
CC From: Harvard University; Boston; USA.
CC Omics: Deep exome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8987 ! 11a
OI CVCL_8989 ! 11c
SX Male
CA Induced pluripotent stem cell
//
ID 11B11
AC CVCL_9139
SY 11 B 11; BSF-1
DR CLO; CLO_0001049
DR ATCC; HB-188
DR BCRJ; 0001
RX PubMed=2582266;
CC Monoclonal antibody target: UniProtKB; P07750; Mouse Il4.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 11B7501
AC CVCL_0E75
DR ATCC; CRL-1940
RX PubMed=20116412;
CC Discontinued: ATCC; CRL-1940; true.
OX NCBI_TaxID=9720; ! Phoca vitulina
SX Male
CA Cancer cell line
//
ID 11c
AC CVCL_8989
SY iPS-11c; hiPS-11c
DR EFO; EFO_0007101
DR ENCODE; ENCBS312LLV
DR GEO; GSM670073
DR ISCR; 1623
RX PubMed=21293464;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8987 ! 11a
OI CVCL_8988 ! 11b
SX Male
CA Induced pluripotent stem cell
//
ID 11E10
AC CVCL_E958
DR CLO; CLO_0001050
DR ATCC; CRL-1907
RX PubMed=3053764;
CC Monoclonal antibody target: UniProtKB; P09385; Bacteriophage 933W Shiga-like toxin 2 subunit A (stxA2).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 11F11
AC CVCL_E959
DR CLO; CLO_0001051
DR ATCC; CRL-1908
RX PubMed=3053764;
CC Monoclonal antibody target: UniProtKB; P09385; Bacteriophage 933W Shiga-like toxin 2 subunit A (stxA2).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 11H4.4
AC CVCL_N022
DR ATCC; PTA-7315
RX Patent=US7737259;
CC Monoclonal antibody target: UniProtKB; Q9GZX6; Human IL22.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 11P0-1
AC CVCL_6551
DR CLO; CLO_0001052
DR ATCC; CRL-2037
RX PubMed=2998805;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/cAn.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 11Z
AC CVCL_0Q72
RX PubMed=11696444;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3014; Endometriosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 12-1B6
AC CVCL_J713
DR CLO; CLO_0050363
DR RCB; RCB0870
CC Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 12-2-2S (clone 5F11)
AC CVCL_G565
DR CLO; CLO_0001058
DR ATCC; HB-50
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 12-A-3
AC CVCL_6760
DR CLO; CLO_0001064
DR ATCC; CRL-6476
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6476; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Transformed cell line
//
ID 12.1
AC CVCL_G222
DR CLO; CLO_0001053
DR ATCC; HB-228
RX PubMed=6790625;
CC Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 12/44
AC CVCL_G753
DR CLO; CLO_0001054
DR ATCC; HB-9070
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 12/49
AC CVCL_G762
DR CLO; CLO_0001055
DR ATCC; HB-9071
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1205Lu
AC CVCL_5239
SY 1205-Lu; 1205 Lu; WM 1205LU; WM-1205LU; WM1205Lu; WM1205; LU1205; Lu1205; WC00058
DR BTO; BTO:0005011
DR CLO; CLO_0001056
DR EFO; EFO_0002810
DR ATCC; CRL-2812
DR BioSample; SAMN03471797
DR Coriell; WC00058
DR Cosmic; 686410
DR Cosmic; 905861
DR Cosmic; 972275
DR Cosmic; 1155274
DR Cosmic; 1155554
DR Cosmic; 1187583
DR Cosmic; 1303026
DR Cosmic; 1507616
DR ESTDAB; ESTDAB-067
DR GEO; GSM188067
DR GEO; GSM188119
DR GEO; GSM188192
DR GEO; GSM188207
DR GEO; GSM188218
DR GEO; GSM188283
DR GEO; GSM188292
DR GEO; GSM952578
DR Lonza; 900
DR PRIDE; PXD004343
DR SKY/M-FISH/CGH; 4946
RX DOI=10.4172/1948-5956.1000196;
RX DOI=10.4172/1948-5956.1000401;
RX PubMed=2068080;
RX PubMed=8342600;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=51603
CC Problematic cell line: Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which is now distributed by Rockland (DOI=10.4172/1948-5956.1000401).
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2812; true.
CC Discontinued: Coriell; WC00058; probable.
CC Derived from metastatic site: Lung.
ST Source(s): ATCC; ESTDAB; Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,14
ST D16S539: 12 (ATCC)
ST D16S539: 11,12 (Wistar)
ST D18S51: 14,15
ST D19S433: 13,15
ST D21S11: 28,29
ST D2S1338: 17,24
ST D3S1358: 14,16
ST D5S818: 10,12
ST D7S820: 10,12
ST D8S1179: 11,12,14
ST FGA: 20,21
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 17 (ATCC; ESTDAB)
ST vWA: 16,17 (Wistar)
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8787 ! WM793
SX Male
CA Cancer cell line
//
ID 121-15B10
AC CVCL_J550
DR ATCC; HB-8954
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8954; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-19B10
AC CVCL_E960
DR CLO; CLO_0001057
DR ATCC; CRL-2652
DR ATCC; HB-8955
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8955; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-1F9
AC CVCL_J551
DR ATCC; HB-8948
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8948; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-3H5
AC CVCL_J552
DR ATCC; HB-8949
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8949; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-4F8
AC CVCL_J553
DR ATCC; HB-8950
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8950; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-5E5
AC CVCL_J554
DR ATCC; HB-8951
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8951; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-8D8
AC CVCL_J555
DR ATCC; HB-8956
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8956; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-9E5
AC CVCL_J556
DR ATCC; HB-8953
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8953; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 121-9G10
AC CVCL_J557
DR ATCC; HB-8952
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8952; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1218E
AC CVCL_C524
SY HT-D
RX PubMed=6169654;
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1221
AC CVCL_2264
DR CLO; CLO_0001009
DR CLDB; cl3
DR ECACC; 90011873
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 1228
AC CVCL_IP60
SY 1228-GSC; GSC-1228
DR BTO; BTO:0006004
RX PubMed=23307328;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 123-10
AC CVCL_E961
DR CLO; CLO_0001059
DR ATCC; CRL-1707
RX PubMed=6090455;
CC Monoclonal antibody target: UniProtKB; P10443; Escherichia coli polC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 123-28
AC CVCL_E962
DR CLO; CLO_0001060
DR ATCC; CRL-1713
CC Monoclonal antibody target: UniProtKB; P06710; Escherichia coli dnaX.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 123.7
AC CVCL_0109
DR MCCL; MCC:0000000
RX PubMed=1645738;
RX PubMed=1651325;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID 1242B
AC CVCL_C525
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1246
AC CVCL_S884
RX DOI=10.1007/978-3-642-69290-1_52;
CC Characteristics: Insulin dependent.
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 1246-3A
AC CVCL_S885
RX DOI=10.1007/978-3-642-69290-1_52;
RX PubMed=2663884;
RX PubMed=3045808;
CC Characteristics: Has lost the insulin dependence of the parent cell line.
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S884 ! 1246
CA Cancer cell line
//
ID 1249
AC CVCL_E430
SY DHOL
DR dbMHC; 48448
DR IHW; IHW9339
DR IMGT/HLA; 10046
WW http://bioinformatics.hsanmartino.it/ecbr/cl339.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 1255-B7
AC CVCL_U954
SY 1255/B7
DR ATCC; CRL-6604
RX PubMed=4330168;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC Discontinued: ATCC; CRL-6604; true.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID 1255O
AC CVCL_C526
SY 1255-O
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1259-mel
AC CVCL_GR81
SY 1259mel; 1259MEL
DR TOKU-E; 4040
RX PubMed=8537970;
RX PubMed=15661905;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 126 BLCL
AC CVCL_E342
DR ECACC; 94031621
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 126-6
AC CVCL_9V02
DR ATCC; CRL-10037
RX Patent=US5731189;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-10037; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 127 BLCL
AC CVCL_E343
DR ECACC; 94031622
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 127-24C7
AC CVCL_J558
DR ATCC; HB-8965
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8965; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 127-24E11
AC CVCL_J559
DR ATCC; HB-8966
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8966; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 127-38G2
AC CVCL_J560
DR ATCC; HB-8967
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8967; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 127-42C11
AC CVCL_J561
SY 127-42C11.SCRF35.4; SCRF 35.4
DR ATCC; HB-9561
RX Patent=US5015571;
RX Patent=US5733738;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 127-50D12
AC CVCL_J562
DR ATCC; HB-8969
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8969; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 127-50D4
AC CVCL_J563
DR ATCC; HB-8968
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8968; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 127-53F8
AC CVCL_J564
DR ATCC; HB-8970
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8970; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 127-60F3
AC CVCL_J565
DR ATCC; HB-8971
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8971; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1273/99
AC CVCL_N588
SY 1273
DR Cosmic; 2307723
RX PubMed=12097301;
RX PubMed=24726063;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1278-mel
AC CVCL_8035
SY 1278-MEL; 1278 mel; 1278
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 127A
AC CVCL_J037
DR ATCC; HB-11905
RX Patent=US5773293;
CC Monoclonal antibody target: UniProtKB; D3ZP29; Rat Icam4/Cd242.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 127H
AC CVCL_J036
DR CLO; CLO_0001061
DR ATCC; HB-11911
RX Patent=US5773293;
CC Monoclonal antibody target: UniProtKB; D3ZP29; Rat Icam4/Cd242.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 127TAg
AC CVCL_6759
DR CLO; CLO_0001062
DR ATCC; CRL-2817
RX PubMed=12882965;
CC Knockout cell: Method=KO mouse; MGI; MGI:104288; Pms2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 128-2
AC CVCL_J861
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1280-mel
AC CVCL_8036
SY 1280-MEL; 1280 mel; 1280
DR Cosmic; 876691
RX PubMed=10048982;
RX PubMed=10754339;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1283.Lu
AC CVCL_S461
DR ATCC; CRL-6297
CC Group: Non-human primate cell line.
CC Discontinued: ATCC; CRL-6297; probable.
OX NCBI_TaxID=9489; ! Saguinus nigricollis
SX Sex undetermined
CA Finite cell line
//
ID 1286-mel
AC CVCL_8037
SY 1286-MEL; 1286 mel; 1286
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1287-mel
AC CVCL_8038
SY 1287-MEL; 1287 mel; 1287
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 129 BLCL
AC CVCL_E344
DR ECACC; 94031623
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 129 Nu 5002-1 Tu
AC CVCL_4807
RX PubMed=9044828;
WW http://capcelllines.ca/details.asp?id=105
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4844 ! HPV-18-C1
SX Male
CA Transformed cell line
//
ID 129 Nu 5010-5 Tu
AC CVCL_4808
RX PubMed=9044828;
WW http://capcelllines.ca/details.asp?id=108
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4844 ! HPV-18-C1
SX Male
CA Transformed cell line
//
ID 129-CUMC/UF
AC CVCL_IJ17
RX PubMed=27789403;
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 1290-mel
AC CVCL_7943
SY 1290-MEL; 1290 mel; 1290; MG-1290; 1290-MEL p14; 1290p14
DR Cosmic; 876682
DR Cosmic; 877280
DR Cosmic; 1042622
DR GEO; GSM218047
DR GEO; GSM218048
DR GEO; GSM1092557
RX PubMed=16470173;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Uterus.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4632 ! 888-mel
OI CVCL_DI11 ! 1858-mel a
OI CVCL_DI12 ! 1858-mel b
OI CVCL_DI13 ! 1858-mel c
OI CVCL_DI14 ! 1936-mel
OI CVCL_DI15 ! 1962-mel
SX Female
CA Cancer cell line
//
ID 129A3/1
AC CVCL_J039
DR CLO; CLO_0001063
DR ATCC; HB-8087
DR IZSLER; BS Hy 33
RX Patent=US4416866;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 129fc-1
AC CVCL_F044
DR RCB; AES0043
DR RCB; RCB2192
CC Discontinued: RCB; RCB2192; true.
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID 129fc-2
AC CVCL_F045
DR RCB; AES0044
DR RCB; RCB2193
CC Discontinued: RCB; RCB2193; true.
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID 12A5B7
AC CVCL_G566
DR CLO; CLO_0001065
DR ATCC; HB-8328
RX Patent=US4595654;
CC Monoclonal antibody target: UniProtKB; P02745; Human C1QA.
CC Monoclonal antibody target: UniProtKB; P02746; Human C1QB.
CC Monoclonal antibody target: UniProtKB; P02747; Human C1QC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 12CFBE22o-
AC CVCL_IN59
RX PubMed=1375758;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 12D7
AC CVCL_W647
DR NIH-ARP; 11411-223
RX PubMed=10698967;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6244 ! A3.01
SX Female
CA Cancer cell line
//
ID 12MBr6
AC CVCL_6342
DR CLO; CLO_0001066
DR ATCC; CRL-1576
DR IZSLER; BS CL 216
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Male
CA Finite cell line
//
ID 12S
AC CVCL_0F17
SY Clone 12S
RX PubMed=2843357;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 12Z
AC CVCL_0Q73
SY 12z; 12-Z; Z12; Z-12
DR BTO; BTO:0005656
DR Cosmic; 1432838
RX PubMed=11696444;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3014; Endometriosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 13-5-9-6-2
AC CVCL_J044
DR CLO; CLO_0001075
DR ATCC; HB-8934
DR IZSLER; BS Hy 57
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 13-9B
AC CVCL_C527
RX PubMed=12485491;
CC Omics: Transcriptome analysis.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6946 ! SUNE1
CA Cancer cell line
//
ID 13.90.2
AC CVCL_J045
SY 13.90
DR CLO; CLO_0001067
DR ATCC; HB-8337
RX Patent=US4650676;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 130 BLCL
AC CVCL_E345
DR ECACC; 94031624
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 130-3-F7-5
AC CVCL_J042
SY CO-301; CO301
DR CLO; CLO_0001068
DR ATCC; HB-8326
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 130-80-2
AC CVCL_6F35
RX PubMed=2307702;
WW http://dshb.biology.uiowa.edu/crystal-protein
CC Monoclonal antibody target: UniProtKB; P21837; Dictyostelium discoideum cryS.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID 1300-mel
AC CVCL_8039
SY 1300-MEL; 1300 mel; 1300
DR Cosmic; 876703
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1301
AC CVCL_2265
DR CLO; CLO_0001010
DR CLDB; cl5401
DR CCRID; 3131C0001001100004
DR Cosmic; 2402466
DR ECACC; 01051619
DR ICLC; HTL01004
DR NCBI_Iran; C512
RX PubMed=223921;
RX PubMed=9685479;
CC Characteristics: Has unusually long telomeres.
ST Source(s): ICLC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 9
ST D16S539: 10,13
ST D21S11: 30,32.2,33.2
ST D5S818: 12,14,15
ST D7S820: 10
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID 1301-U1
AC CVCL_IS05
RX PubMed=9685479;
CC Characteristics: Has unusually long telomeres.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2265 ! 1301
SX Female
CA Cancer cell line
//
ID 1301-U2
AC CVCL_IS06
RX PubMed=9685479;
CC Characteristics: Has unusually long telomeres.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2265 ! 1301
SX Female
CA Cancer cell line
//
ID 1306
AC CVCL_2266
DR CLO; CLO_0001011
DR CLDB; cl4
DR ECACC; 90011887
RX PubMed=3110595;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7297 ! GM00637
SX Female
CA Transformed cell line
//
ID 1308.1
AC CVCL_L903
RX PubMed=8500519;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 130C3/2B/8
AC CVCL_J040
DR CLO; CLO_0001069
DR ATCC; HB-8088
DR IZSLER; BS Hy 58
RX Patent=US4416866;
CC Discontinued: IZSLER; BS Hy 58; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 131 BLCL
AC CVCL_E346
DR ECACC; 94031625
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 131-94H4
AC CVCL_E963
DR CLO; CLO_0001070
DR ATCC; CRL-2739
DR ATCC; HB-9003
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9003; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 131.2F8.5.9
AC CVCL_J991
SY 5.9; CHIR-5.9
DR ATCC; PTA-5542
RX Patent=US20070098718;
RX Patent=US20070218060;
RX Patent=US8333970;
CC Monoclonal antibody target: UniProtKB; P25942; Human CD40.
CC Discontinued: ATCC; PTA-5542; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1317-mel
AC CVCL_8040
SY 1317-MEL; 1317 mel; 1317
DR Cosmic; 876692
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 132-1C8
AC CVCL_E964
DR CLO; CLO_0001071
DR ATCC; CRL-2737
DR ATCC; HB-8927
RX Patent=US5015571;
RX Patent=US5733738;
CC Monoclonal antibody target: UniProtKB; P10242; Human MYB.
CC Discontinued: ATCC; HB-8927; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 132-7C9
AC CVCL_J566
DR ATCC; HB-8924
RX Patent=US5015571;
RX Patent=US5733738;
CC Monoclonal antibody target: UniProtKB; P10242; Human MYB.
CC Discontinued: ATCC; HB-8924; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1321N1
AC CVCL_0110
SY 1321-N1; 1321 N1
DR BTO; BTO:0003605
DR CLO; CLO_0001072
DR MCCL; MCC:0000001
DR CLDB; cl5
DR BioSample; SAMN03471026
DR CCLE; 1321N1_CENTRAL_NERVOUS_SYSTEM
DR ECACC; 86030402
DR GEO; GSM827421
DR GEO; GSM886835
DR GEO; GSM887898
DR GEO; GSM1374373
DR IZSLER; BS TCL 109
DR Lonza; 642
DR NCBI_Iran; C118
RX PubMed=17254797;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; PubMed=17254797; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12 (ECACC; PubMed=25877200)
ST CSF1PO: 11 (PubMed=17254797)
ST D13S317: 9,11
ST D16S539: 12,13
ST D18S51: 13,14
ST D19S433: 13
ST D21S11: 27 (PubMed=17254797)
ST D21S11: 27,32.2 (PubMed=25877200)
ST D2S1338: 23,25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 14,15
ST FGA: 18,23,24
ST Penta D: 10,13
ST Penta E: 7
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D317 ! 1181N1
SX Male
CA Cancer cell line
//
ID 1321N1 (+Galpha16) AequoScreen
AC CVCL_5I82
WW http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A28
CC Transfected with: UniProtKB; P07164; Aequorin.
CC Transfected with: HGNC; 4383; GNA15.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 1321N1 AequoScreen
AC CVCL_5I83
WW http://www.perkinelmer.com/Catalog/Product/ID/ES-000-A27
CC Transfected with: UniProtKB; P07164; Aequorin.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 1321N1/P2Y1
AC CVCL_H355
WW http://www.genscript.com/molecule/M00250-P2Y1.html
CC Transfected with: HGNC; 8539; P2YR1.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 1321N1/P2Y11
AC CVCL_H356
WW http://www.genscript.com/molecule/M00298-P2Y11.html
CC Transfected with: HGNC; 8540; P2RY11.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 1321N1/P2Y12/Galpha15
AC CVCL_H357
WW http://www.genscript.com/molecule/M00261-P2Y12.html
CC Transfected with: HGNC; 18124; P2RY12.
CC Transfected with: HGNC; 4383; GNA15.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 1321N1/P2Y2
AC CVCL_H358
WW http://www.genscript.com/molecule/M00318-P2Y2.html
CC Transfected with: HGNC; 8541; P2RY2.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 1321N1/P2Y4
AC CVCL_H359
WW http://www.genscript.com/molecule/M00297-P2Y4.html
CC Transfected with: HGNC; 8542; P2RY4.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 1321N1/P2Y6
AC CVCL_H360
WW http://www.genscript.com/molecule/M00346-P2Y6.html
CC Transfected with: HGNC; 8543; P2RY6.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0110 ! 1321N1
SX Male
CA Cancer cell line
//
ID 132C4A/4
AC CVCL_J041
DR CLO; CLO_0001073
DR ATCC; HB-8086
RX Patent=US4416866;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 133
AC CVCL_J918
SY Anti PDGF hybridoma #133
DR ATCC; HB-9357
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 133 BLCL
AC CVCL_E347
DR ECACC; 94031626
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 133-10F6
AC CVCL_E965
DR CLO; CLO_0001074
DR ATCC; CRL-2738
DR ATCC; HB-9077
RX Patent=US5015571;
RX Patent=US5733738;
CC Monoclonal antibody target: UniProtKB; P10242; Human MYB.
CC Discontinued: ATCC; HB-9077; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 133-1E10
AC CVCL_J567
DR ATCC; HB-8888
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8888; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 133-6C10
AC CVCL_J568
DR ATCC; HB-8897
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8897; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1335-mel
AC CVCL_Z019
SY 1335-MEL
DR Cosmic; 876693
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 133B
AC CVCL_J917
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1352-mel
AC CVCL_Z020
SY 1352-MEL
DR Cosmic; 876694
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1359-mel
AC CVCL_8041
SY 1359-MEL; 1359 mel; 1359; Mel-1359
DR Cosmic; 2163791
DR ESTDAB; ESTDAB-047
RX PubMed=10048982;
RX PubMed=10754339;
CC Derived from metastatic site: Not specified.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,14
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 8
ST FGA: 20
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 136-2
AC CVCL_W281
DR Cosmic; 1418452
RX PubMed=3402430;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1362-mel
AC CVCL_S560
SY 1362-MEL; 1362 mel; 1362mel
DR CGH-DB; 9294-4
DR Cosmic; 905208
RX PubMed=10048982;
RX PubMed=15467732;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1363-mel
AC CVCL_8042
SY 1363-MEL; 1363 mel; 1363
DR Cosmic; 876704
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1375-4f1
AC CVCL_DP69
DR GEO; GSM1040262
DR GEO; GSM1040332
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 1376-mel
AC CVCL_8043
SY 1376-MEL; 1376 mel; 1376
DR Cosmic; 876695
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 13762 MAT B III
AC CVCL_3475
SY 13762 Mat B III; 13762-MAT-B-III; MAT 13762; 13762; MatB 13762; Mat B-III; Mat B III ; MatB
DR CLO; CLO_0001076
DR ATCC; CRL-1666
DR BCRC; 60520
DR ChEMBL-Cells; CHEMBL3308080
DR ChEMBL-Targets; CHEMBL613867
DR IZSLER; BS TCL 168
RX PubMed=1997182;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-392.html
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Derived from metastatic site: Ascites.
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID 1377-4f1
AC CVCL_DP70
DR GEO; GSM1040263
DR GEO; GSM1040333
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 1383-mel
AC CVCL_8044
SY 1383-MEL; 1383 mel; 1383
DR BTO; BTO:0002948
DR Cosmic; 876696
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1388-mel
AC CVCL_8045
SY 1388-MEL; 1388 mel; 1388
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 138D
AC CVCL_5446
DR ECACC; 93090808
RX PubMed=8795574;
CC Discontinued: ECACC; 93090808; probable.
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 139-CUMC/UF
AC CVCL_IJ18
RX PubMed=27789403;
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 1390-mel
AC CVCL_8046
SY 1390-MEL; 1390 mel; 1390
DR Cosmic; 876697
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1392-4f2
AC CVCL_DP71
DR GEO; GSM1040264
DR GEO; GSM1040334
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 139A
AC CVCL_J802
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 13C1
AC CVCL_L104
DR ATCC; CRL-8796
RX Patent=US4834975;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 13C4
AC CVCL_4466
DR CLO; CLO_0001077
DR CLDB; cl5137
DR ATCC; CRL-1794
DR ECACC; 95032701
DR IZSLER; BS Hy 42
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 13CB-1
AC CVCL_9Q47
RX PubMed=186420;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
OX NCBI_TaxID=9557; ! Papio hamadryas
OI CVCL_9Q48 ! 8CB-1
OI CVCL_4087 ! 26CB-1
SX Male
CA Transformed cell line
//
ID 13D10
AC CVCL_T729
DR CLO; CLO_0050350
DR RCB; RCB1923
RX DOI=10.1508/cytologia.68.271;
CC Monoclonal antibody target: Lygodium japonicum strain an-1 basal apparatus.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 13F7.B6.A7
AC CVCL_IV60
DR ATCC; PTA-8331
RX Patent=US8022175;
CC Monoclonal antibody target: Newcastle disease viruses HN protein.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 13W09502
AC CVCL_6G63
SY TER226; TER303
DR IMGT/HLA; 12644
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 14-4-4S
AC CVCL_G569
DR CLO; CLO_0001090
DR ATCC; HB-32
DR IZSLER; BS Hy 59
DR NCBI_Iran; H137
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 14.012.8.1
AC CVCL_F251
DR CLO; CLO_0001078
DR CLDB; cl8
RX PubMed=208448;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/a14-012.htm
CC Transformant: NCBI_TaxID; 10298; Human herpesvirus 1 (HSV-1).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Transformed cell line
//
ID 14.8
AC CVCL_9140
DR CLO; CLO_0001079
DR ATCC; TIB-164
RX PubMed=6975314;
CC Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 141-LCL
AC CVCL_6752
DR CLO; CLO_0051013
DR BioSample; SAMN03472056
DR RCB; RCB2083
DR TKG; TKG 0611
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 11
ST D5S818: 10,13
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,13
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 141-LCL-MUC1
AC CVCL_8071
DR CLO; CLO_0051014
DR RCB; RCB2541
DR TKG; TKG 0499
DR TKG; TKG 0634
CC Transfected with: HGNC; 7508; MUC1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: TKG; TKG 0499; probable.
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 11
ST D5S818: 10,13
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,13
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6752 ! 141-LCL
CA Transformed cell line
//
ID 1410 KG7
AC CVCL_G567
DR CLO; CLO_0001080
DR ATCC; HB-43
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1411H
AC CVCL_2268
SY 1411HP
DR Cosmic; 2077184
DR Cosmic; 2439937
DR ECACC; 06011805
RX PubMed=2581684;
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L942 ! 1411HRQmet
SX Male
CA Cancer cell line
//
ID 1411HRQmet
AC CVCL_L942
RX PubMed=2581684;
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2268 ! 1411H
SX Male
CA Cancer cell line
//
ID 141PF11
AC CVCL_G568
DR CLO; CLO_0001081
DR ATCC; HB-45
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 142-24E5
AC CVCL_E966
SY 1/24-24E05; 1/24E05; 142-24E05; SCRF 35.1
DR CLO; CLO_0001082
DR ATCC; CRL-2649
DR ATCC; HB-8679
RX Patent=US5015571;
RX Patent=US5733738;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 142BR
AC CVCL_2269
DR CLO; CLO_0001083
DR CLDB; cl9
DR ECACC; 90011806
RX PubMed=1672363;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 143-2-A6-11
AC CVCL_J043
SY CO-431; CO431
DR CLO; CLO_0001086
DR ATCC; HB-8325
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 143-4-2
AC CVCL_E967
DR CLO; CLO_0001087
DR ATCC; CRL-1970
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 143.98.2
AC CVCL_3476
DR CLO; CLO_0001085
DR ATCC; CRL-11226
RX Patent=US5543297;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2270 ! 143B
SX Female
CA Cancer cell line
//
ID 143B
AC CVCL_2270
SY 143b; 143 B; 143B TK-; 143BTK-; 143TK-; HOS-143B; HOS-143b; GM05887
DR BTO; BTO:0003167
DR CLO; CLO_0001084
DR CLO; CLO_0001088
DR CLO; CLO_0024221
DR EFO; EFO_0006355
DR CLDB; cl10
DR CLDB; cl11
DR ATCC; CRL-8303
DR BCRC; 60439
DR BioSample; SAMN03471904
DR CCLE; 143B_BONE
DR CCRID; 3111C0001CCC000363
DR CCRID; 3142C0001000000075
DR ChEMBL-Cells; CHEMBL3307382
DR ChEMBL-Targets; CHEMBL614508
DR Coriell; GM05887
DR Cosmic; 1074398
DR Cosmic; 1529910
DR Cosmic; 2009541
DR ECACC; 91112502
DR GEO; GSM320829
DR GEO; GSM879206
DR GEO; GSM886836
DR GEO; GSM887899
DR IZSLER; BS TCL 77
DR Lonza; 136
DR TOKU-E; 132
RX PubMed=19787792;
RX PubMed=21519327;
RX PubMed=22460905;
RX PubMed=25485619;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/1/cell-lines-detail-310.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: Could be identical to HTK- (CVCL_2522).
CC Misspelling: 'I43B' in Cosmic 1529910.
ST Source(s): ATCC; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D18S51: 17
ST D21S11: 31.2,32.2
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 11,12
ST D8S1179: 11,14
ST FGA: 24
ST Penta D: 9,10
ST Penta E: 7,12
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0312 ! HOS
SX Female
CA Cancer cell line
//
ID 143B pML BK TK
AC CVCL_3477
SY 143B PML BK TK
DR CLO; CLO_0001089
DR ATCC; CRL-8304
RX Patent=US4562155;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2270 ! 143B
SX Female
CA Cancer cell line
//
ID 143BTK-
AC CVCL_9W36
SY 143B/TK^(-)neo^(R)
DR CLO; CLO_0050098
DR RCB; RCB0701
RX PubMed=3413074;
CC Transfected with: UniProtKB; P01117; Kirsten murine sarcoma virus Ki-Ras.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2270 ! 143B
SX Female
CA Cancer cell line
//
ID 143B.206
AC CVCL_U923
SY 143B206; 143-B306; 143B/206; 143B.206 rho0; 143B-206rho0; 143B/206 rho0; 143B206 rho(0); 143B206 rho-zero; 206rho0
RX PubMed=2814477;
CC Characteristics: Cell line devoid of mitochondrial DNA (rho0).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2270 ! 143B
SX Female
CA Cancer cell line
//
ID 144BR
AC CVCL_8779
RX PubMed=1672363;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2551 ! LB173
SX Male
CA Finite cell line
//
ID 145 BLCL
AC CVCL_E348
DR ECACC; 94031627
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 145-2C11
AC CVCL_7234
SY 2C11
DR CLO; CLO_0001091
DR ATCC; CRL-1975
DR BCRJ; 0002
DR CCRID; 3111C0001CCC000211
DR KCLB; 21975
RX PubMed=2950524;
CC Monoclonal antibody target: UniProtKB; P22646; Mouse Cd3e.
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 146-03E04
AC CVCL_E968
SY 146-3E4
DR CLO; CLO_0001092
DR ATCC; CRL-2650
DR ATCC; HB-8997
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8997; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 146-17A3
AC CVCL_J569
DR ATCC; HB-8998
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8998; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 146-8D11
AC CVCL_J570
DR ATCC; HB-8999
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8999; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 147 BLCL
AC CVCL_E349
DR ECACC; 94031688
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 147-67C6
AC CVCL_E969
DR CLO; CLO_0001093
DR ATCC; CRL-2654
DR ATCC; HB-9278
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9278; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1479-mel
AC CVCL_8047
SY 1479-MEL; 1479 mel; 1479; Mel-1479
DR Cosmic; 2163792
DR ESTDAB; ESTDAB-048
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 10,13
ST FGA: 21
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 147A
AC CVCL_J803
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 148 BLCL
AC CVCL_E350
DR ECACC; 94031628
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1488-4f1
AC CVCL_DP72
SY 1488-4F1
DR GEO; GSM1040265
DR GEO; GSM1040335
DR GEO; GSM1899763
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 149 BLCL
AC CVCL_E351
DR ECACC; 94031629
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1495-mel
AC CVCL_8048
SY 1495-MEL; 1495 mel; 1495
RX PubMed=10048982;
RX PubMed=10754339;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 149BR
AC CVCL_2271
DR CLO; CLO_0001094
DR CLDB; cl12
DR ECACC; 90011807
RX PubMed=1672363;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2552 ! LB182
SX Male
CA Finite cell line
//
ID 14C2
AC CVCL_J021
DR ATCC; HB-8515
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 14E5
AC CVCL_J046
DR CLO; CLO_0001095
DR ATCC; HB-174
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 14F
AC CVCL_B380
RX PubMed=2981238;
RX PubMed=6693503;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B420 ! MBA-14
CA Stromal cell line
//
ID 14M
AC CVCL_B381
RX PubMed=2981238;
RX PubMed=6693503;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B420 ! MBA-14
CA Stromal cell line
//
ID 14M1
AC CVCL_B382
RX PubMed=2981238;
RX PubMed=6693503;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B420 ! MBA-14
CA Stromal cell line
//
ID 15-1-5P
AC CVCL_J064
DR CLO; CLO_0001098
DR ATCC; HB-53
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 15-3-1S
AC CVCL_G570
DR CLO; CLO_0001101
DR ATCC; HB-13
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 15-5-5S
AC CVCL_D290
SY 15.5.5S
DR CLO; CLO_0001103
DR ATCC; HB-24
DR BCRJ; 0003
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 15-79-2
AC CVCL_J080
DR CLO; CLO_0001105
DR ATCC; HB-34
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 15.84
AC CVCL_J169
SY 15.84.4
DR ATCC; HB-8335
RX Patent=US4650676;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 150 BLCL
AC CVCL_E352
DR ECACC; 94031630
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1503-4f1
AC CVCL_DP73
DR GEO; GSM1040266
DR GEO; GSM1040336
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 1507.2
AC CVCL_1Y71
SY S1507-2
RX PubMed=21695156;
RX PubMed=23437333;
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 151 BLCL
AC CVCL_E353
DR ECACC; 94031631
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 151-5-G2-12
AC CVCL_J081
SY CO-512; CO512
DR CLO; CLO_0001096
DR ATCC; HB-8322
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 151-5-G3-5
AC CVCL_J082
SY CO-513; CO513
DR CLO; CLO_0001097
DR ATCC; HB-8323
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 151-6-A7-9
AC CVCL_J083
SY CO-514; CO514
DR CLO; CLO_0001099
DR ATCC; HB-8324
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1510-CPTX
AC CVCL_4809
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=87
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 1512-CPTX
AC CVCL_4810
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=92
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4811 ! 1512-normal
SX Male
CA Transformed cell line
//
ID 1512-normal
AC CVCL_4811
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=88
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4810 ! 1512-CPTX
SX Male
CA Transformed cell line
//
ID 1519-CPTX
AC CVCL_4812
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=94
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4813 ! 1519-normal
SX Male
CA Transformed cell line
//
ID 1519-normal
AC CVCL_4813
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=93
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4812 ! 1519-CPTX
SX Male
CA Transformed cell line
//
ID 151TAg
AC CVCL_6343
DR CLO; CLO_0001100
DR ATCC; CRL-2823
RX PubMed=12882965;
CC Knockout cell: Method=KO mouse; MGI; MGI:104288; Pms2.
CC Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 152-6D11
AC CVCL_J572
DR ATCC; CRL-2665
DR ATCC; HB-8996
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; CRL-2665; true.
CC Discontinued: ATCC; HB-8996; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1520-mel
AC CVCL_8049
SY 1520-MEL; 1520 mel; 1520
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 153.8E2.D10.D6.12.12
AC CVCL_J992
SY 12.12; CHIR-12.12
DR ATCC; PTA-5543
RX Patent=US20070098718;
RX Patent=US20070218060;
RX Patent=US8333970;
CC Monoclonal antibody target: UniProtKB; P25942; Human CD40.
CC Discontinued: ATCC; PTA-5543; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1532-CPTX-1
AC CVCL_4814
SY 1532-CP1TX
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=96
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4815 ! 1532-CPTX-2
OI CVCL_4816 ! 1532-normal
SX Male
CA Transformed cell line
//
ID 1532-CPTX-2
AC CVCL_4815
SY 1532-CP2TX
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=97
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4814 ! 1532-CPTX-1
OI CVCL_4816 ! 1532-normal
SX Male
CA Transformed cell line
//
ID 1532-normal
AC CVCL_4816
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=95
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4814 ! 1532-CPTX-1
OI CVCL_4815 ! 1532-CPTX-2
SX Male
CA Transformed cell line
//
ID 1535-CPTX-1
AC CVCL_4817
SY 1535-CP1TX
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=100
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4818 ! 1535-CPTX-2
OI CVCL_4819 ! 1535-normal prostate
OI CVCL_4820 ! 1535-seminal vesicle
SX Male
CA Transformed cell line
//
ID 1535-CPTX-2
AC CVCL_4818
SY 1535-CP2TX
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=101
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4817 ! 1535-CPTX-1
OI CVCL_4819 ! 1535-normal prostate
OI CVCL_4820 ! 1535-seminal vesicle
SX Male
CA Transformed cell line
//
ID 1535-normal prostate
AC CVCL_4819
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=98
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4817 ! 1535-CPTX-1
OI CVCL_4818 ! 1535-CPTX-2
OI CVCL_4820 ! 1535-seminal vesicle
SX Male
CA Transformed cell line
//
ID 1535-seminal vesicle
AC CVCL_4820
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=99
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4817 ! 1535-CPTX-1
OI CVCL_4818 ! 1535-CPTX-2
OI CVCL_4819 ! 1535-normal prostate
SX Male
CA Transformed cell line
//
ID 153BR
AC CVCL_2272
DR CLO; CLO_0001102
DR CLDB; cl13
DR ECACC; 90011808
RX PubMed=1672363;
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 11
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2553 ! LB185
SX Male
CA Finite cell line
//
ID 1542-CPTX-1
AC CVCL_4821
SY 1542-CP1TX
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=104
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4822 ! 1542-CPTX-2
OI CVCL_4823 ! 1542-CPTX-3
OI CVCL_4824 ! 1542-normal
OI CVCL_4825 ! 1542-seminal vesicle
SX Male
CA Transformed cell line
//
ID 1542-CPTX-2
AC CVCL_4822
SY 1542-CP2TX
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=104
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4821 ! 1542-CPTX-1
OI CVCL_4823 ! 1542-CPTX-3
OI CVCL_4824 ! 1542-normal
OI CVCL_4825 ! 1542-seminal vesicle
SX Male
CA Transformed cell line
//
ID 1542-CPTX-3
AC CVCL_4823
SY 1542-CP3TX
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=104
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4821 ! 1542-CPTX-1
OI CVCL_4822 ! 1542-CPTX-2
OI CVCL_4824 ! 1542-normal
OI CVCL_4825 ! 1542-seminal vesicle
SX Male
CA Transformed cell line
//
ID 1542-normal
AC CVCL_4824
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=102
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4821 ! 1542-CPTX-1
OI CVCL_4822 ! 1542-CPTX-2
OI CVCL_4823 ! 1542-CPTX-3
OI CVCL_4825 ! 1542-seminal vesicle
SX Male
CA Transformed cell line
//
ID 1542-seminal vesicle
AC CVCL_4825
RX PubMed=9041206;
WW http://capcelllines.ca/details.asp?id=103
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4821 ! 1542-CPTX-1
OI CVCL_4822 ! 1542-CPTX-2
OI CVCL_4823 ! 1542-CPTX-3
OI CVCL_4824 ! 1542-normal
SX Male
CA Transformed cell line
//
ID 155
AC CVCL_J919
SY Anti PDGF hybridoma #155
DR ATCC; HB-9354
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 155-11C7
AC CVCL_J573
DR ATCC; HB-8976
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8976; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 155-8G1
AC CVCL_J574
DR ATCC; HB-9001
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9001; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 155-9F6
AC CVCL_J575
DR ATCC; HB-9000
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9000; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 155BR
AC CVCL_2273
DR CLO; CLO_0001104
DR CLDB; cl16
DR ECACC; 90011809
RX PubMed=1672363;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 156 BLCL
AC CVCL_E354
DR ECACC; 94031633
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1563
AC CVCL_E431
SY CDUA
DR dbMHC; 48449
DR ECACC; 94071415
DR IHW; IHW9337
DR IMGT/HLA; 10075
WW http://bioinformatics.hsanmartino.it/ecbr/cl337.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94071415; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 1568
AC CVCL_E432
SY LJAC
DR dbMHC; 48450
DR IHW; IHW9346
DR IMGT/HLA; 10077
WW http://bioinformatics.hsanmartino.it/ecbr/cl346.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 157748
AC CVCL_V363
DR IMGT/HLA; 14465
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 158 BLCL
AC CVCL_E355
DR ECACC; 94031635
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 158.2
AC CVCL_9141
SY MA158.2
DR CLO; CLO_0001106
DR ATCC; HB-8466
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1580WU
AC CVCL_M136
SY Wu-1580
DR Cosmic; 2362659
RX PubMed=15793295;
RX PubMed=22976800;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 159-2
AC CVCL_IT51
DR PRIDE; PXD000589
RX PubMed=22170606;
RX PubMed=25894527;
CC Omics: Cell surface proteome.
CC Omics: DNA methylation analysis.
CC Breed/subspecies: 129 x C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID 15b
AC CVCL_8990
SY iPS-15b; hiPS-15b
DR EFO; EFO_0007102
DR ENCODE; ENCBS196IDK
DR ENCODE; ENCBS201ENZ
DR ENCODE; ENCBS448IJH
DR GEO; GSM537687
DR GEO; GSM537690
DR GEO; GSM537691
DR GEO; GSM537692
DR GEO; GSM537696
DR GEO; GSM621433
DR GEO; GSM621444
DR GEO; GSM621557
DR GEO; GSM621721
DR GEO; GSM772767
DR ISCR; 1624
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/0000012c-c6d6-49e5-a061-4a6580000000
CC From: Harvard University; Boston; USA.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 15B2
AC CVCL_J020
DR CLO; CLO_0001107
DR ATCC; HB-8510
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
CC Discontinued: ATCC; HB-8510; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 15B3
AC CVCL_IQ41
RX Patent=US7259246;
RX PubMed=9363892;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2298.
CC Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (specifically recognizes infectious PrP(Sc)).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 15C6 [Mouse hybridoma]
AC CVCL_D147
DR CLO; CLO_0001108
DR ATCC; CRL-2431
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 15C6 [Mouse/rat hybridoma]
AC CVCL_9142
DR CLO; CLO_0001109
DR ATCC; HB-326
RX PubMed=9531266;
CC Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 15C9
AC CVCL_0H97
DR ATCC; PTA-5106
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 15F3-1
AC CVCL_J084
DR CLO; CLO_0001110
DR ATCC; HB-47
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 15F7
AC CVCL_9143
DR CLO; CLO_0001111
DR ATCC; HB-322
RX PubMed=9531266;
CC Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 15P-1
AC CVCL_6552
DR CLO; CLO_0001112
DR ATCC; CRL-2618
DR CCRID; 3111C0001CCC000271
RX PubMed=8393161;
RX PubMed=15541572;
RX PubMed=23891577;
CC Transfected with: UniProtKB; P03073; Murine polyomavirus (strain A2) large T antigen.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID 15PC3
AC CVCL_D647
SY 15PC-3
DR BTO; BTO:0002220
RX PubMed=11929820;
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 16-1-11N
AC CVCL_J085
DR CLO; CLO_0001114
DR ATCC; HB-16
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 16-1-2N
AC CVCL_J086
DR CLO; CLO_0001115
DR ATCC; HB-14
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 16-10A1
AC CVCL_8937
DR CLO; CLO_0001113
DR ATCC; HB-301
RX PubMed=1373896;
CC Monoclonal antibody target: UniProtKB; Q00609; Mouse Cd80.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 16-23
AC CVCL_U054
DR ECACC; 99043001
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 16-3-1N
AC CVCL_J089
DR CLO; CLO_0001119
DR ATCC; HB-25
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 16-3-22S
AC CVCL_G571
DR CLO; CLO_0001120
DR ATCC; HB-5
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 16-8
AC CVCL_J270
DR JCRB; JCRB0013
RX PubMed=6675779;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 160 BLCL
AC CVCL_E356
DR ECACC; 94031636
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 161 BLCL
AC CVCL_E357
DR ECACC; 94031637
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1616-EB
AC CVCL_F949
DR TKG; TKG 0613
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 1616-MUC1
AC CVCL_F950
DR TKG; TKG 0612
CC Transfected with: HGNC; 7508; MUC1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F949 ! 1616-EB
SX Male
CA Transformed cell line
//
ID 1618-K
AC CVCL_S505
SY 1618K
DR DSMZ; ACC-752
RX CelloPub=CLPUB00009;
CC Doubling time: ~40 hours (DSMZ).
ST Source(s): DSMZ; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 13
ST D18S51: 10,19
ST D21S11: 31.2
ST D5S818: 12
ST D7S820: 7
ST D8S1179: 13,14
ST FGA: 20
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 161BR
AC CVCL_2274
SY 161-Br; 161 BR
DR CLO; CLO_0001116
DR CLDB; cl17
DR ECACC; 90011810
RX PubMed=1672363;
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,14
ST D16S539: 11
ST D5S818: 9,11
ST D7S820: 8,13
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 162
AC CVCL_J920
SY Anti PDGF hybridoma #162
DR ATCC; HB-9356
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 162-21.2
AC CVCL_J087
SY Anti-Trop-1
DR CLO; CLO_0001117
DR ATCC; HB-241
RX PubMed=7029529;
CC Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 162-46.2
AC CVCL_J088
SY Anti-Trop-2
DR CLO; CLO_0001118
DR ATCC; HB-187
RX PubMed=7029529;
CC Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 163 BLCL
AC CVCL_E358
DR ECACC; 94031638
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 164 BLCL
AC CVCL_E359
DR ECACC; 94031639
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 164-3F3
AC CVCL_J576
DR ATCC; CRL-2736
DR ATCC; HB-9040
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; CRL-2736; true.
CC Discontinued: ATCC; HB-9040; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 164T2
AC CVCL_8099
DR BTO; BTO:0002972
RX PubMed=9427718;
CC Breed/subspecies: C57BL/Ka.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 165-28E7
AC CVCL_0F07
DR ATCC; CRL-2735
CC Discontinued: ATCC; CRL-2735; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 165-34E4
AC CVCL_J577
DR ATCC; HB-9279
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9279; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 166 BLCL
AC CVCL_E360
DR ECACC; 94031640
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 166-ME SK
AC CVCL_3478
DR CLO; CLO_0001121
DR ATCC; CRL-1533
DR BioSample; SAMN03473643
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 8,11
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8,10
ST vWA: 15,19
DI NCIt; C3339; Familial adenomatous polyposis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 16610D9
AC CVCL_0111
DR MCCL; MCC:0000002
RX PubMed=10587351;
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 167 BLCL
AC CVCL_E361
DR ECACC; 94031641
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 167.2
AC CVCL_V058
DR CLO; CLO_0001004
DR CLDB; cl20
DR IHW; IHW8126
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID 1670
AC CVCL_DF12
SY #1670
RX PubMed=195090;
RX PubMed=226983;
RX PubMed=4633909;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
OX NCBI_TaxID=9521; ! Saimiri sciureus
SX Male
CA Cancer cell line
//
ID 168
AC CVCL_0I84
SY Line 168
RX PubMed=210930;
RX PubMed=2413152;
RX PubMed=3426919;
RX PubMed=3940214;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_W343 ! 410.4
OI CVCL_9722 ! 66 [Mouse mammary tumor]
OI CVCL_0I87 ! 67 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID 168 BLCL
AC CVCL_E362
DR ECACC; 94031642
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1682A
AC CVCL_F665
SY 1682-A
DR BTO; BTO:0004320
RX PubMed=16322250;
CC Breed/subspecies: ACI.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID 1687-4f2
AC CVCL_DP74
SY 1687-4F2
DR GEO; GSM1040267
DR GEO; GSM1040337
DR GEO; GSM1899764
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 168FAR
AC CVCL_0I85
RX PubMed=3940214;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0I84 ! 168
SX Female
CA Cancer cell line
//
ID 168FARN
AC CVCL_0I86
RX PubMed=1540948;
RX PubMed=1993557;
RX PubMed=15671244;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0I85 ! 168FAR
SX Female
CA Cancer cell line
//
ID 169A
AC CVCL_0B41
DR Cosmic; 2163759
RX PubMed=24812411;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 16B
AC CVCL_N540
RX PubMed=6206890;
CC Monoclonal antibody target: ChEBI; CHEBI:61151; Poly-ADP-D-ribose (Poly(adenosine diphosphate ribose)).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 16C7
AC CVCL_0H98
DR ATCC; PTA-5107
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 16D6-3
AC CVCL_CW59
RX PubMed=25897609;
CC Monoclonal antibody target: UniProtKB; P02776; Human PF4/CXCL4.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 16H3
AC CVCL_E970
DR CLO; CLO_0001122
DR ATCC; CRL-2385
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6971 ! FOX-NY
CA Hybridoma
//
ID 16H9
AC CVCL_0H99
DR ATCC; PTA-5108
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 16HBE14o-
AC CVCL_0112
SY 16-HBE14o; 16HBE140; 16-HBEo; 16HBEo-; 16-HBE; 16HBE
DR BTO; BTO:0002734
DR BTO; BTO:0004394
DR BTO; BTO:0005749
DR MCCL; MCC:0000003
DR TOKU-E; 4023
RX PubMed=1282304;
RX PubMed=7507342;
RX PubMed=9614386;
RX PubMed=10498856;
RX PubMed=12711171;
RX PubMed=15463957;
RX PubMed=18441018;
WW http://www.dartmouth.edu/~cysfib/cell-lines.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 16M3F10
AC CVCL_8938
DR CLO; CLO_0001123
DR ATCC; HB-8363
RX Patent=US4689299;
RX PubMed=6607295;
CC Monoclonal antibody target: UniProtKB; P00588; Corynephage beta diphetheria toxin.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 16Q
AC CVCL_T481
SY LSQC-16Q
RX PubMed=67703;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=93934; ! Coturnix coturnix japonica
CA Transformed cell line
//
ID 17-1
AC CVCL_J862
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 17-3-3S
AC CVCL_G572
DR CLO; CLO_0001130
DR ATCC; HB-6
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 17-71
AC CVCL_0B18
SY 1771
DR GEO; GSM1974773
RX PubMed=3594482;
RX PubMed=22236332;
RX PubMed=23365669;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID 17-94
AC CVCL_D704
SY 17.94; 17,94
DR Cosmic; 1716565
DR DSMZ; ACC-741
RX PubMed=22749038;
CC Doubling time: ~1 week (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 17-G4
AC CVCL_0F00
DR ATCC; CRL-2574
RX PubMed=9067641;
CC Monoclonal antibody target: UniProtKB; P18428; Human LBP.
CC Discontinued: ATCC; CRL-2574; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 17/14
AC CVCL_J097
DR CLO; CLO_0001124
DR ATCC; HB-8153
RX Patent=US4521510;
RX Patent=US4524025;
CC Monoclonal antibody target: ChEBI; CHEBI:28177; Theophylline.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 170 BLCL
AC CVCL_E363
DR ECACC; 94031643
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 171-10E5
AC CVCL_J544
DR ATCC; HB-9098
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9098; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 171-11B9
AC CVCL_E971
DR CLO; CLO_0001125
DR ATCC; CRL-2661
DR ATCC; HB-9117
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9117; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 171-19B10
AC CVCL_J546
DR ATCC; HB-9097
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9097; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 171-4
AC CVCL_G573
DR CLO; CLO_0001126
DR ATCC; HB-296
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 171BR
AC CVCL_8778
SY 171-Br
DR CLO; CLO_0001127
DR CLDB; cl21
DR ECACC; 90011811
RX PubMed=1672363;
CC Discontinued: ECACC; 90011811; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID 172-12A4
AC CVCL_E972
DR CLO; CLO_0001128
DR ATCC; CRL-2660
DR ATCC; HB-9005
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9005; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 172-12G7
AC CVCL_J578
DR ATCC; HB-9004
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9004; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 173-1C11
AC CVCL_E973
DR CLO; CLO_0001129
DR ATCC; CRL-2659
DR ATCC; HB-8894
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8894; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 173-8D2
AC CVCL_J579
DR ATCC; HB-8896
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8896; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 173E
AC CVCL_J038
DR ATCC; HB-11912
RX Patent=US5773293;
CC Monoclonal antibody target: UniProtKB; Q14773; Human ICAM4/CD242.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 174BR
AC CVCL_2275
DR CLO; CLO_0001131
DR CLDB; cl22
DR ECACC; 90011895
RX PubMed=1672363;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 175BR
AC CVCL_2276
DR CLO; CLO_0001132
DR CLDB; cl23
DR ECACC; 90011863
RX PubMed=1672363;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 176-2-5
AC CVCL_6F36
RX PubMed=1661669;
WW http://dshb.biology.uiowa.edu/coronin
CC Monoclonal antibody target: UniProtKB; P27133; Dictyostelium discoideum corA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 1765-92
AC CVCL_S817
SY MLS 1765-92; MLS-1765; MLS1765
DR Cosmic; 1672268
DR Cosmic; 2307720
RX PubMed=16983332;
RX PubMed=20515481;
RX PubMed=24726063;
RX PubMed=25393000;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 1777N Rpmet
AC CVCL_2277
SY 1777N RpMet; 1777N RPMET; 1777N
DR Cosmic; 2077189
DR Cosmic; 2439938
DR ECACC; 06011801
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 1783
AC CVCL_U758
DR Cosmic; 802250
RX PubMed=9671307;
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 1795/4A
AC CVCL_AX27
SY 1795-4A
DR Cosmic; 2361370
RX PubMed=8547074;
DI NCIt; C7539; Lymphoid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 17a
AC CVCL_8991
SY iPS-17a; hiPS-17a; iPS17a
DR EFO; EFO_0007103
DR ENCODE; ENCBS868JUD
DR GEO; GSM621699
DR ISCR; 1625
RX PubMed=21293464;
RX PubMed=21368825;
WW http://harvard.eagle-i.net/i/0000012c-c6d9-11a7-a061-4a6580000000
CC From: Harvard University; Boston; USA.
CC Omics: Deep exome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8992 ! 17b
SX Female
CA Induced pluripotent stem cell
//
ID 17aba
AC CVCL_J090
DR CLO; CLO_0001133
DR ATCC; HB-248
CC Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b (also reacts with dog and rat).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 17b
AC CVCL_8992
SY iPS-17b; hiPS-17b; iPS17b
DR EFO; EFO_0007104
DR ENCODE; ENCBS041ZVO
DR GEO; GSM621714
DR GEO; GSM670062
DR GEO; GSM670067
DR ISCR; 1626
RX PubMed=21293464;
RX PubMed=21368825;
CC From: Harvard University; Boston; USA.
CC Omics: Deep exome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8991 ! 17a
SX Female
CA Induced pluripotent stem cell
//
ID 17CM98
AC CVCL_0C82
DR GEO; GSM1974774
RX PubMed=15965647;
RX PubMed=22901430;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID 17D
AC CVCL_G088
DR CLO; CLO_0001134
DR ATCC; HB-262
DR ECACC; 91060551
CC Monoclonal antibody target: UniProtKB; P05542; Sheep CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 17F4.F4
AC CVCL_IV61
DR ATCC; PTA-8332
RX Patent=US8022175;
CC Monoclonal antibody target: Newcastle disease viruses HN protein.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 17G1
AC CVCL_DN54
RX PubMed=18158780;
CC Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 18-26-4
AC CVCL_0E27
DR ATCC; CRL-2486
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 18-8
AC CVCL_GR72
SY BM18-8
RX PubMed=200369;
RX PubMed=222460;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 18-81
AC CVCL_GR73
RX PubMed=222460;
RX PubMed=6322175;
RX PubMed=6787596;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_GR72 ! 18-8
CA Transformed cell line
//
ID 18-9B10
AC CVCL_J580
DR ATCC; HB-8800
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8800; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 18/20PAC2
AC CVCL_DB46
DR ATCC; HB-7
CC Discontinued: ATCC; HB-7; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 180BR
AC CVCL_2278
DR CLO; CLO_0001135
DR CLDB; cl24
DR ECACC; 90011862
RX PubMed=1672363;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID 180D
AC CVCL_5447
DR ECACC; 93090809
RX PubMed=8795574;
CC Discontinued: ECACC; 93090809; probable.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 182.1
AC CVCL_V059
DR CLO; CLO_0001005
DR CLDB; cl26
DR IHW; IHW8127
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID 182-PF SK
AC CVCL_3479
DR CLO; CLO_0001136
DR ATCC; CRL-1532
DR BioSample; SAMN03473642
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 12
ST D5S818: 9,13
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 11
ST vWA: 15,16
DI NCIt; C3339; Familial adenomatous polyposis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 183 BLCL
AC CVCL_E364
DR ECACC; 94031648
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 183-1
AC CVCL_J863
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 184
AC CVCL_K049
SY HMEC-184; HMEC 184; HMEC184
DR EFO; EFO_0001190
RX PubMed=9671407;
WW http://hmec.lbl.gov/mreview.htm
CC Doubling time: 2.5 days (PubMed=9671407).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 184-hTERT
AC CVCL_K053
SY 184-hTert; 184hTERT
RX PubMed=17395154;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K049 ! 184
SX Female
CA Telomerase immortalized cell line
//
ID 184A1
AC CVCL_3040
AS CVCL_8222
SY H184A1
DR CLO; CLO_0001137
DR ATCC; CRL-8798
DR BioSample; SAMN03471210
DR GEO; GSM350522
DR GEO; GSM845393
DR GEO; GSM843436
DR IZSLER; BS CL 178
DR LINCS; 51088
RX DOI=10.1007/978-1-4612-0411-4_26;
RX Patent=US4808532;
RX PubMed=2702624;
RX PubMed=3857588;
RX PubMed=9671407;
RX PubMed=12661003;
RX PubMed=19582160;
RX PubMed=28196595;
WW http://hmec.lbl.gov/mreview.htm
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC Omics: CNV analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K049 ! 184
SX Female
CA Transformed cell line
//
ID 184A1N4
AC CVCL_9665
SY A1N4
DR BTO; BTO:0002179
RX DOI=10.1007/978-1-4612-0411-4_26;
RX PubMed=3293776;
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3040 ! 184A1
SX Female
CA Transformed cell line
//
ID 184A1N4-H
AC CVCL_IQ01
SY A1N4-H; 184A1N4-ras
RX PubMed=3293776;
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9665 ! 184A1N4
SX Female
CA Transformed cell line
//
ID 184A1N4-T
AC CVCL_IQ02
SY A1N4-T
RX PubMed=3293776;
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9665 ! 184A1N4
SX Female
CA Transformed cell line
//
ID 184A1N4-TH
AC CVCL_IQ03
SY A1N4-TH; 184A1N4-T-ras
RX DOI=10.1007/978-1-4612-0411-4_26;
RX PubMed=1638679;
RX PubMed=3293776;
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9665 ! 184A1N4
SX Female
CA Transformed cell line
//
ID 184B5
AC CVCL_4688
AS CVCL_B387; CVCL_Y092
SY 184-B5; B5/589; H184B5
DR BTO; BTO:0000598
DR BTO; BTO:0002180
DR CLO; CLO_0001138
DR ATCC; CRL-8799
DR BioSample; SAMN03471211
DR IZSLER; BS CL 170
DR LINCS; 50576
RX DOI=10.1007/978-1-4612-0411-4_10;
RX DOI=10.1007/978-1-4612-0411-4_26;
RX Patent=US4808532;
RX PubMed=2702624;
RX PubMed=3857588;
RX PubMed=9303071;
RX PubMed=9671407;
RX PubMed=28196595;
WW http://hmec.lbl.gov/mreview.htm
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K049 ! 184
SX Female
CA Transformed cell line
//
ID 1858-mel a
AC CVCL_DI11
SY 1858-MEL a; 1858-MEL a (Fragment)
DR Cosmic; 1042624
DR GEO; GSM218060
RX PubMed=16470173;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous; right flank.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4632 ! 888-mel
OI CVCL_7943 ! 1290-mel
OI CVCL_DI12 ! 1858-mel b
OI CVCL_DI13 ! 1858-mel c
OI CVCL_DI14 ! 1936-mel
OI CVCL_DI15 ! 1962-mel
SX Female
CA Cancer cell line
//
ID 1858-mel b
AC CVCL_DI12
SY 1858-MEL b; 1858-MEL b (Medimachine)
DR GEO; GSM218050
RX PubMed=16470173;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous; right flank.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4632 ! 888-mel
OI CVCL_7943 ! 1290-mel
OI CVCL_DI11 ! 1858-mel a
OI CVCL_DI13 ! 1858-mel c
OI CVCL_DI14 ! 1936-mel
OI CVCL_DI15 ! 1962-mel
SX Female
CA Cancer cell line
//
ID 1858-mel c
AC CVCL_DI13
SY 1858-MEL c; 1858-MEL c (Wash)
DR GEO; GSM218059
RX PubMed=16470173;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous; right flank.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4632 ! 888-mel
OI CVCL_7943 ! 1290-mel
OI CVCL_DI11 ! 1858-mel a
OI CVCL_DI12 ! 1858-mel b
OI CVCL_DI14 ! 1936-mel
OI CVCL_DI15 ! 1962-mel
SX Female
CA Cancer cell line
//
ID 187-1
AC CVCL_J864
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 187.1
AC CVCL_9144
DR CLO; CLO_0001139
DR ATCC; HB-58
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 18a
AC CVCL_8993
SY iPS-18a; hiPS-18a
DR EFO; EFO_0007105
DR ENCODE; ENCBS223PPW
DR ENCODE; ENCBS424LHN
DR ENCODE; ENCBS463LFL
DR GEO; GSM772935
DR GEO; GSM773023
DR GEO; GSM773024
DR GEO; GSM773027
DR GEO; GSM773028
DR GEO; GSM773029
DR GEO; GSM773030
DR GEO; GSM773033
DR ISCR; 1627
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/0000012c-c6d9-88d3-a061-4a6580000000
CC From: Harvard University; Boston; USA.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8994 ! 18b
OI CVCL_8995 ! 18c
SX Female
CA Induced pluripotent stem cell
//
ID 18b
AC CVCL_8994
SY iPS-18b; IPS cell line 18b
DR EFO; EFO_0007106
DR ENCODE; ENCBS799NIQ
DR ENCODE; ENCBS869TCU
DR GEO; GSM621411
DR GEO; GSM621695
DR GEO; GSM981284
DR ISCR; 1628
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/00000144-087f-80d6-0803-96bd80000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8993 ! 18a
OI CVCL_8995 ! 18c
SX Female
CA Induced pluripotent stem cell
//
ID 18c
AC CVCL_8995
SY iPS-18c
DR EFO; EFO_0007107
DR ENCODE; ENCBS101JWL
DR ENCODE; ENCBS182TVB
DR ENCODE; ENCBS184AWY
DR ENCODE; ENCBS391PLF
DR ENCODE; ENCBS529YKY
DR ENCODE; ENCBS841ZKV
DR ENCODE; ENCBS851LMU
DR ENCODE; ENCBS954GPE
DR GEO; GSM537671
DR GEO; GSM537674
DR GEO; GSM537675
DR GEO; GSM537676
DR GEO; GSM537677
DR GEO; GSM537678
DR GEO; GSM621407
DR GEO; GSM621564
DR GEO; GSM621725
DR GEO; GSM981285
DR ISCR; 1629
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/00000144-0880-72b8-0803-96bd80000000
CC From: Harvard University; Boston; USA.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8993 ! 18a
OI CVCL_8994 ! 18b
SX Female
CA Induced pluripotent stem cell
//
ID 18C2.8.3
AC CVCL_J098
DR CLO; CLO_0001140
DR ATCC; HB-9571
RX Patent=US5194593;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 18E9.G3.D7
AC CVCL_IV62
DR ATCC; PTA-8334
RX Patent=US8022175;
CC Monoclonal antibody target: Newcastle disease viruses HN protein.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 18Nco
AC CVCL_IP99
SY HFK-18Nco
RX DOI=10.1007/978-1-4612-0411-4_17;
RX PubMed=2556677;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 19-7
AC CVCL_J271
DR JCRB; JCRB0014
RX PubMed=6675779;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 191
AC CVCL_J921
SY Anti PDGF hybridoma #191
DR ATCC; HB-9368
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 192B
AC CVCL_7930
RX PubMed=66978;
RX PubMed=944089;
RX PubMed=6244232;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 193 BLCL
AC CVCL_E365
DR ECACC; 94031649
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1936-mel
AC CVCL_DI14
SY 1936-MEL; 1936-MEL (Medimachine); MG-1936
DR Cosmic; 1042625
DR GEO; GSM218049
RX PubMed=16470173;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous; right chest wall.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4632 ! 888-mel
OI CVCL_7943 ! 1290-mel
OI CVCL_DI11 ! 1858-mel a
OI CVCL_DI12 ! 1858-mel b
OI CVCL_DI13 ! 1858-mel c
OI CVCL_DI15 ! 1962-mel
SX Female
CA Cancer cell line
//
ID 1939-3G5
AC CVCL_G574
DR CLO; CLO_0001141
DR ATCC; HB-8133
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1939-8G2
AC CVCL_G575
DR CLO; CLO_0001142
DR ATCC; HB-8134
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 194 BLCL
AC CVCL_E366
DR ECACC; 94031650
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 1955-91
AC CVCL_S815
SY 1955/91; MLS 1955-91
DR Cosmic; 1105000
DR Cosmic; 1105010
RX PubMed=1283316;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 196 BLCL
AC CVCL_E367
DR ECACC; 94031651
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 1962-mel
AC CVCL_DI15
SY 1962-MEL; MG-1962
DR Cosmic; 1042626
DR GEO; GSM218045
RX PubMed=16470173;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous; right breast.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4632 ! 888-mel
OI CVCL_7943 ! 1290-mel
OI CVCL_DI11 ! 1858-mel a
OI CVCL_DI12 ! 1858-mel b
OI CVCL_DI13 ! 1858-mel c
OI CVCL_DI14 ! 1936-mel
SX Female
CA Cancer cell line
//
ID 197 BLCL
AC CVCL_E368
DR ECACC; 94031652
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 198
AC CVCL_J922
SY Anti PDGF hybridoma #198
DR ATCC; HB-9369
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 199 BLCL
AC CVCL_E369
DR ECACC; 94031653
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 19F8
AC CVCL_9145
DR CLO; CLO_0001143
DR ATCC; HB-321
RX PubMed=9531266;
CC Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 19G4
AC CVCL_0E07
DR ATCC; CRL-2432
CC Discontinued: ATCC; CRL-2432; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 19KW
AC CVCL_HA39
RX PubMed=9237802;
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID 19X14
AC CVCL_V060
SY 19 X 14
DR CLO; CLO_0001144
DR CLDB; cl27
DR IHW; IHW8010
RX PubMed=1692821;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Transfected with: HGNC; 4931; HLA-A (allele HLA-A26).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID 1A2
AC CVCL_3480
DR CLO; CLO_0001146
DR EFO; EFO_0002094
DR ATCC; CRL-8119
DR BioSample; SAMN03471192
DR ECACC; 93031502
DR IGRhCellID; 1A2
RX Patent=US4834975;
RX Patent=US5662905;
CC Problematic cell line: Misidentified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Discontinued: ECACC; 93031502; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D870 ! GM01500
SX Male
CA Transformed cell line
//
ID 1A2 [Rat glioma]
AC CVCL_Y001
SY 1A2(R)
DR ECACC; 93040129
RX PubMed=221002;
CC Discontinued: ECACC; 93040129; probable.
CC Breed/subspecies: BDIX.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID 1A3
AC CVCL_J099
DR CLO; CLO_0001145
DR ATCC; HB-8563
DR BCRC; 60406
RX Patent=US4618585;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 1A3.1
AC CVCL_J100
DR CLO; CLO_0001147
DR ATCC; CRL-1961
RX PubMed=2592009;
CC Monoclonal antibody target: Giardia muris trophozoite surface antigens.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1A3.1.1
AC CVCL_U720
SY anti-FcRH4-1A3
DR ATCC; PTA-6339
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1A3.3.13
AC CVCL_H999
DR CLO; CLO_0001148
DR ATCC; HB-11894
RX Patent=US5646036;
RX Patent=US5686292;
CC Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 1A6
AC CVCL_6344
SY 5637 subclone 1A6
DR CLO; CLO_0001149
DR ATCC; CRL-2742
DR ATCC; PTA-556
DR Cosmic; 2037945
DR GEO; GSM827286
DR GEO; GSM1374374
RX Patent=US6114166;
RX PubMed=24018021;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2742; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0126 ! 5637
SX Male
CA Cancer cell line
//
ID 1A8
AC CVCL_U273
SY LBRM-33-1A8
DR ATCC; HB-8090
RX Patent=US4473642;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3896 ! BW5147
HI CVCL_K174 ! LBRM-33
CA Hybrid cell line
//
ID 1A81
AC CVCL_J225
DR TKG; TKG 0349
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1A8C3C10
AC CVCL_U274
SY LBRM-33-1A8C3C10; IA8C3C10
DR ATCC; HB-8089
RX Patent=US4473642;
RX PubMed=6971310;
CC Discontinued: ATCC; HB-8089; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_U273 ! 1A8
CA Hybrid cell line
//
ID 1A9
AC CVCL_H619
SY A2780-1A9; A2780/1A9; A2780(1A9)
DR ChEMBL-Cells; CHEMBL3307529
DR ChEMBL-Targets; CHEMBL614075
DR GEO; GSM95437
RX PubMed=16382445;
CC Misspelling: Occasionally 'IA9'.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0134 ! A2780
SX Female
CA Cancer cell line
//
ID 1A9/T80
AC CVCL_CZ93
SY 1A9 T80; 1A9T80
DR GEO; GSM95438
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H619 ! 1A9
SX Female
CA Cancer cell line
//
ID 1A9PTX10
AC CVCL_H620
SY 1A9/PTX10; 1A9/ptx-10; 1A9/Ptx-10; PTX10
DR ChEMBL-Cells; CHEMBL3307629
DR ChEMBL-Targets; CHEMBL614509
RX PubMed=9202030;
RX PubMed=10871860;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Misspelling: Occasionally 'IA9-PTX10'.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H619 ! 1A9
SX Female
CA Cancer cell line
//
ID 1A9PTX15
AC CVCL_H622
SY PTX15
RX PubMed=10871860;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H619 ! 1A9
SX Female
CA Cancer cell line
//
ID 1A9PTX22
AC CVCL_H621
SY 1A9/PTX22; 1A9/ptx-22; 1A9/Ptx-22; PTX22
DR ChEMBL-Cells; CHEMBL3308076
DR ChEMBL-Targets; CHEMBL613858
RX PubMed=9202030;
RX PubMed=10871860;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H619 ! 1A9
SX Female
CA Cancer cell line
//
ID 1B1.1
AC CVCL_J714
RX PubMed=2592009;
CC Monoclonal antibody target: Giardia muris trophozoite surface antigens.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1B10
AC CVCL_N504
RX PubMed=8133033;
RX PubMed=8988857;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 1B2-1B7
AC CVCL_J101
SY 1B2
DR CLO; CLO_0001150
DR ATCC; TIB-189
RX PubMed=7287743;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1B2A3
AC CVCL_G576
DR CLO; CLO_0001151
DR ATCC; CRL-1965
DR IZSLER; BS Hy 52
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1B2C6
AC CVCL_U822
DR CLO; CLO_0050258
DR BioSample; SAMN03472239
DR RCB; RCB0795
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 8,9
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U823 ! 1C3D3
OI CVCL_U824 ! 1C3IKEI
OI CVCL_U825 ! 2C6
CA Finite cell line
//
ID 1B2E12
AC CVCL_U322
DR ATCC; HB-8144
RX Patent=US4724211;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Hybridoma
//
ID 1B7.11
AC CVCL_J102
DR CLO; CLO_0001152
DR ATCC; TIB-191
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1B8-F11
AC CVCL_G089
DR CLO; CLO_0001153
DR ATCC; CRL-1852
DR ECACC; 95022202
CC Monoclonal antibody target: UniProtKB; P0CK30; Bovine herpesvirus 1.1 gD.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1BR.3.G
AC CVCL_2280
SY 1BR3.G; 1BR.3gpt
DR BTO; BTO:0004971
DR CLO; CLO_0001154
DR CLDB; cl28
DR ECACC; 90020507
RX PubMed=3002824;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-gpt].
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 12,14
ST D21S11: 30
ST D8S1179: 12,14
ST FGA: 21,22
ST TH01: 9.3
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2279 ! 1BR3
SX Male
CA Transformed cell line
//
ID 1BR.3.GN
AC CVCL_2281
SY 1BR3.GN
DR CLO; CLO_0001155
DR CLDB; cl29
DR ECACC; 90020509
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2280 ! 1BR.3.G
SX Male
CA Transformed cell line
//
ID 1BR.3.N
AC CVCL_2282
SY 1BR3.N; 1BR.3NEO; 1BR.3neo; 1BR3neo
DR CLO; CLO_0001156
DR CLDB; cl30
DR ECACC; 90020508
RX PubMed=2903889;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
ST Source(s): ECACC; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 9,13
ST D13S317: 9,12
ST D16S539: 12,14
ST D21S11: 30
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 12,14
ST FGA: 21,22
ST TH01: 9.3
ST TPOX: 11
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2279 ! 1BR3
SX Male
CA Transformed cell line
//
ID 1BR3
AC CVCL_2279
SY 1BR.3; 1BR
DR CLO; CLO_0001157
DR CLDB; cl31
DR ECACC; 90011801
RX PubMed=2903889;
RX PubMed=2973075;
RX PubMed=6600729;
RX PubMed=7471106;
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 12,14
ST D21S11: 30
ST D8S1179: 12,14
ST FGA: 21,22
ST TH01: 6,9.3
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 1C1
AC CVCL_4T75
DR ATCC; CRL-8941
RX Patent=US5662905;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-8941; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 1C11
AC CVCL_U279
DR ATCC; HB-9115
RX Patent=US4904581;
CC Discontinued: ATCC; HB-9115; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1C3
AC CVCL_D148
DR CLO; CLO_0001158
DR ATCC; CRL-2441
CC Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 1C3D3
AC CVCL_U823
DR CLO; CLO_0050259
DR RCB; RCB0796
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 8,9
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U822 ! 1B2C6
OI CVCL_U824 ! 1C3IKEI
OI CVCL_U825 ! 2C6
CA Finite cell line
//
ID 1C3IKEI
AC CVCL_U824
DR CLO; CLO_0050257
DR RCB; RCB0797
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 8,9
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U822 ! 1B2C6
OI CVCL_U823 ! 1C3D3
OI CVCL_U825 ! 2C6
CA Finite cell line
//
ID 1C5
AC CVCL_IQ47
RX Patent=EP0162812A2;
RX PubMed=3527953;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-316.
CC Monoclonal antibody target: UniProtKB; P14174; Human MIF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1C7
AC CVCL_T731
DR CLO; CLO_0050349
DR RCB; RCB1922
RX DOI=10.1508/cytologia.68.271;
CC Monoclonal antibody target: Lygodium japonicum strain an-1 basal apparatus.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1C9
AC CVCL_C695
SY Lexicon ES cell line 1C9
DR BTO; BTO:0004751
WW http://www.mmrrc.org/catalog/cellLineSDS.php?mmrrc_id=29773
CC Breed/subspecies: 129S5/SvEvBrd.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C696 ! Lex-1
CA Embryonic stem cell
//
ID 1CB4
AC CVCL_CZ91
RX PubMed=3882896;
CC Monoclonal antibody target: C.elegans antigen on membranous organelles.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 1Cc8
AC CVCL_L893
SY 1CC8; SCC-1CC8; SC8
RX PubMed=18297114;
CC Selected for resistance to: Cetuximab (Erbitux).
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7707 ! UM-SCC-1
SX Male
CA Cancer cell line
//
ID 1D10(AAT) Clone 8D10
AC CVCL_U070
SY 1D10(ATT) Clone A6
DR ECACC; 02043018
CC Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1D11.16.8
AC CVCL_J162
SY 1D11.16
DR CLO; CLO_0001160
DR ATCC; HB-9849
RX Patent=US5571714;
CC Monoclonal antibody target: UniProtKB; P18341; Bovine TGFB1.
CC Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1D3
AC CVCL_9146
DR CLO; CLO_0001161
DR ATCC; HB-305
DR CCRID; 3142C0001000000419
RX PubMed=8566073;
CC Monoclonal antibody target: UniProtKB; P09055; Mouse Itgb1/Cd19.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1D4
AC CVCL_J163
DR CLO; CLO_0001162
DR ATCC; HB-8068
DR IZSLER; BS Hy 7
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1D4 iPS
AC CVCL_IT49
DR GEO; GSM344761
DR GEO; GSM344762
RX PubMed=18371336;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_IT48 ! 2D4 iPS
SX Female
CA Induced pluripotent stem cell
//
ID 1D6.3.8
AC CVCL_U721
SY anti-FcRH1,2-1D6
DR ATCC; PTA-6334
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1E2
AC CVCL_U275
DR ATCC; HB-9100
RX Patent=US4904581;
CC Discontinued: ATCC; HB-9100; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1E7
AC CVCL_J153
DR ATCC; HB-10136
RX Patent=US5011778;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1E7(GC) Clone B
AC CVCL_U071
DR ECACC; 02043020
CC Monoclonal antibody target: UniProtKB; P02774; Human GC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1E8 [Human leukemia]
AC CVCL_L811
RX PubMed=7528218;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (BLIN-1) has been shown to be a NALM-6 derivative (PubMed=20143388).
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8173 ! BLIN-1
SX Male
CA Cancer cell line
//
ID 1E8 [Mouse hybridoma]
AC CVCL_D141
DR BCRJ; 0004
RX PubMed=1720625;
CC Monoclonal antibody target: UniProtKB; P37301; Chicken MPZ.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1F11
AC CVCL_0H91
DR ATCC; PTA-11448
RX Patent=US8399207;
CC Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID 1F5
AC CVCL_D142
DR CLO; CLO_0001163
DR ATCC; HB-9645
DR BCRC; 60427
DR BCRJ; 0005
RX Patent=US4975278;
CC Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1F9.1.1
AC CVCL_U722
SY anti-FcRH1-1F9
DR ATCC; PTA-6332
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 1G1
AC CVCL_1929
DR DSMZ; ACC-424
RX PubMed=9208228;
CC Doubling time: ~30 hours (DSMZ).
CC Monoclonal antibody target: Chicken dorsal retina cytoplasmic membranes (1G1 antigen).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 1G10
AC CVCL_9147
DR CLO; CLO_0001165
DR ATCC; CRL-2223
RX PubMed=7509723;
RX PubMed=7510738;
CC Monoclonal antibody target: UniProtKB; Q00609; Mouse Cd80.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1G10.1.5
AC CVCL_J986
DR ATCC; PTA-4297
RX Patent=US20080171036;
CC Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
CC Discontinued: ATCC; PTA-4297; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 1G12
AC CVCL_J164
DR CLO; CLO_0001166
DR ATCC; CRL-2827
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 1G2
AC CVCL_6345
SY HKB11 clone 1G2
DR CLO; CLO_0001167
DR ATCC; CRL-13005
DR ATCC; PTA-87
DR BioSample; SAMN03471349
RX Patent=US6136599;
CC Transfected with: HGNC; 6014; IL4 (with D-37 and E-145 = IL-4SA).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9,12
ST D7S820: 8,11,12
ST TH01: 7,9,9.3
ST TPOX: 11
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3712 ! HKB-11
CA Hybrid cell line
//
ID 1G3
AC CVCL_D149
DR CLO; CLO_0001168
DR ATCC; CRL-2434
RX PubMed=7889418;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 1G5
AC CVCL_X694
DR NIH-ARP; 1819-249
RX PubMed=8018390;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID 1G8
AC CVCL_5384
SY IG8
DR CLO; CLO_0001169
DR ATCC; CRL-2756
RX PubMed=8988857;
RX PubMed=18824023;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 1H
AC CVCL_J416
RX PubMed=11437454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 1H10-6
AC CVCL_J165
SY 1H10
DR CLO; CLO_0001170
DR ATCC; HB-48
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 1H11
AC CVCL_J166
DR CLO; CLO_0001171
DR ATCC; HB-10611
RX Patent=US5300434;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 1H3
AC CVCL_G577
DR CLO; CLO_0001172
DR ATCC; HB-284
CC Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 1HAEo-
AC CVCL_0113
SY 1HAEo; 1HAEo(-)
DR BTO; BTO:0002636
DR MCCL; MCC:0000004
RX PubMed=15463957;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 1HB
AC CVCL_J417
RX PubMed=11437454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 1R
AC CVCL_DD99
RX PubMed=4309885;
RX PubMed=4516198;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID 1xN/2b
AC CVCL_6761
SY IxN/2b
RX PubMed=2324686;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=1xN%2F2b
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID 2-179-E11
AC CVCL_J659
SY 2.179.E11
DR ECACC; 92030602
DR NCBI_Iran; H128
CC Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 2-1D5
AC CVCL_9V13
RX DOI=10.1007/978-1-4684-4949-5_8;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W179 ! SBC-H20
CA Hybridoma
//
ID 2-2
AC CVCL_T341
DR CLO; CLO_0050507
DR RCB; RCB1375
RX PubMed=8973332;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0229 ! CV-1
SX Male
CA Transformed cell line
//
ID 2-7
AC CVCL_T366
DR CLO; CLO_0050509
DR RCB; RCB1376
RX PubMed=8973332;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
HI CVCL_0229 ! CV-1
SX Male
CA Transformed cell line
//
ID 2.03.7
AC CVCL_J167
SY 2.03
DR CLO; CLO_0001174
DR ATCC; HB-8389
RX Patent=US4650676;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2.040 pRSV-T
AC CVCL_6346
SY 2.040
DR CLO; CLO_0001175
DR ATCC; CRL-11516
DR BioSample; SAMN03471339
RX Patent=US5672498;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 9.3,10
ST TPOX: 8,9
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 2.28 M1
AC CVCL_J174
SY A2,28M1
DR CLO; CLO_0001177
DR ATCC; HB-166
RX PubMed=1377666;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J171 ! Sp2/08A2
CA Hybridoma
//
ID 2.43
AC CVCL_7235
DR CLO; CLO_0001178
DR ATCC; TIB-210
DR BCRC; 60473
DR CCRID; 3131C0001000600044
DR IZSLER; BS Hy 53
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2.4G2
AC CVCL_9148
DR CLO; CLO_0001179
DR ATCC; HB-197
DR BCRJ; 0006
RX PubMed=90108;
CC Monoclonal antibody target: UniProtKB; P08508; Mouse Fcgr3/Cd16.
CC Monoclonal antibody target: UniProtKB; P08101; Mouse Fcgr2/Cd32.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 20
AC CVCL_J923
SY Anti PDGF hybridoma #20
DR ATCC; HB-9355
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
CC Discontinued: ATCC; HB-9355; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 20-10-5S
AC CVCL_G578
DR CLO; CLO_0001183
DR ATCC; HB-23
RX PubMed=6174608;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 20-8-4S
AC CVCL_G579
DR CLO; CLO_0001189
DR ATCC; HB-11
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 20.27 (SBU-T6, anti-CD1)
AC CVCL_T975
DR ECACC; 93070779
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 20.3
AC CVCL_J620
SY TAb 250; Tab 250
DR CLO; CLO_0001180
DR ATCC; CRL-2655
DR ATCC; HB-10646
RX Patent=US6884418;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 20.6.5
AC CVCL_D659
DR BCRJ; 0007
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID 20.76
AC CVCL_M026
DR ECACC; 93100510
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 200 BLCL
AC CVCL_E370
DR ECACC; 94031654
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 200-3-G6-4
AC CVCL_J511
SY 20.4
DR CLO; CLO_0001181
DR ATCC; HB-8737
RX Patent=US4786593;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 2004
AC CVCL_U759
DR Cosmic; 802248
RX PubMed=9671307;
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 2006042530
AC CVCL_V364
DR IMGT/HLA; 14457
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 2008/C13*5.25
AC CVCL_0114
SY 2008/C13_5_25; 2008/c13*5.25; OV 2008/C13*5.25; OV2008/C13; 2008C13; 2008 C-13; C13; 2008/C13.R; ME180C13
DR BTO; BTO:0003989
DR MCCL; MCC:0000005
DR BioSample; SAMN03151842
DR Cosmic; 948294
DR GEO; GSM851911
DR NCBI_Iran; C446
RX PubMed=22710073;
RX PubMed=27561551;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=22710073
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 12
ST D19S433: 15.2
ST D21S11: 30,31
ST D2S1338: 18
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 14
ST FGA: 23
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 15,17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0473 ! OV-2008
SX Female
CA Cancer cell line
//
ID 200D
AC CVCL_5448
DR CLO; CLO_0001182
DR CLDB; cl34
DR ECACC; 93092101
RX PubMed=8795574;
CC Discontinued: ECACC; 93092101; probable.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 201 BLCL
AC CVCL_E371
DR ECACC; 94031655
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 201-45E9
AC CVCL_J316
DR CLO; CLO_0001184
DR ATCC; CRL-2670
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2012 [Human B-cell]
AC CVCL_E433
SY WELA
DR dbMHC; 48451
DR ECACC; 94071416
DR IHW; IHW9347
DR IMGT/HLA; 10095
WW http://bioinformatics.hsanmartino.it/ecbr/cl347.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 2012 [Mouse fetal liver stromal]
AC CVCL_U402
RX PubMed=8639765;
RX PubMed=9108096;
RX PubMed=9192756;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 2013
AC CVCL_G029
SY WEWI
DR IMGT/HLA; 10096
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2018
AC CVCL_6553
DR CLO; CLO_0001185
DR ATCC; CRL-10907
RX Patent=US5621090;
RX PubMed=8639765;
RX PubMed=9108096;
RX PubMed=9192756;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 201B1
AC CVCL_A062
SY 201-B1; KUIFMSi004-A
DR hPSCreg; KUIFMSi004-A
DR ISCR; 34
RX PubMed=18035408;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 201B2
AC CVCL_A063
SY 201-B2; KUIFMSi004-D; vWT-201B2
DR GEO; GSM1040248
DR GEO; GSM1040318
DR hPSCreg; KUIFMSi004-D
DR ISCR; 35
DR SKIP; SKIP000536
RX PubMed=18035408;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 201B3
AC CVCL_A064
SY 201-B3; KUIFMSi004-E
DR hPSCreg; KUIFMSi004-E
DR ISCR; 36
RX PubMed=18035408;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 201B6
AC CVCL_A065
SY 201-B6; KUIFMSi004-B
DR GEO; GSM1040249
DR GEO; GSM1040319
DR GEO; GSM1489217
DR GEO; GSM1489422
DR hPSCreg; KUIFMSi004-B
DR ISCR; 37
RX PubMed=18035408;
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 201B7
AC CVCL_A324
SY 201-B7; 201B-7; KYOU-DXR0109B; KUIFMSi004-C; vWT-201B7
DR ATCC; ACS-1023
DR GEO; GSM241846
DR GEO; GSM701542
DR GEO; GSM1040250
DR GEO; GSM1040320
DR GEO; GSM1489218
DR GEO; GSM1489423
DR hPSCreg; KUIFMSi004-C
DR ISCR; 38
DR PRIDE; PXD000071
DR RCB; HPS0001
DR RCB; HPS0063
DR SKIP; SKIP000001
DR SKIP; SKIP000537
DR Wikidata; Q27554318
RX PubMed=18035408;
RX PubMed=21460823;
RX PubMed=21900357;
RX PubMed=22802639;
RX PubMed=23210603;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; HPS0001; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 201T
AC CVCL_X481
DR Cosmic; 910550
DR Cosmic-CLP; 1287381
DR GDSC; 1287381
DR GEO; GSM827492
DR GEO; GSM1669564
RX PubMed=9816093;
RX PubMed=15735034;
RX PubMed=27397505;
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 7,13
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 6,8
ST vWA: 15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 202 BLCL
AC CVCL_E372
DR ECACC; 94031656
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 202-11A8
AC CVCL_J317
SY 202-11AB
DR CLO; CLO_0001186
DR ATCC; CRL-2669
DR ATCC; HB-8895
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8895; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 202-9D10
AC CVCL_J581
DR ATCC; HB-8900
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8900; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 202002
AC CVCL_E434
DR dbMHC; 48452
DR IHW; IHW9395
DR IMGT/HLA; 25999
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 203 BLCL
AC CVCL_E373
DR ECACC; 94031657
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 203-6F5
AC CVCL_J582
DR ATCC; HB-8899
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8899; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 203-7D10
AC CVCL_J543
DR CLO; CLO_0001187
DR ATCC; CRL-2651
DR ATCC; HB-8898
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8898; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 203-glioma
AC CVCL_S828
SY 203 glioma; 203G
RX PubMed=6603902;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 204-3
AC CVCL_J865
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 204-4
AC CVCL_J571
DR CLO; CLO_0001188
DR ATCC; HB-185
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2041
AC CVCL_E435
SY BLJU
DR dbMHC; 48453
DR ECACC; 94071408
DR IHW; IHW9336
DR IMGT/HLA; 10097
WW http://bioinformatics.hsanmartino.it/ecbr/cl336.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 2044L
AC CVCL_C520
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 205 BLCL
AC CVCL_E374
DR ECACC; 94031659
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2061H
AC CVCL_C521
SY HT-H
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 207
AC CVCL_K034
AS CVCL_8860
SY Line 207; EU-2
RX PubMed=6982733;
RX PubMed=7888679;
CC From: Emory University; USA.
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 208-2
AC CVCL_J866
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 208F
AC CVCL_4086
DR CLO; CLO_0001190
DR CLDB; cl36
DR ECACC; 85103116
RX PubMed=228482;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-76.html
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0492 ! Rat1
CA Transformed cell line
//
ID 209/MDCT
AC CVCL_CZ90
DR ATCC; CRL-3250
RX PubMed=1322939;
CC Transformant: Ad12-SV40.
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID 2094
AC CVCL_E436
SY CRJC
DR dbMHC; 48454
DR ECACC; 94071412
DR IHW; IHW9338
DR IMGT/HLA; 10098
WW http://bioinformatics.hsanmartino.it/ecbr/cl338.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 20b
AC CVCL_8996
SY iPS-20b; hiPS-20b
DR EFO; EFO_0007108
DR ENCODE; ENCBS206WTA
DR ENCODE; ENCBS364SXM
DR ENCODE; ENCBS391JPU
DR ENCODE; ENCBS606XXJ
DR ENCODE; ENCBS760MYS
DR ENCODE; ENCBS939PXA
DR GEO; GSM772804
DR GEO; GSM772841
DR GEO; GSM772842
DR GEO; GSM772843
DR GEO; GSM772844
DR GEO; GSM772845
DR GEO; GSM772846
DR GEO; GSM772847
DR GEO; GSM772848
DR GEO; GSM981286
DR ISCR; 1630
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/0000012c-c6d9-e2c0-a061-4a6580000000
CC From: Harvard University; Boston; USA.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 20B8
AC CVCL_6347
DR CLO; CLO_0001191
DR ATCC; CRL-12582
DR BioSample; SAMN03471346
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9,12
ST D7S820: 10,11
ST TH01: 7,9,9.3
ST TPOX: 6,11
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3712 ! HKB-11
CA Hybrid cell line
//
ID 20C2
AC CVCL_9149
SY 4H12:20C2.G6.C9
DR CLO; CLO_0001192
DR ATCC; CRL-2382
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 20H11
AC CVCL_6348
DR CLO; CLO_0001193
DR ATCC; CRL-9300
DR BioSample; SAMN03471215
RX Patent=US4834976;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,14
ST D13S317: 8,12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 20H2
AC CVCL_9150
DR CLO; CLO_0001194
DR ATCC; HB-323
RX PubMed=9531266;
CC Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2102EP
AC CVCL_C522
SY 2102Ep
DR BTO; BTO:0005287
DR EFO; EFO_0002957
DR Cosmic; 2077185
DR Cosmic; 2163762
RX PubMed=6169654;
RX PubMed=7095898;
RX PubMed=7471097;
RX PubMed=17284651;
RX PubMed=20428235;
RX PubMed=24812411;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C523 ! 2102ER
SX Male
CA Cancer cell line
//
ID 2102ER
AC CVCL_C523
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C522 ! 2102EP
SX Male
CA Cancer cell line
//
ID 2106LN
AC CVCL_M068
DR CLS; 300166/p13905_2106LN
RX PubMed=21684623;
CC Derived from metastatic site: Lymph node.
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10
ST D16S539: 8,11
ST D5S818: 11,14
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M069 ! 2106T
SX Male
CA Cancer cell line
//
ID 2106T
AC CVCL_M069
DR CLS; 300165/p13898_2106T
RX PubMed=21684623;
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10
ST D16S539: 8,11
ST D5S818: 11,14
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M068 ! 2106LN
SX Male
CA Cancer cell line
//
ID 211 BLCL
AC CVCL_E375
DR ECACC; 94031660
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 211-LCL
AC CVCL_8069
DR CLO; CLO_0051017
DR BioSample; SAMN03471957
DR RCB; RCB2288
DR TKG; TKG 0616
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 7,11
ST D13S317: 8,10
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 11
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 211-LCL-MUC1
AC CVCL_8070
DR CLO; CLO_0050079
DR RCB; RCB1876
DR TKG; TKG 0615
CC Transfected with: HGNC; 7508; MUC1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 7,11
ST D13S317: 8,10
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 11
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8069 ! 211-LCL
SX Male
CA Transformed cell line
//
ID 211A
AC CVCL_U658
SY Line 211A
RX Patent=US7232899;
RX PubMed=9634089;
CC Group: Adenovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 211B
AC CVCL_U659
SY Line 211B
RX Patent=US7232899;
RX PubMed=9634089;
CC Group: Adenovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 211R
AC CVCL_U660
SY Line 211R
RX Patent=US7232899;
RX PubMed=9634089;
CC Group: Adenovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 212 BLCL
AC CVCL_E376
DR ECACC; 94031661
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 213 BLCL
AC CVCL_E377
DR ECACC; 94031662
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 214 BLCL
AC CVCL_E378
DR ECACC; 94031663
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 215 BLCL
AC CVCL_E379
DR ECACC; 94031664
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 215-2
AC CVCL_J867
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 216 BLCL
AC CVCL_E380
DR ECACC; 94031665
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 218A
AC CVCL_0B42
DR Cosmic; 2163760
RX PubMed=24812411;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 219
AC CVCL_G580
SY Anti PDGF hybridoma #219
DR CLO; CLO_0001195
DR ATCC; HB-9371
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 219 BLCL
AC CVCL_E381
DR ECACC; 94031666
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 21A7.B12.F8
AC CVCL_IV63
DR ATCC; PTA-8641
RX Patent=US8022175;
CC Monoclonal antibody target: Newcastle disease viruses HN protein.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 21B8
AC CVCL_0U24
DR ATCC; CRL-9301
RX Patent=US4834976;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 21H3
AC CVCL_DB42
DR ATCC; HB-9970
RX Patent=WO1990008185A1;
RX PubMed=2717936;
CC Characteristics: Produces a catalytic monoclonal antibody that acts as a lipase.
CC Discontinued: ATCC; HB-9970; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 21MT-1
AC CVCL_7931
SY 21MT1
RX DOI=10.1007/978-1-4612-0411-4_18;
RX PubMed=1977518;
RX PubMed=8482634;
RX PubMed=20458274;
CC Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC Doubling time: 36.8 +- 0.6 hours (in alpha H&E medium), 42.3 +- 4.7 hours (in D medium) (PubMed=8482634).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7932 ! 21MT-2
OI CVCL_7933 ! 21NT
OI CVCL_7934 ! 21PT
OI CVCL_IP81 ! H16F1
OI CVCL_IP82 ! H16N-2
OI CVCL_IP83 ! H16N-3
SX Female
CA Cancer cell line
//
ID 21MT-2
AC CVCL_7932
SY 21MT2
RX DOI=10.1007/978-1-4612-0411-4_18;
RX PubMed=1977518;
RX PubMed=8482634;
CC Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC Doubling time: 42.0 +- 2.5 hours (in alpha H&E medium), 42.3 +- 4.7 hours (in D medium) (PubMed=8482634).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7931 ! 21MT-1
OI CVCL_7933 ! 21NT
OI CVCL_7934 ! 21PT
OI CVCL_IP81 ! H16F1
OI CVCL_IP82 ! H16N-2
OI CVCL_IP83 ! H16N-3
SX Female
CA Cancer cell line
//
ID 21NT
AC CVCL_7933
DR GEO; GSM1664566
RX DOI=10.1007/978-1-4612-0411-4_18;
RX PubMed=1977518;
RX PubMed=8482634;
RX PubMed=20458274;
CC Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC Doubling time: 31.4 +- 2.6 hours (in alpha H&E medium), 38.6 +- 2.9 hours (in D medium) (PubMed=8482634).
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7931 ! 21MT-1
OI CVCL_7932 ! 21MT-2
OI CVCL_7934 ! 21PT
OI CVCL_IP81 ! H16F1
OI CVCL_IP82 ! H16N-2
OI CVCL_IP83 ! H16N-3
SX Female
CA Cancer cell line
//
ID 21PT
AC CVCL_7934
RX DOI=10.1007/978-1-4612-0411-4_18;
RX PubMed=1977518;
RX PubMed=8482634;
RX PubMed=20458274;
CC Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC Doubling time: 35.5 +- 1.1 hours (in alpha H&E medium), 42.3 +- 4.7 hours (in D medium) (PubMed=8482634).
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7931 ! 21MT-1
OI CVCL_7932 ! 21MT-2
OI CVCL_7933 ! 21NT
OI CVCL_IP81 ! H16F1
OI CVCL_IP82 ! H16N-2
OI CVCL_IP83 ! H16N-3
SX Female
CA Cancer cell line
//
ID 220 BLCL
AC CVCL_E382
DR ECACC; 94031667
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2211
AC CVCL_F248
DR CLO; CLO_0001012
DR CLDB; cl37
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID 222
AC CVCL_1T15
DR BioSample; SAMN03151885
RX PubMed=1918981;
RX PubMed=2227544;
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PA-1 derivative (PubMed=22710073).
CC Derived from metastatic site: Ascites.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0479 ! PA-1
SX Female
CA Cancer cell line
//
ID 222 BLCL
AC CVCL_E383
DR ECACC; 94031669
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 222-35C8
AC CVCL_J583
DR ATCC; HB-9052
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9052; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 222TR
AC CVCL_1T16
RX PubMed=1918981;
CC Problematic cell line: Contaminated. Parent cell line (222) has been shown to be a PA-1 derivative.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1T15 ! 222
SX Female
CA Cancer cell line
//
ID 223 BLCL
AC CVCL_E384
DR ECACC; 94031670
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 224 BLCL
AC CVCL_E385
DR ECACC; 94031671
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 225
AC CVCL_J594
DR CLO; CLO_0001196
DR ATCC; HB-8508
RX Patent=US4943533;
CC Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J593 ! NS-1-503
CA Hybridoma
//
ID 225 BLCL
AC CVCL_E386
DR ECACC; 94031675
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 225-1
AC CVCL_J868
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 225-G11
AC CVCL_F957
DR TKG; TKG 0608
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 2254-62.2
AC CVCL_6349
DR CLO; CLO_0001197
DR ATCC; CRL-8544
DR BCRC; 60184
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID 225C7
AC CVCL_DP91
DR GEO; GSM1040269
DR GEO; GSM1040339
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP65 ! HDF1419
SX Female
CA Induced pluripotent stem cell
//
ID 226H
AC CVCL_J621
DR CLO; CLO_0001198
DR ATCC; HB-12592
RX Patent=US6251395;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 227 BLCL
AC CVCL_E387
DR ECACC; 94031673
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 227-341-4
AC CVCL_CW45
RX PubMed=9230077;
WW http://dshb.biology.uiowa.edu/talinA-N-terminal
CC Monoclonal antibody target: UniProtKB; P0CE94; Dictyostelium discoideum talA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 228A
AC CVCL_0B43
DR Cosmic; 2163761
RX PubMed=24812411;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 22D1
AC CVCL_0F11
DR ATCC; CRL-2841
RX PubMed=14694198;
CC Monoclonal antibody target: UniProtKB; Q8CJ91; Mouse Cd209b.
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 22D6
AC CVCL_H534
SY 22-D6
RX PubMed=6277505;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 22F.Li
AC CVCL_2H35
DR ATCC; CRL-6530
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6530; true.
OX NCBI_TaxID=9704; ! Zalophus californianus
SX Sex undetermined
CA Finite cell line
//
ID 22Rv1
AC CVCL_1045
SY 22RV1; 22Rv-1; 22rV1; CWR22-Rv1; CWR22R-V1; CWR22-R1; CWR22Rv1; CWR22R
DR BTO; BTO:0002999
DR BTO; BTO:0005936
DR CLO; CLO_0001199
DR CLO; CLO_0001200
DR EFO; EFO_0002095
DR ATCC; CRL-2505
DR BCRC; 60545
DR BioSample; SAMN03471600
DR BioSample; SAMN03472052
DR CCLE; 22RV1_PROSTATE
DR CCRID; 3131C0001000700100
DR ChEMBL-Cells; CHEMBL3308004
DR ChEMBL-Targets; CHEMBL612657
DR Cosmic; 924100
DR Cosmic; 1075276
DR Cosmic; 1028699
DR Cosmic; 1071480
DR Cosmic; 1172629
DR Cosmic; 1330911
DR Cosmic; 1689707
DR Cosmic; 1995323
DR Cosmic; 2537791
DR Cosmic; 2580126
DR Cosmic-CLP; 924100
DR DSMZ; ACC-438
DR ECACC; 05092802
DR GDSC; 924100
DR GEO; GSM91926
DR GEO; GSM525793
DR GEO; GSM648815
DR GEO; GSM827396
DR GEO; GSM886837
DR GEO; GSM887900
DR GEO; GSM1374375
DR GEO; GSM1669565
DR IGRhCellID; 22Rv1
DR KCB; KCB 200731YJ
DR Lonza; 1442
RX PubMed=10462204;
RX PubMed=12725112;
RX PubMed=14518029;
RX PubMed=15486987;
RX PubMed=22460905;
RX PubMed=23671654;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://capcelllines.ca/details.asp?id=53
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-524.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~49 hours (PubMed=10462204); 55 hours (PubMed=25984343); 40-60 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (PubMed=23671654; Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 12
ST D18S51: 13,14
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 11,12,13 (ATCC; DSMZ)
ST D5S818: 11,12 (Cosmic-CLP; ECACC)
ST D5S818: 11,13 (PubMed=25877200)
ST D7S820: 9,10,11 (ATCC; DSMZ; PubMed=25877200)
ST D7S820: 10,11 (Cosmic-CLP; ECACC)
ST D8S1179: 13,14
ST FGA: 20,23
ST Penta D: 9,12
ST Penta E: 5,13
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 15,21
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3967 ! CWR22
SX Male
CA Cancer cell line
//
ID 22Rv1 R
AC CVCL_4Y35
RX PubMed=21982118;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1045 ! 22Rv1
SX Male
CA Cancer cell line
//
ID 23 ScCr
AC CVCL_3634
SY 10ScNCr/23
DR CLO; CLO_0001201
DR ATCC; CRL-2751
RX PubMed=12183533;
CC Breed/subspecies: C57BL/10ScN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID 230 BLCL
AC CVCL_E388
DR ECACC; 94031674
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 230699
AC CVCL_E437
SY TER149; TER198
DR dbMHC; 48455
DR IHW; IHW9370
DR IMGT/HLA; 25981
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 230C
AC CVCL_J804
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 23132/87
AC CVCL_1046
SY 23132-87; 2313287; St 23132; St23132
DR CLO; CLO_0001202
DR EFO; EFO_0006528
DR CLDB; cl38
DR BioSample; SAMN03470944
DR BioSample; SAMN03473375
DR CCLE; 2313287_STOMACH
DR ChEMBL-Cells; CHEMBL3308702
DR ChEMBL-Targets; CHEMBL1075382
DR Cosmic; 910924
DR Cosmic; 1995324
DR Cosmic; 2484956
DR Cosmic-CLP; 910924
DR DSMZ; ACC-201
DR GDSC; 910924
DR GEO; GSM827572
DR GEO; GSM886838
DR GEO; GSM887901
DR GEO; GSM1374371
DR GEO; GSM1374372
DR GEO; GSM1669566
DR Lonza; 312
RX PubMed=8100658;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 9,10 (Cosmic-CLP)
ST CSF1PO: 8,9,10 (DSMZ; PubMed=25877200)
ST D13S317: 11,12
ST D16S539: 11,14 (Cosmic-CLP; DSMZ)
ST D16S539: 11,13,14 (PubMed=25877200)
ST D18S51: 12,13
ST D19S433: 12,13
ST D21S11: 28,31.2
ST D2S1338: 17,19,20
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 10,12,13 (Cosmic-CLP; DSMZ)
ST D7S820: 9.3,12 (PubMed=25877200)
ST D8S1179: 11,12,13,15
ST FGA: 21,22
ST Penta D: 9,12
ST Penta E: 6,16
ST TH01: 9,9.3
ST TPOX: 10,11
ST vWA: 15,18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 232
AC CVCL_G581
SY Anti PDGF hybridoma #232
DR CLO; CLO_0001203
DR ATCC; HB-9372
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 232-A4
AC CVCL_Y556
SY 232 A4-LCL; 232A4
DR DSMZ; ACC-774
RX PubMed=8127151;
RX PubMed=23297799;
CC Doubling time: ~30-40 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 9,13
ST D5S818: 10
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y436 ! 232-B4
SX Male
CA Transformed cell line
//
ID 232-B4
AC CVCL_Y436
SY 232 B4-CLL; 232B4
DR NCBI_Iran; C545
RX PubMed=8127151;
RX PubMed=23297799;
CC Misspelling: '2J2-B4' in NCBI_Iran C545.
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y556 ! 232-A4
SX Male
CA Transformed cell line
//
ID 233 BLCL
AC CVCL_E389
DR ECACC; 11061001
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 234 BLCL
AC CVCL_E390
DR ECACC; 94031676
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 235-1
AC CVCL_U363
RX PubMed=6433612;
RX PubMed=15541569;
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_2117 ! MMQ
CA Cancer cell line
//
ID 236L
AC CVCL_J622
DR CLO; CLO_0001204
DR ATCC; HB-12593
RX Patent=US6251395;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 239 BLCL
AC CVCL_E391
DR ECACC; 94031678
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 23A-5-21S
AC CVCL_G582
DR CLO; CLO_0001205
DR ATCC; HB-36
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 23B2
AC CVCL_S152
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 23B6
AC CVCL_9151
DR CLO; CLO_0001206
DR ATCC; HB-8521
CC Discontinued: ATCC; HB-8521; probable.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID 23CLN
AC CVCL_6530
DR CLO; CLO_0001207
DR CLO; CLO_0050472
DR CLDB; cl39
DR ECACC; 94042257
DR RCB; RCB0179
WW http://cell.brc.riken.jp/en/announcement/23cln
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of bovine origin but found to be a porcine cell (see Riken web site).
CC Discontinued: ECACC; 94042257; probable.
CC Discontinued: RCB; RCB0179; true.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID 23F2G
AC CVCL_4W87
DR ATCC; HB-11081
RX Patent=US5854070;
CC Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 240-13D10
AC CVCL_E974
DR CLO; CLO_0001208
DR ATCC; CRL-2672
DR ATCC; HB-9144
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9144; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 240A
AC CVCL_J805
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 240E-W
AC CVCL_Z068
RX Patent=US7429487;
RX PubMed=21633632;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_J972 ! 240E1-1-2
CA Cancer cell line
//
ID 240E-W2
AC CVCL_Z069
RX Patent=US7429487;
RX PubMed=21633632;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_Z068 ! 240E-W
CA Cancer cell line
//
ID 240E1-1
AC CVCL_J971
SY 240E1; 240E-1
DR ATCC; CRL-11872
RX Patent=US5675063;
RX PubMed=7568130;
RX PubMed=21633632;
CC Discontinued: ATCC; CRL-11872; true.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Cancer cell line
//
ID 240E1-1-2
AC CVCL_J972
SY 240E 1-1-2; 240E-1-1-2
DR ATCC; HB-11870
RX Patent=US5675063;
RX PubMed=7568130;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Discontinued: ATCC; HB-11870; probable.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_J971 ! 240E1-1
CA Cancer cell line
//
ID 241-10C10
AC CVCL_0F05
DR ATCC; CRL-2671
CC Discontinued: ATCC; CRL-2671; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 242 BLCL
AC CVCL_E392
DR ECACC; 94031680
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2427T
AC CVCL_M070
DR CLS; 300167/p13917_2427T
RX PubMed=21684623;
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 8
ST D16S539: 12
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 10,11
ST vWA: 14,18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 243
AC CVCL_D570
RX PubMed=16357141;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 243H1
AC CVCL_C102
SY KUIFMSi009-A
DR hPSCreg; KUIFMSi009-A
DR ISCR; 39
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 243H7
AC CVCL_C103
SY KUIFMSi009-B
DR hPSCreg; KUIFMSi009-B
DR ISCR; 40
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 245 BLCL
AC CVCL_E393
DR ECACC; 94031681
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 245A
AC CVCL_J806
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 245E7
AC CVCL_J904
DR ATCC; HB-8489
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 246 BLCL
AC CVCL_E394
DR ECACC; 94031682
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 246B1
AC CVCL_C237
DR ISCR; 41
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 246B2
AC CVCL_C238
DR ISCR; 42
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 246B3
AC CVCL_C239
DR ISCR; 43
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 246B4
AC CVCL_C240
DR ISCR; 44
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 246B5
AC CVCL_C241
DR ISCR; 45
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 246B6
AC CVCL_C242
DR ISCR; 46
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 246G1
AC CVCL_C243
SY KUIFMSi011-A
DR GEO; GSM1040270
DR GEO; GSM1040340
DR GEO; GSM1489424
DR hPSCreg; KUIFMSi011-A
DR ISCR; 47
RX PubMed=18035408;
RX PubMed=24259714;
CC From: Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 246G3
AC CVCL_C244
SY KUIFMSi011-B
DR hPSCreg; KUIFMSi011-B
DR ISCR; 48
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 246G4
AC CVCL_C245
SY KUIFMSi011-C
DR hPSCreg; KUIFMSi011-C
DR ISCR; 49
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 246G5
AC CVCL_C246
SY KUIFMSi011-D
DR hPSCreg; KUIFMSi011-D
DR ISCR; 50
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 246G6
AC CVCL_C247
SY KUIFMSi011-E
DR hPSCreg; KUIFMSi011-E
DR ISCR; 51
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 247 BLCL
AC CVCL_E395
DR ECACC; 94031683
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2474/90
AC CVCL_9556
SY St 2474; St2474
DR BioSample; SAMN03151783
RX PubMed=8100658;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a gastric carcinoma.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID 249L4
AC CVCL_L025
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID 24BC
AC CVCL_S153
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 24IA2E2E10D5
AC CVCL_G583
SY 24IA2
DR CLO; CLO_0001209
DR ATCC; HB-8049
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 25-32
AC CVCL_J715
DR ECACC; 91060546
CC Monoclonal antibody target: UniProtKB; W5QBV7; Sheep CD44.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 25-5-16S
AC CVCL_G584
DR CLO; CLO_0001211
DR ATCC; HB-37
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 25-9-17S
AC CVCL_D660
SY 25.9.17S
DR BCRJ; 0008
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 25-9-17S II
AC CVCL_G335
DR CLO; CLO_0001212
DR ATCC; HB-26
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D660 ! 25-9-17S
CA Hybridoma
//
ID 25-9-3S
AC CVCL_G585
DR CLO; CLO_0001213
DR ATCC; HB-38
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 25/1506
AC CVCL_E438
DR dbMHC; 48456
DR IHW; IHW9252
DR IMGT/HLA; 10112
WW http://bioinformatics.hsanmartino.it/ecbr/cl252.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 250-9G06
AC CVCL_J584
DR ATCC; HB-9260
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9260; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 251 BLCL
AC CVCL_E396
DR ECACC; 94031685
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 252 BLCL
AC CVCL_E397
DR ECACC; 94031686
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 253D
AC CVCL_5449
DR CLO; CLO_0001210
DR CLDB; cl41
DR ECACC; 93090807
RX PubMed=8795574;
CC Discontinued: ECACC; 93090807; probable.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 253F1
AC CVCL_B513
DR ISCR; 52
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 253F2
AC CVCL_B514
DR ISCR; 53
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 253F3
AC CVCL_B515
DR ISCR; 54
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 253F4
AC CVCL_B516
DR ISCR; 55
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 253F5
AC CVCL_B517
DR ISCR; 1
RX PubMed=18035408;
CC From: Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 253G1
AC CVCL_B518
SY 253-G1
DR GEO; GSM1040251
DR GEO; GSM1040321
DR GEO; GSM1489219
DR GEO; GSM1489425
DR RCB; HPS0002
DR SKIP; SKIP000002
RX PubMed=18059259;
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 253G4
AC CVCL_T792
SY 253-G4; 253G-4
DR GEO; GSM1040252
DR GEO; GSM1040322
DR GEO; GSM1489220
DR GEO; GSM1489250
DR GEO; GSM1489426
RX PubMed=18059259;
RX PubMed=21460823;
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 253J
AC CVCL_7935
AS CVCL_7938
SY 253-J; 253 J; 253J-P; 253J-Parental; 253J P; 253JP
DR BTO; BTO:0004796
DR CCLE; 253J_URINARY_TRACT
DR Cosmic; 715794
DR Cosmic; 760476
DR Cosmic; 845564
DR Cosmic; 925827
DR Cosmic; 928820
DR Cosmic; 1016884
DR Cosmic; 1046680
DR Cosmic; 1082644
DR Cosmic; 1938694
DR Cosmic; 1285102
DR Cosmic; 1285997
DR Cosmic; 1927305
DR Cosmic; 2050426
DR Cosmic; 2057433
DR Cosmic; 2444255
DR GEO; GSM1574546
DR GEO; GSM1574574
DR KCLB; 80001
RX PubMed=66978;
RX PubMed=327080;
RX PubMed=944089;
RX PubMed=3708594;
RX PubMed=4431054;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=7658585;
RX PubMed=8873383;
RX PubMed=11207054;
RX PubMed=12127398;
RX PubMed=16885334;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=26621286;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): KCLB; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D18S51: 11,13
ST D21S11: 28,29
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 9
ST D8S1179: 11
ST FGA: 23,24
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 253J laval
AC CVCL_7936
SY 253J-Laval; 253JLAVAL
DR BTO; BTO:0004893
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7935 ! 253J
SX Male
CA Cancer cell line
//
ID 253J-BV
AC CVCL_7937
SY 253JB-V; 253J B-V; 253JBV
DR BTO; BTO:0004894
DR CCLE; 253JBV_URINARY_TRACT
DR Cosmic; 846282
DR Cosmic; 1082645
DR Cosmic; 1938695
DR KCLB; 80002
RX PubMed=7658585;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Derived from metastatic site: Lymph node.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 9
ST FGA: 23,24
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7935 ! 253J
SX Male
CA Cancer cell line
//
ID 253J-Lung-IV
AC CVCL_6G34
SY 253J-Lung
RX PubMed=7658585;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7935 ! 253J
SX Male
CA Cancer cell line
//
ID 256 BLCL
AC CVCL_E398
DR ECACC; 94031687
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2563
AC CVCL_M629
DR BioSample; SAMN03151658
RX CelloPub=CLPUB00262;
RX PubMed=66321;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388). Originally thought to originate from a male patient lung adenocarcinoma. The 2563 cell line is said to be derived from the MAC-21 cell line (CVCL_M627) which is also HeLa contaminated but which has never been tested for such a contamination.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID 257 BLCL
AC CVCL_E399
DR ECACC; 94031689
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 259 BLCL
AC CVCL_E400
DR ECACC; 94031691
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 25B
AC CVCL_S154
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 26-7-11S
AC CVCL_G586
DR CLO; CLO_0001217
DR ATCC; HB-15
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 26-8-16S
AC CVCL_G587
DR CLO; CLO_0001218
DR ATCC; HB-42
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 26/27
AC CVCL_E439
SY 02627
DR dbMHC; 48457
DR ECACC; 94022517
DR IHW; IHW9251
DR IMGT/HLA; 10114
WW http://bioinformatics.hsanmartino.it/ecbr/cl251.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 260-33C4
AC CVCL_J623
DR CLO; CLO_0001215
DR ATCC; CRL-2667
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 260F9
AC CVCL_J908
DR ATCC; HB-8488
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 260F9-1C9
AC CVCL_J909
DR ATCC; HB-8662
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J908 ! 260F9
CA Hybridoma
//
ID 261-1F3
AC CVCL_0F04
DR ATCC; CRL-2666
CC Discontinued: ATCC; CRL-2666; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 262C
AC CVCL_J807
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 264040
AC CVCL_V365
DR IMGT/HLA; 14451
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 2645-94
AC CVCL_S816
SY MLS 2645-94
RX PubMed=10449603;
RX PubMed=16651630;
RX PubMed=20515481;
RX PubMed=25393000;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 264E
AC CVCL_J808
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 265A
AC CVCL_J809
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 266-6
AC CVCL_3481
DR CLO; CLO_0001216
DR ATCC; CRL-2151
DI NCIt; C34036; Mouse pancreatic acinar neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 266B2
AC CVCL_J912
DR ATCC; HB-8486
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 267B1
AC CVCL_4827
DR EFO; EFO_0001080
RX PubMed=2541897;
RX PubMed=8378190;
RX PubMed=12085227;
WW http://capcelllines.ca/details.asp?id=131
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_K058 ! 272E1
OI CVCL_K059 ! 272E4
SX Male
CA Transformed cell line
//
ID 267B1/Ki-ras
AC CVCL_9871
SY 267B1/Ki-Ras; 267B1 Ki-ras; 267B1/v-Ki-ras; 267B1/K-Ras; 267B1/Kras
DR EFO; EFO_0001081
RX PubMed=8378190;
RX PubMed=12085227;
CC Transfected with: UniProtKB; P01117; Kirsten murine sarcoma virus Ki-Ras.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4827 ! 267B1
SX Male
CA Transformed cell line
//
ID 267T2
AC CVCL_8101
DR BTO; BTO:0002973
RX PubMed=9427718;
CC Breed/subspecies: C57BL/Ka.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 2681943
AC CVCL_V366
DR IMGT/HLA; 14459
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 26931
AC CVCL_E440
DR dbMHC; 48458
DR ECACC; 94071422
DR IHW; IHW9276
DR IMGT/HLA; 10116
WW http://bioinformatics.hsanmartino.it/ecbr/cl276.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 26B
AC CVCL_S155
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 26CB-1
AC CVCL_4087
SY 26 CB1
DR CLO; CLO_0001214
DR CLO; CLO_0001219
DR CLDB; cl42
DR ATCC; CRL-1495
DR ECACC; 89072101
RX PubMed=186420;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
OX NCBI_TaxID=9557; ! Papio hamadryas
OI CVCL_9Q48 ! 8CB-1
OI CVCL_9Q47 ! 13CB-1
SX Male
CA Transformed cell line
//
ID 26ic
AC CVCL_J624
DR CLO; CLO_0001220
DR ATCC; HB-246
DR NCBI_Iran; H160
CC Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 26v-006
AC CVCL_6D18
DR RCB; AES1232
CC Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 26v-009
AC CVCL_6D19
DR RCB; AES1233
CC Knockout cell: Method=Gene trap; MGI; MGI:99204; Zfp57.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 26v-023
AC CVCL_6D20
DR RCB; AES1240
CC Knockout cell: Method=Gene trap; MGI; MGI:1860486; Tdp2.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 2708
AC CVCL_E441
SY DURO
DR dbMHC; 48459
DR ECACC; 94071406
DR IHW; IHW9341
DR IMGT/HLA; 10119
WW http://bioinformatics.hsanmartino.it/ecbr/cl341.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94071406; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 272E1
AC CVCL_K058
RX PubMed=2541897;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4827 ! 267B1
OI CVCL_K059 ! 272E4
SX Male
CA Transformed cell line
//
ID 272E4
AC CVCL_K059
RX PubMed=2541897;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4827 ! 267B1
OI CVCL_K058 ! 272E1
SX Male
CA Transformed cell line
//
ID 273T
AC CVCL_X482
DR Cosmic; 910551
DR GEO; GSM784285
DR GEO; GSM827491
RX PubMed=15735034;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 274D
AC CVCL_J810
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 277-LCL
AC CVCL_8073
DR CLO; CLO_0051016
DR BioSample; SAMN03471953
DR RCB; RCB2283
DR TKG; TKG 0609
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 9,11
ST D16S539: 10,11
ST D5S818: 10,11
ST D7S820: 10
ST TH01: 8,9
ST TPOX: 9,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 27b
AC CVCL_8997
SY iPS-27b; hiPS-27b; 27b-ALS
DR EFO; EFO_0007109
DR ENCODE; ENCBS466JVT
DR GEO; GSM670070
DR ISCR; 1631
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/0000012c-c6db-a8a9-a061-4a6580000000
CC From: Harvard University; Boston; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8998 ! 27e
SX Female
CA Induced pluripotent stem cell
//
ID 27e
AC CVCL_8998
SY iPS-27e; hiPS-27e; 27e-ALS
DR EFO; EFO_0007110
DR ENCODE; ENCBS626IJF
DR GEO; GSM670064
DR ISCR; 1632
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/00000144-0881-cdae-0803-96bd80000000
CC From: Harvard University; Boston; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8997 ! 27b
SX Female
CA Induced pluripotent stem cell
//
ID 27X1
AC CVCL_0B44
DR Cosmic; 2163757
RX PubMed=24812411;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 28-11-5S
AC CVCL_G588
DR CLO; CLO_0001221
DR ATCC; HB-19
DR IZSLER; BS Hy 60
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 28-13-3S
AC CVCL_G589
DR CLO; CLO_0001222
DR ATCC; HB-41
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 28-14-8S
AC CVCL_G590
DR CLO; CLO_0001223
DR ATCC; HB-27
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 28-16-8S
AC CVCL_G591
DR CLO; CLO_0001224
DR ATCC; HB-35
RX PubMed=6935293;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 28-2-7
AC CVCL_0E28
DR ATCC; CRL-2487
RX PubMed=9455702;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 28-4-3
AC CVCL_0E29
RX PubMed=9455702;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 28-5-15
AC CVCL_0E30
DR ATCC; CRL-2490
RX PubMed=9455702;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 28-6-20
AC CVCL_0E31
DR ATCC; CRL-2489
RX PubMed=9455702;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 28-8-6S
AC CVCL_G592
DR CLO; CLO_0001226
DR ATCC; HB-51
DR KCLB; 80051
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 280599
AC CVCL_E442
DR dbMHC; 48460
DR IHW; IHW9368
DR IMGT/HLA; 25979
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 280A
AC CVCL_J811
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 280B
AC CVCL_J812
RX PubMed=6189834;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 280D11
AC CVCL_J911
DR ATCC; HB-8487
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 283TAg
AC CVCL_6554
DR CLO; CLO_0001225
DR ATCC; CRL-2822
CC Knockout cell: Method=KO mouse; MGI; MGI:97073; Mpg.
CC Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 286-1
AC CVCL_J869
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 287-3
AC CVCL_J870
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 288-3
AC CVCL_J871
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 289 DPP3
AC CVCL_GZ32
RX PubMed=8752169;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8760 ! T-289
CA Cancer cell line
//
ID 289 TAM6
AC CVCL_GZ33
SY 289/TAM6
RX PubMed=8752169;
RX PubMed=10661763;
CC Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8760 ! T-289
CA Cancer cell line
//
ID 28iALS-n1
AC CVCL_W558
DR SKIP; SKIP000320
RX PubMed=24154603;
CC Characteristics: Has a hexanucleotide repeat expansion in the 1st intron of C9orf72.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 28S.3
AC CVCL_5486
DR CLO; CLO_0001227
DR ATCC; CRL-2758
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 28SC-ES
AC CVCL_EP74
SY 28SC-Endotoxin Sensitive
DR JCRB; JCRB1647
RX PubMed=12944673;
CC Problematic cell line: Probably contaminated. From its STR profile the parent cell line (SC) seems to be a U-937 derivative.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6444 ! SC
SX Male
CA Cancer cell line
//
ID 29.0.C.27
AC CVCL_V061
DR CLO; CLO_0001228
DR CLDB; cl43
DR IHW; IHW8131
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID 290-4E10
AC CVCL_J547
DR CLO; CLO_0001229
DR ATCC; CRL-2662
DR ATCC; HB-9133
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9133; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 292W
AC CVCL_6G30
RX PubMed=944089;
RX PubMed=6244232;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 293 EcR Shh
AC CVCL_6351
DR CLO; CLO_0001232
DR ATCC; CRL-2782
DR ATCC; JHU-64
CC Transfected with: MGI; MGI:98297; Shh.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-2782; true.
CC Discontinued: ATCC; JHU-64; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293 GTP-AC-free
AC CVCL_2285
DR ECACC; 05011003
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293 N3S
AC CVCL_2286
SY 293N3S
DR CLO; CLO_0001233
DR CLDB; cl48
DR ATCC; CRL-2125
DR ECACC; 92052131
RX PubMed=3819703;
CC Doubling time: 30 hours (ECACC).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-2125; true.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293 TRE/Cont
AC CVCL_4W25
DR JCRB; JCRB1533
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293 TRE/FLAG-POLK
AC CVCL_4W26
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-CD40
AC CVCL_9832
SY 293.CD40
DR BTO; BTO:0003466
CC Transfected with: HGNC; 11919; CD40.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-CD40L
AC CVCL_4V25
RX PubMed=16040385;
CC Transfected with: HGNC; 11935; CD40LG.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-CD40L-sCD40L
AC CVCL_4V26
RX PubMed=16040385;
CC Transfected with: HGNC; 11935; CD40LG.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V25 ! 293-CD40L
SX Female
CA Transformed cell line
//
ID 293-Db
AC CVCL_8468
SY 293Db; 293DB; 293 Db
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-Hektor
AC CVCL_2283
DR ECACC; 05030204
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-IL-1RI
AC CVCL_9831
SY 293.IL-1RI; 293/IL-1RI; 293 IL-1RI; HEK293R1; HEK293RI; HEK293-IL-1RI
DR BTO; BTO:0003465
RX PubMed=8837778;
CC Transfected with: HGNC; 5993; IL1R1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-Kb
AC CVCL_8469
SY 293Kb; 293KB; 293 Kb
DR CCRID; 3111C0001CCC000154
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-LA
AC CVCL_A783
SY 293 clone LA
RX PubMed=7537736;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-PERV-PK-CIRCE
AC CVCL_2284
DR ECACC; 97051411
RX PubMed=9055854;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293-VnR
AC CVCL_M907
SY HEK-293VnR; HEK293VnR; 293VnR; 293-15D
DR BTO; BTO:0005839
RX Patent=US5578704;
RX Patent=US5652110;
RX PubMed=7683273;
CC Transfected with: HGNC; 6150; ITGAV.
CC Transfected with: HGNC; 6156; ITGB3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/5-HT7/CRE-Luc
AC CVCL_H361
WW http://www.genscript.com/molecule/M00423-5-HT7.html
CC Transfected with: HGNC; 5302; HTR7.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H364 ! 293/CRE-Luc
SX Female
CA Transformed cell line
//
ID 293/ACE2
AC CVCL_DR94
DR PRIDE; PXD001330
RX PubMed=14647384;
RX PubMed=25764339;
CC Transfected with: HGNC; 13557; ACE2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293/ADORA1/Galpha15
AC CVCL_H362
WW http://www.genscript.com/molecule/M00255-ADORA1.html
CC Transfected with: HGNC; 262; ADORA1.
CC Transfected with: HGNC; 4383; GNA15.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/ADRB3/CRE-Luc
AC CVCL_H363
WW http://www.genscript.com/molecule/M00335-ADRB3.html
CC Transfected with: HGNC; 288; ADRB3.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H364 ! 293/CRE-Luc
SX Female
CA Transformed cell line
//
ID 293/CHE-Fc
AC CVCL_6352
DR CLO; CLO_0001234
DR ATCC; CRL-2368
RX PubMed=8052660;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/CRE-Luc
AC CVCL_H364
SY 293/CRE-Luciferase
WW http://www.genscript.com/molecule/M00188-CRE_Luc.html
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/CrmA
AC CVCL_J499
SY 293-CrmA
DR CLO; CLO_0050892
DR BioSample; SAMN03472112
DR RCB; RCB1668
RX PubMed=9874266;
CC Transfected with: UniProtKB; P33967; B.cereus Bsr.
CC Transfected with: UniProtKB; P07385; Cowpox virus crmA.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 13
ST D5S818: 8,9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/D4
AC CVCL_H365
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 3025; DRD4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/EP1
AC CVCL_H366
WW http://www.genscript.com/molecule/M00228-EP1.html
CC Transfected with: HGNC; 9593; PTGER1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/EP4
AC CVCL_H367
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 9596; PTGER4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/FP/Galpha15
AC CVCL_H368
WW http://www.genscript.com/molecule/M00155-FP.html
CC Transfected with: HGNC; 9600; PTGFR.
CC Transfected with: HGNC; 4383; GNA15.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/GHRH/Galpha15
AC CVCL_H369
WW http://www.genscript.com/molecule/M00314-GHRH.html
CC Transfected with: HGNC; 4266; GHRHR.
CC Transfected with: HGNC; 4383; GNA15.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/H1
AC CVCL_H370
WW http://www.genscript.com/molecule/M00131-H1.html
CC Transfected with: HGNC; 5182; HRH1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hMD2-CD14
AC CVCL_Y384
WW http://www.invivogen.com/293-md2-cd14
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 17156; LY96.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR1-HA
AC CVCL_Y385
WW http://www.invivogen.com/293-tlr1-ha
CC Transfected with: HGNC; 11847; TLR1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR10-HA
AC CVCL_Y386
WW http://www.invivogen.com/293-tlr10-ha
CC Transfected with: HGNC; 15634; TLR10.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR1-TLR2
AC CVCL_Y417
SY 293-hTLR1/TLR2; 293-hTLR1/2
WW http://www.invivogen.com/PDF/293-hTLR1-2_TDS.pdf
CC Transfected with: HGNC; 11847; TLR1.
CC Transfected with: HGNC; 11848; TLR2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR2
AC CVCL_Y387
WW http://www.invivogen.com/293-tlr2
CC Transfected with: HGNC; 11848; TLR2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR2-CD14
AC CVCL_Y388
SY HEK293-TLR2-CD14
DR NCBI_Iran; C632
WW http://www.invivogen.com/293-tlr2-cd14
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 11848; TLR2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR2-HA
AC CVCL_Y389
WW http://www.invivogen.com/293-tlr2-ha
CC Transfected with: HGNC; 11848; TLR2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR2-TLR6
AC CVCL_Y390
SY HEK293-hTLR2/6
DR NCBI_Iran; C630
WW http://www.invivogen.com/293-tlr2-6
CC Transfected with: HGNC; 11848; TLR2.
CC Transfected with: HGNC; 16711; TLR6.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR3
AC CVCL_Y391
WW http://www.invivogen.com/293-tlr3
CC Transfected with: HGNC; 11849; TLR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR3-HA
AC CVCL_Y392
WW http://www.invivogen.com/293-tlr3-ha
CC Transfected with: HGNC; 11849; TLR3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR4A
AC CVCL_Y393
SY 293/hTLR4
WW http://www.invivogen.com/293-tlr4
CC Transfected with: HGNC; 11850; TLR4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR4-HA
AC CVCL_Y394
WW http://www.invivogen.com/293-tlr4-ha
CC Transfected with: HGNC; 11850; TLR4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR4A-MD2-CD14
AC CVCL_Y395
WW http://www.invivogen.com/293-tlr4-md2-cd14
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 17156; LY96.
CC Transfected with: HGNC; 11850; TLR4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR5
AC CVCL_Y396
SY HEK293-hTLR5; HEK293-hTLR-5
WW http://www.invivogen.com/293-tlr5
CC Transfected with: HGNC; 11851; TLR5.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR5-CD14
AC CVCL_Y397
WW http://www.invivogen.com/293-tlr5-cd14
CC Transfected with: HGNC; 1628; CD14.
CC Transfected with: HGNC; 11851; TLR5.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR5-HA
AC CVCL_Y398
WW http://www.invivogen.com/293-tlr5-ha
CC Transfected with: HGNC; 11851; TLR5.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/hTLR6-HA
AC CVCL_Y399
WW http://www.invivogen.com/293-tlr6-ha
CC Transfected with: HGNC; 16711; TLR6.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/KDR
AC CVCL_9V14
SY HEK29-KDR
DR NCBI_Iran; C589
RX PubMed=11570839;
CC Transfected with: HGNC; 6307; KDR.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/LacZ
AC CVCL_Y101
SY 293 / LacZ
WW http://www.invivogen.com/PDF/293-LacZ_TDS.pdf
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/MC3/CRE-Luc
AC CVCL_H371
WW http://www.genscript.com/molecule/M00337-MC3.html
CC Transfected with: HGNC; 6931; MC3R.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H364 ! 293/CRE-Luc
SX Female
CA Transformed cell line
//
ID 293/MCH1
AC CVCL_H372
WW http://www.genscript.com/molecule/M00211-MCH1.html
CC Transfected with: HGNC; 4479; /MCHR1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR1
AC CVCL_Y400
WW http://www.invivogen.com/293-tlr1
CC Transfected with: MGI; MGI:1341295; Tlr1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR1-TLR2
AC CVCL_Y401
SY 293-mTLR1/2
WW http://www.invivogen.com/293-tlr1-2
CC Transfected with: MGI; MGI:1341295; Tlr1.
CC Transfected with: MGI; MGI:1346060; Tlr2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR2
AC CVCL_Y402
WW http://www.invivogen.com/293-tlr2
CC Transfected with: MGI; MGI:1346060; Tlr2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR2-TLR6
AC CVCL_Y403
SY 293-mTLR2/6
WW http://www.invivogen.com/293-tlr2-6
CC Transfected with: MGI; MGI:1346060; Tlr2.
CC Transfected with: MGI; MGI:1341296; Tlr6.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR3
AC CVCL_Y404
WW http://www.invivogen.com/293-tlr3
CC Transfected with: MGI; MGI:2156367; Tlr3.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR4
AC CVCL_Y405
WW http://www.invivogen.com/293-tlr4
CC Transfected with: MGI; MGI:96824; Tlr4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR4-MD2-CD14
AC CVCL_Y406
WW http://www.invivogen.com/293-tlr4-md2-cd14
CC Transfected with: MGI; MGI:88318; Cd14.
CC Transfected with: MGI; MGI:1341909; Ly96.
CC Transfected with: MGI; MGI:96824; Tlr4.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR5
AC CVCL_Y407
SY HEK293-mTLR-5
WW http://www.invivogen.com/293-tlr5
CC Transfected with: MGI; MGI:1858171; Tlr5.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR6
AC CVCL_Y408
WW http://www.invivogen.com/293-tlr6
CC Transfected with: MGI; MGI:1341296; Tlr6.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/mTLR9
AC CVCL_Y409
WW http://www.invivogen.com/293-tlr9
CC Transfected with: MGI; MGI:1932389; Tlr9.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/NPY1
AC CVCL_H373
WW http://www.genscript.com/catalog_cell_lines.html
CC Transfected with: HGNC; 7956; NPY1R.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/pmiR-155
AC CVCL_IM63
DR GEO; GSM235038
DR GEO; GSM235039
DR GEO; GSM235040
DR GEO; GSM235041
RX PubMed=17881434;
CC Transfected with: HGNC; 31542; MIR155.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/pmiR-K12-11
AC CVCL_IM64
DR GEO; GSM235042
DR GEO; GSM235043
DR GEO; GSM235044
DR GEO; GSM235045
RX PubMed=17881434;
CC Transfected with: KSHV-miR-K12-11.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293/PTH2/CRE-Luc
AC CVCL_H374
WW http://www.genscript.com/molecule/M00270-PTH2.html
CC Transfected with: HGNC; 9609; PTH2R.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H364 ! 293/CRE-Luc
SX Female
CA Transformed cell line
//
ID 293/TP
AC CVCL_H375
WW http://www.genscript.com/molecule/M00309-TP.html
CC Transfected with: HGNC; 11608; TBXA2R.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293B9
AC CVCL_L026
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID 293Flp-In T-REx MAPPIT
AC CVCL_6E37
SY 293FTM
DR BioSamples; SAMEA2018186
RX PubMed=25182477;
WW http://hek293genome.org/v2/
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Omics: Genome sequenced.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U427 ! Flp-In-T-REx-293
SX Female
CA Transformed cell line
//
ID 293GP
AC CVCL_E072
SY 293-GP; 293gp; GP-293
DR CLO; CLO_0050902
DR NCBI_Iran; C560
DR RCB; RCB2354
RX PubMed=7937806;
RX PubMed=8396259;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293GP/bsr
AC CVCL_5F70
SY 293gp/bsr; 293 gp/bsr
RX PubMed=10535980;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P33967; B.cereus Bsr.
CC Transfected with: UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E072 ! 293GP
SX Female
CA Transformed cell line
//
ID 293GP/LZRNL
AC CVCL_5F71
SY 293GP-LZRNL
RX PubMed=7937806;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transfected with: UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E072 ! 293GP
SX Female
CA Transformed cell line
//
ID 293LAP10
AC CVCL_DD14
SY 293Lap10
DR ATCC; CRL-12586
RX Patent=WO2000006751A2;
RX PubMed=10073694;
CC Transfected with: UniProtKB; P03023; E.coli lacI (modified version LAP348 with at the N-terminal a nuclear localization signal from SV40 T antigen and at the C-terminal the transactivator domain from HSV-1 VP16/Vmw65).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-12586; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293LAP13
AC CVCL_DD15
SY 293Lap13
DR ATCC; CRL-12587
RX Patent=WO2000006751A2;
RX PubMed=10073694;
CC Transfected with: UniProtKB; P03023; E.coli lacI (modified version LAP348 with at the N-terminal a nuclear localization signal from SV40 T antigen and at the C-terminal the transactivator domain from HSV-1 VP16/Vmw65).
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-12587; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293RC21
AC CVCL_W338
RX PubMed=10953917;
CC Group: Adeno-associated virus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293sars181A
AC CVCL_V648
DR CCRID; 3111C0001CCC000170
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 293SGlycoDelete
AC CVCL_6E38
SY 293SGGD
DR BioSamples; SAMEA2018187
RX PubMed=24752077;
RX PubMed=25182477;
WW http://hek293genome.org/v2/
CC Transfected with: UniProtKB; C4RA89; H.jecorina endoT.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Omics: Genome sequenced.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A785 ! HEK293S GnTI-
SX Female
CA Transformed cell line
//
ID 293T GNE
AC CVCL_0V13
DR BioSample; SAMN03471905
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 17,19
ST D21S11: 28,30.2
ST D3S1358: 15,17
ST D5S818: 8,9
ST D7S820: 11,12
ST D8S1179: 11,12,14,15
ST FGA: 20,23
ST Penta D: 9,10
ST Penta E: 7,14,15
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293T-CEP4SIVtat
AC CVCL_1H20
DR NIH-ARP; 8123-334
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293T-FIX
AC CVCL_AU00
RX PubMed=26802680;
CC Transfected with: HGNC; 3551; F9.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1926 ! HEK293T/17
SX Female
CA Transformed cell line
//
ID 293T/APOBEC3G
AC CVCL_W645
SY 293-APOBEC3G-HA
DR NIH-ARP; 10203-381
RX PubMed=14564014;
CC Transfected with: HGNC; 17357; APOBEC3G.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293T/AT1
AC CVCL_H376
WW http://www.genscript.com/molecule/M00448-AT1.html
CC Transfected with: HGNC; 336; AGTR1.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293T/NMU2
AC CVCL_H377
WW http://www.genscript.com/molecule/M00244-NMU2.html
CC Transfected with: HGNC; 16454; NMUR2.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293Ta
AC CVCL_BT05
SY Lenti-Pac 293Ta
DR KCB; KCB 2013068YJ
WW http://www.genecopoeia.com/wp-content/uploads/oldpdfs/product/lentiviral/pdf/293ta_packaging_cell_line.pdf
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293TGPRT+R1
AC CVCL_AR71
DR ECACC; 04072121
RX PubMed=12679787;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293TGPRT+R1-A
AC CVCL_AR72
DR ECACC; 04072120
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AR71 ! 293TGPRT+R1
SX Female
CA Transformed cell line
//
ID 293TsiLL
AC CVCL_9705
SY 293T-siLL
DR EFO; EFO_0001083
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293TT
AC CVCL_1D85
SY HEK293TT; NCI-293TT
RX PubMed=14694107;
WW http://home.ccr.cancer.gov/Lco/293TT.htm
WW http://www.ott.nih.gov/erma/nci-293tt-cell-line
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 293XL/hTLR7
AC CVCL_Y413
WW http://www.invivogen.com/293-tlr7
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: HGNC; 15631; TLR7.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y381 ! 293XL/null
SX Female
CA Transformed cell line
//
ID 293XL/hTLR7-HA
AC CVCL_Y410
WW http://www.invivogen.com/293-tlr7-ha
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: HGNC; 15631; TLR7.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y381 ! 293XL/null
SX Female
CA Transformed cell line
//
ID 293XL/hTLR8
AC CVCL_Y414
WW http://www.invivogen.com/293-tlr8
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: HGNC; 15632; TLR8.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y381 ! 293XL/null
SX Female
CA Transformed cell line
//
ID 293XL/hTLR8-HA
AC CVCL_Y411
WW http://www.invivogen.com/293-tlr8-ha
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: HGNC; 15632; TLR8.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y381 ! 293XL/null
SX Female
CA Transformed cell line
//
ID 293XL/hTLR9
AC CVCL_Y415
SY 293XL/hTLR9A; 293XL-hTLR 9
WW http://www.invivogen.com/293-tlr9
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: HGNC; 15633; TLR9.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y381 ! 293XL/null
SX Female
CA Transformed cell line
//
ID 293XL/hTLR9-HA
AC CVCL_Y412
WW http://www.invivogen.com/293-tlr9-ha
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: HGNC; 15633; TLR9.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y381 ! 293XL/null
SX Female
CA Transformed cell line
//
ID 293XL/mTLR7
AC CVCL_Y416
SY HEK293XL-mTLR7
WW http://www.invivogen.com/293-tlr7
CC Transfected with: HGNC; 992; BCL2L1.
CC Transfected with: MGI; MGI:2176882; Tlr7.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y381 ! 293XL/null
SX Female
CA Transformed cell line
//
ID 293XL/null
AC CVCL_Y381
SY 293XL / null; 293XL; HEK293XL; HEK-293XL; HEK293-xl
WW http://www.invivogen.com/PDF/293XL_Null_TDS.pdf
CC Transfected with: HGNC; 992; BCL2L1.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 2957/90
AC CVCL_9557
SY St 2957; St2957; ST2957
DR BioSample; SAMN03151784
DR Cosmic; 887218
RX PubMed=8100658;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a gastric carcinoma.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID 296
AC CVCL_J924
SY Anti PDGF hybridoma #296
DR ATCC; HB-9370
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 29a
AC CVCL_8999
AS CVCL_B520
SY 29A; A29a; iPS29A
DR ISCR; 210
RX PubMed=18669821;
RX PubMed=21368825;
CC From: Harvard University; Boston; USA.
CC Omics: Deep exome analysis.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9000 ! 29b
OI CVCL_B522 ! 29c
OI CVCL_9001 ! 29d
OI CVCL_9002 ! 29e
SX Female
CA Induced pluripotent stem cell
//
ID 29b
AC CVCL_9000
AS CVCL_B521
SY 29B; A29b
DR ISCR; 213
RX PubMed=18669821;
CC From: Harvard University; Boston; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8999 ! 29a
OI CVCL_B522 ! 29c
OI CVCL_9001 ! 29d
OI CVCL_9002 ! 29e
SX Female
CA Induced pluripotent stem cell
//
ID 29c
AC CVCL_B522
SY A29c
DR ISCR; 214
RX PubMed=18669821;
CC From: Harvard University; Boston; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8999 ! 29a
OI CVCL_9000 ! 29b
OI CVCL_9001 ! 29d
OI CVCL_9002 ! 29e
SX Female
CA Induced pluripotent stem cell
//
ID 29d
AC CVCL_9001
SY 29d-ALS
DR ISCR; 1633
RX PubMed=21293464;
WW http://harvard.eagle-i.net/i/00000144-0883-0b63-0803-96bd80000000
CC From: Harvard University; Boston; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8999 ! 29a
OI CVCL_9000 ! 29b
OI CVCL_B522 ! 29c
OI CVCL_9002 ! 29e
SX Female
CA Induced pluripotent stem cell
//
ID 29e
AC CVCL_9002
SY 29e-ALS; iPS29e
DR ISCR; 1634
RX PubMed=21293464;
RX PubMed=21368825;
WW http://harvard.eagle-i.net/i/00000144-0884-ebca-0803-96bd80000000
CC From: Harvard University; Boston; USA.
CC Omics: Deep exome analysis.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8999 ! 29a
OI CVCL_9000 ! 29b
OI CVCL_B522 ! 29c
OI CVCL_9001 ! 29d
SX Female
CA Induced pluripotent stem cell
//
ID 29iALS-n1
AC CVCL_W559
DR SKIP; SKIP000321
RX PubMed=24154603;
CC Characteristics: Has a hexanucleotide repeat expansion in the 1st intron of C9orf72.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 2A
AC CVCL_6353
DR CLO; CLO_0001236
DR ATCC; CRL-12013
DR BioSample; SAMN03471344
RX Patent=US5591624;
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 2A1
AC CVCL_1930
DR CLO; CLO_0001237
DR DSMZ; ACC-281
CC Doubling time: ~25 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 2A10.1.1
AC CVCL_U723
SY anti-FcRH1-2A10
DR ATCC; PTA-6333
RX Patent=US7888478;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2A11
AC CVCL_J625
DR CLO; CLO_0001238
DR ATCC; CRL-2442
CC Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2A2-6E10-1D8
AC CVCL_J626
SY 1D8
DR CLO; CLO_0001239
DR ATCC; HB-12465
RX Patent=US5861241;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2A2(PGM1) Clone A6
AC CVCL_U072
DR ECACC; 02043024
CC Monoclonal antibody target: UniProtKB; P36871; Human PGM1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2A3
AC CVCL_0D71
DR ATCC; CRL-3212
RX PubMed=21314983;
ST Source(s): ATCC
ST Amelogenin: Not_detected
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 8
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1218 ! FaDu
SX Male
CA Cancer cell line
//
ID 2A3A1H
AC CVCL_J627
SY 2A3
DR CLO; CLO_0001240
DR ATCC; HB-8555
RX Patent=US4845198;
CC Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 2A5 [Mouse hybridoma against human GRN]
AC CVCL_X853
DR ATCC; PTA-5589
RX Patent=US7091047;
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 2A5 [Mouse hybridoma against human HFE]
AC CVCL_D143
AS CVCL_D144
DR CLO; CLO_0001241
DR ATCC; CRL-2444
DR BCRJ; 0010
RX PubMed=10022372;
CC Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 2AB1-IA10
AC CVCL_9152
DR CLO; CLO_0001242
DR ATCC; HB-8210
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2B4
AC CVCL_4Z38
SY 2B4-T; 2B4 T
DR BTO; BTO:0005682
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 2B5
AC CVCL_J448
SY 2B5-G4-F4
DR CLO; CLO_0001243
DR ATCC; HB-8963
RX Patent=US4908431;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2B5.3
AC CVCL_J450
DR CLO; CLO_0001244
DR ATCC; CRL-1960
RX PubMed=2592009;
CC Monoclonal antibody target: Giardia muris trophozoite surface antigens of 31 kDa and 35 kDa.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 2B6
AC CVCL_DC13
RX PubMed=10201911;
CC Monoclonal antibody target: UniProtKB; Q99665; Human IL12RB2.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2B7
AC CVCL_J451
DR CLO; CLO_0001245
DR ATCC; CRL-2443
CC Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2B8
AC CVCL_6354
DR CLO; CLO_0001246
DR ATCC; CRL-12569
RX Patent=US6136599;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W740 ! HH514-16
SX Male
CA Cancer cell line
//
ID 2BS
AC CVCL_BT02
DR CCRID; 3111C0002000000003
DR KCB; KCB 93016YJ
RX PubMed=3769747;
RX PubMed=7564558;
RX PubMed=8028398;
RX PubMed=15265694;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 2BD4E4 K99
AC CVCL_4479
SY 2 BD4 E4 K99
DR CLO; CLO_0001173
DR CLO; CLO_0001247
DR CLDB; cl5027
DR ATCC; HB-8178
DR IZSLER; BS Hy 34
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 2BN
AC CVCL_8087
DR BTO; BTO:0004321
RX PubMed=12604777;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 2BNhTERT
AC CVCL_8089
SY 2BN hTERT
DR BTO; BTO:0004323
RX PubMed=12604777;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8087 ! 2BN
SX Female
CA Telomerase immortalized cell line
//
ID 2BNneo
AC CVCL_8088
DR BTO; BTO:0004322
RX PubMed=12604777;
CC Characteristics: SV40-transformed but with a finite life span.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8087 ! 2BN
SX Female
CA Finite cell line
//
ID 2C012
AC CVCL_F332
DR CLO; CLO_0051076
DR RCB; HSC0044
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C067
AC CVCL_F333
DR CLO; CLO_0051340
DR RCB; HSC0139
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2C076
AC CVCL_F334
DR CLO; CLO_0051341
DR RCB; HSC0141
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C087
AC CVCL_F335
DR CLO; CLO_0051170
DR RCB; HSC0134
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C088
AC CVCL_F336
DR CLO; CLO_0051169
DR RCB; HSC0133
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2C089
AC CVCL_F337
DR CLO; CLO_0051131
DR RCB; HSC0041
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2C090
AC CVCL_F338
DR CLO; CLO_0051123
DR RCB; HSC0097
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C092
AC CVCL_F339
DR CLO; CLO_0051068
DR RCB; HSC0033
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2C100
AC CVCL_F340
DR CLO; CLO_0051152
DR RCB; HSC0046
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia (Mestizo).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C101
AC CVCL_F341
DR CLO; CLO_0051071
DR RCB; HSC0036
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2C114
AC CVCL_F342
DR CLO; CLO_0051069
DR RCB; HSC0034
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C116
AC CVCL_F343
DR CLO; CLO_0051336
DR RCB; HSC0061
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2C118
AC CVCL_F344
DR CLO; CLO_0051091
DR RCB; HSC0062
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 2C122
AC CVCL_F345
DR CLO; CLO_0051102
DR RCB; HSC0075
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C123
AC CVCL_F346
DR CLO; CLO_0051100
DR RCB; HSC0073
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 2C1H7
AC CVCL_J452
SY PTA-2846
DR CLO; CLO_0001248
DR ATCC; CRL-2746
DR ATCC; PTA-2686
RX Patent=US6306615;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2C3
AC CVCL_DE32
DR ATCC; CRL-13018
DR ATCC; PTA-1595
RX Patent=US6524583;
RX PubMed=9581838;
CC Monoclonal antibody target: UniProtKB; P15692; Human VEGFA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2C4 [Human fibrosarcoma]
AC CVCL_1D50
RX PubMed=7901766;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID 2C4 [Mouse hybridoma]
AC CVCL_7236
DR CLO; CLO_0001249
DR ATCC; CRL-1760
DR CCRID; 3111C0001CCC00M017
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2C4 gamma1A/JAK2
AC CVCL_1D51
SY Gamma2A/JAK2
DR Ximbio; 151681
RX PubMed=7901766;
CC Transfected with: MGI; MGI:96629; Jak2.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1D50 ! 2C4 [Human fibrosarcoma]
SX Male
CA Cancer cell line
//
ID 2C5
AC CVCL_0H92
DR ATCC; PTA-11447
RX Patent=US8399207;
CC Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID 2C5-6
AC CVCL_J628
DR CLO; CLO_0001250
DR ATCC; HB-8995
RX PubMed=10926660;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 2C6
AC CVCL_U825
DR CLO; CLO_0050256
DR RCB; RCB0794
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 8,9
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U822 ! 1B2C6
OI CVCL_U823 ! 1C3D3
OI CVCL_U824 ! 1C3IKEI
CA Finite cell line
//
ID 2CFSMEo-
AC CVCL_IN60
RX PubMed=1375758;
CC Characteristics: Heterozygous for the CFTR p.Phe508del and p.Gln2Ter mutations.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN62 ! 6CFSMEo-
CA Transformed cell line
//
ID 2D-7
AC CVCL_J629
DR CLO; CLO_0001254
DR ATCC; HB-9667
RX Patent=US5196307;
CC Monoclonal antibody target: UniProtKB; P07199; Human CENPB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2D10
AC CVCL_9153
DR CLO; CLO_0001251
DR ATCC; CRL-2226
RX PubMed=7510738;
CC Monoclonal antibody target: UniProtKB; P42082; Mouse Cd86.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2D12
AC CVCL_E975
DR CLO; CLO_0001252
DR ATCC; CRL-1689
DR ECACC; 91051509
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2D4
AC CVCL_G090
DR CLO; CLO_0001253
DR ATCC; TIB-185
RX PubMed=512581;
CC Monoclonal antibody target: ChEBI; CHEBI:27731; Asialo-GM2 ganglioside.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 2D4 iPS
AC CVCL_IT48
SY 2D4-iPS
DR GEO; GSM344763
DR GEO; GSM344764
DR PRIDE; PXD000589
RX PubMed=18371336;
RX PubMed=25894527;
CC Omics: Cell surface proteome.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_IT49 ! 1D4 iPS
SX Female
CA Induced pluripotent stem cell
//
ID 2D7F10
AC CVCL_G593
DR CLO; CLO_0001255
DR ATCC; CRL-2025
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2D9
AC CVCL_7892
RX PubMed=8288893;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=2D9
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7259 ! 86HG39
CA Cancer cell line
//
ID 2E.6
AC CVCL_9154
DR CLO; CLO_0001256
DR ATCC; HB-128
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2E10-H2
AC CVCL_1931
DR CLO; CLO_0001257
DR CLDB; cl50
DR ATCC; CRL-1812
DR DSMZ; ACC-178
RX PubMed=3281371;
CC Monoclonal antibody target: Canine adenovirus serotype 1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2E11
AC CVCL_0H93
DR ATCC; PTA-11449
RX Patent=US8399207;
CC Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID 2E6
AC CVCL_8939
DR CLO; CLO_0001258
DR ATCC; HB-226
RX PubMed=2185332;
CC Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2E8
AC CVCL_6555
DR CLO; CLO_0001259
DR ATCC; TIB-239
RX PubMed=1821694;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=2E8
CC Characteristics: IL7 dependent.
CC Breed/subspecies: BALB/c.xid.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID 2F-2B
AC CVCL_6556
DR CLO; CLO_0001261
DR ATCC; CRL-2168
DR CCRID; 3131C0001001200007
RX PubMed=8496612;
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID 2F.11.15
AC CVCL_J630
DR CLO; CLO_0001260
DR ATCC; TIB-194
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 2F10
AC CVCL_0H94
DR ATCC; PTA-11450
RX Patent=US8399207;
CC Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID 2F7
AC CVCL_3482
DR CLO; CLO_0001262
DR ATCC; CRL-10237
DR CCRID; 3142C0001000000550
RX Patent=US5108920;
CC Discontinued: ATCC; CRL-10237; probable.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 2F8
AC CVCL_J704
DR CLO; CLO_0050391
DR RCB; RCB2709
RX PubMed=8593829;
CC Monoclonal antibody target: UniProtKB; P30559; Human OXTR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 2FLB.Ln
AC CVCL_3452
SY 2 FLB.Ln
DR CLO; CLO_0001263
DR ATCC; CRL-6045
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6045; true.
DI NCIt; C131469; Bovine leukemia
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Cancer cell line
//
ID 2fTGH
AC CVCL_0115
SY 2FTGH; 2-fTGH
DR BTO; BTO:0005765
DR MCCL; MCC:0000007
DR ECACC; 12021508
DR Ximbio; 151484
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID 2fTGH-U2A
AC CVCL_M019
SY U2A
DR ECACC; 12021502
DR Ximbio; 151807
RX PubMed=1837150;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0115 ! 2fTGH
SX Male
CA Cancer cell line
//
ID 2fTGH-U3A
AC CVCL_9469
SY U3A
DR ECACC; 12021503
DR Ximbio; 151810
RX PubMed=1837150;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0115 ! 2fTGH
SX Male
CA Cancer cell line
//
ID 2fTGH-U4A
AC CVCL_9470
SY U4A
DR ECACC; 12021504
DR Ximbio; 151809
RX PubMed=1837150;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0115 ! 2fTGH
SX Male
CA Cancer cell line
//
ID 2fTGH-U4C
AC CVCL_D314
SY U4C
DR ECACC; 12021505
DR Ximbio; 151806
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0115 ! 2fTGH
SX Male
CA Cancer cell line
//
ID 2fTGH-U5A
AC CVCL_D315
SY U5A
DR ECACC; 12021506
DR Ximbio; 151808
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0115 ! 2fTGH
SX Male
CA Cancer cell line
//
ID 2fTGH-U6A
AC CVCL_D316
SY U6A
DR ECACC; 12021507
DR Ximbio; 151805
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0115 ! 2fTGH
SX Male
CA Cancer cell line
//
ID 2G2B(AAT) Clone 4D4
AC CVCL_U073
DR ECACC; 02043016
CC Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2G3 [Mouse hybridoma against FcRn]
AC CVCL_J631
DR CLO; CLO_0001264
DR ATCC; CRL-2435
RX PubMed=7889418;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 2G3 [Mouse hybridoma against HMW mucin]
AC CVCL_J902
DR ATCC; HB-8491
RX Patent=US4753894;
RX Patent=US5629197;
CC Discontinued: ATCC; HB-8491; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2G7
AC CVCL_J154
DR ATCC; HB-10137
RX Patent=US5011778;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2G8.D6
AC CVCL_G594
DR CLO; CLO_0001265
DR ATCC; HB-8190
RX Patent=US4543439;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2H-11
AC CVCL_6762
DR CLO; CLO_0001266
DR ATCC; CRL-2163
RX PubMed=8496612;
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID 2H6
AC CVCL_DB41
DR ATCC; HB-9969
RX Patent=WO1990008185A1;
RX PubMed=2717936;
CC Characteristics: Produces a catalytic monoclonal antibody that acts as a lipase.
CC Discontinued: ATCC; HB-9969; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2H6-C2
AC CVCL_G091
DR CLO; CLO_0001267
DR ATCC; CRL-1853
DR ECACC; 95022203
CC Monoclonal antibody target: UniProtKB; P0CK30; Bovine herpesvirus 1.1 gD.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2H9
AC CVCL_0H95
DR ATCC; PTA-11446
RX Patent=US8399207;
CC Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID 2Hx-2
AC CVCL_1932
SY 2HX-2
DR CLO; CLO_0001268
DR CLDB; cl51
DR ATCC; HB-8117
DR DSMZ; ACC-183
RX Patent=US4487829;
RX PubMed=6339552;
RX PubMed=7222481;
CC Monoclonal antibody target: UniProtKB; P03277; Adenovirus 2 hexon protein.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 2LBLN
AC CVCL_3635
DR CLO; CLO_0001269
DR ATCC; CRL-6047
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6047; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID 2LMP
AC CVCL_EQ20
SY 2-LMP
DR GEO; GSM1401670
RX PubMed=9739048;
CC Omics: Deep RNAseq analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0062 ! MDA-MB-231
SX Female
CA Cancer cell line
//
ID 2M6
AC CVCL_1933
DR CLO; CLO_0001270
DR CLDB; cl373
DR DSMZ; ACC-205
RX PubMed=1879342;
RX PubMed=1914140;
CC Doubling time: ~35 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; Q90634; Chicken TOPAP.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 2MAC
AC CVCL_5979
RX PubMed=9178646;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=2MAC
OX NCBI_TaxID=9606; ! Homo sapiens
CA Spontaneously immortalized cell line
//
ID 2PK-3
AC CVCL_3483
SY 2PK3
DR CLO; CLO_0001271
DR ATCC; TIB-203
DR BCRC; 60309
DR Lonza; 1142
RX PubMed=161906;
RX PubMed=3495708;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-436.html
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 2T8-3E10
AC CVCL_J632
DR CLO; CLO_0001273
DR ATCC; HB-8213
RX Patent=US4550086;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 2TP-084
AC CVCL_6D33
DR RCB; AES1913
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 2TS22C
AC CVCL_E266
SY 2TS22c
DR EFO; EFO_0006529
DR GEO; GSM1385516
DR RCB; AES0125
DR RCB; RCB2690
RX PubMed=17515932;
CC Discontinued: RCB; RCB2690; true.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9108 ! ES-E14TG2a
SX Male
CA Embryonic stem cell
//
ID 2V6.11
AC CVCL_6355
DR CLO; CLO_0001274
DR ATCC; CRL-2784
DR ATCC; JHU-67
DR BioSample; SAMN03471789
DR CCRID; 3131C0001000200026
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-2784; true.
CC Discontinued: ATCC; JHU-67; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 7,11,12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 3-2H3
AC CVCL_J719
DR CLO; CLO_0050360
DR RCB; RCB0867
RX PubMed=3028450;
CC Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3-83P
AC CVCL_J720
DR CLO; CLO_0001322
DR ATCC; HB-20
RX PubMed=7188699;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 3.155
AC CVCL_9157
DR CLO; CLO_0001277
DR ATCC; TIB-211
CC Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3.334 SC5/8
AC CVCL_7237
DR CLO; CLO_0001278
DR CLDB; cl54
DR ECACC; 86082107
DR Ximbio; 153249
RX PubMed=6247175;
CC Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) [Strain Bratislava-77 (B77)].
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_9116 ! NIH 3T3-TK-
CA Hybrid cell line
//
ID 3.C2
AC CVCL_J716
DR ECACC; 92092320
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3'-mRLh-2
AC CVCL_D104
DR JCRB; JCRB0431
RX PubMed=1836893;
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID 3'-mRLN-30
AC CVCL_L639
DR JCRB; JCRB0421
RX CelloPub=CLPUB00010;
CC Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID 3'-mRLN-31
AC CVCL_L640
DR JCRB; JCRB0422
RX CelloPub=CLPUB00010;
CC Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID 30
AC CVCL_J925
SY Anti PDGF hybridoma #30
DR ATCC; HB-9366
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 30-5-7S
AC CVCL_G595
DR CLO; CLO_0001280
DR ATCC; HB-31
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 30-C7
AC CVCL_9155
DR CLO; CLO_0001282
DR ATCC; TIB-106
RX PubMed=398327;
CC Monoclonal antibody target: UniProtKB; Q01965; Mouse Ly9/Cd229/Lgp100a.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 30-H12
AC CVCL_9156
DR CLO; CLO_0001283
DR ATCC; TIB-107
RX PubMed=398327;
CC Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (allotype 1.2).
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 30/15
AC CVCL_J633
DR CLO; CLO_0001279
DR ATCC; HB-8152
RX Patent=US4521510;
RX Patent=US4524025;
CC Monoclonal antibody target: ChEBI; CHEBI:28177; Theophylline.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 300-19
AC CVCL_6238
SY 300.19
DR Lonza; 138
RX PubMed=3096716;
RX PubMed=6277505;
RX PubMed=7689875;
WW http://www.masstechportal.org/IP4382.aspx
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: NIH Swiss.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 302-1
AC CVCL_J872
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 3051/80
AC CVCL_9558
SY St 3051; St3051
DR BioSample; SAMN03151785
RX PubMed=8100658;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a gastric carcinoma.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID 305M
AC CVCL_6531
DR CLO; CLO_0050642
DR BioSample; SAMN03472339
DR RCB; RCB0156
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 308TAg
AC CVCL_6763
DR CLO; CLO_0001281
DR ATCC; CRL-2819
CC Knockout cell: Method=KO mouse; MGI; MGI:97073; Mpg.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 30A-5
AC CVCL_0117
SY 30A5
DR MCCL; MCC:0000009
RX PubMed=2901666;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0190 ! C3H/10T1/2 clone 8
CA Spontaneously immortalized cell line
//
ID 30F
AC CVCL_8627
SY IM-2 cl 30F; Line 30F
RX PubMed=2466037;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S548 ! IM-2
SX Female
CA Spontaneously immortalized cell line
//
ID 30F73.Ln
AC CVCL_S380
DR ATCC; CRL-6516
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6516; true.
OX NCBI_TaxID=34884; ! Callorhinus ursinus
OI CVCL_S381 ! 30F73.Lu
OI CVCL_S382 ! 30F73.Mu
OI CVCL_S383 ! 30F73.Pla
OI CVCL_S384 ! 30F73.Sk
OI CVCL_S385 ! 30F73.Ur
SX Female
CA Finite cell line
//
ID 30F73.Lu
AC CVCL_S381
DR ATCC; CRL-6517
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6517; true.
OX NCBI_TaxID=34884; ! Callorhinus ursinus
OI CVCL_S380 ! 30F73.Ln
OI CVCL_S382 ! 30F73.Mu
OI CVCL_S383 ! 30F73.Pla
OI CVCL_S384 ! 30F73.Sk
OI CVCL_S385 ! 30F73.Ur
SX Female
CA Finite cell line
//
ID 30F73.Mu
AC CVCL_S382
DR ATCC; CRL-6518
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6518; true.
OX NCBI_TaxID=34884; ! Callorhinus ursinus
OI CVCL_S380 ! 30F73.Ln
OI CVCL_S381 ! 30F73.Lu
OI CVCL_S383 ! 30F73.Pla
OI CVCL_S384 ! 30F73.Sk
OI CVCL_S385 ! 30F73.Ur
SX Female
CA Finite cell line
//
ID 30F73.Pla
AC CVCL_S383
DR ATCC; CRL-6519
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6519; true.
OX NCBI_TaxID=34884; ! Callorhinus ursinus
OI CVCL_S380 ! 30F73.Ln
OI CVCL_S381 ! 30F73.Lu
OI CVCL_S382 ! 30F73.Mu
OI CVCL_S384 ! 30F73.Sk
OI CVCL_S385 ! 30F73.Ur
SX Female
CA Finite cell line
//
ID 30F73.Sk
AC CVCL_S384
DR ATCC; CRL-6520
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6520; true.
OX NCBI_TaxID=34884; ! Callorhinus ursinus
OI CVCL_S380 ! 30F73.Ln
OI CVCL_S381 ! 30F73.Lu
OI CVCL_S382 ! 30F73.Mu
OI CVCL_S383 ! 30F73.Pla
OI CVCL_S385 ! 30F73.Ur
SX Female
CA Finite cell line
//
ID 30F73.Ur
AC CVCL_S385
DR ATCC; CRL-6521
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6521; true.
OX NCBI_TaxID=34884; ! Callorhinus ursinus
OI CVCL_S380 ! 30F73.Ln
OI CVCL_S381 ! 30F73.Lu
OI CVCL_S382 ! 30F73.Mu
OI CVCL_S383 ! 30F73.Pla
OI CVCL_S384 ! 30F73.Sk
SX Female
CA Finite cell line
//
ID 30iALS-n1
AC CVCL_W560
DR SKIP; SKIP000322
RX PubMed=24154603;
CC Characteristics: Has a hexanucleotide repeat expansion in the 1st intron of C9orf72.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 31-3-4S
AC CVCL_G596
DR CLO; CLO_0001287
DR ATCC; HB-77
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 31-42-19
AC CVCL_J635
DR CLO; CLO_0001288
DR ATCC; HB-9726
RX Patent=US4983529;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 31-90-25
AC CVCL_J636
DR CLO; CLO_0001290
DR ATCC; HB-9725
RX Patent=US4983529;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 310-29F7
AC CVCL_J585
DR CLO; CLO_0001284
DR ATCC; CRL-2656
DR ATCC; HB-9053
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9053; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 310-5F5
AC CVCL_J586
DR ATCC; HB-9002
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9002; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 311
AC CVCL_Z994
DR CLO; CLO_0001006
DR CLDB; cl56
DR ECACC; 90070547
DR KCB; KCB 94027YJ
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 311-3D4
AC CVCL_J634
DR CLO; CLO_0001285
DR ATCC; CRL-2657
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 312-13E8
AC CVCL_J587
SY 312-13E08
DR CLO; CLO_0001286
DR ATCC; CRL-2658
DR ATCC; HB-9208
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9208; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 31227ABO
AC CVCL_E443
SY 31227 ABO; ABUC; ABU; WT9; GM08600
DR CLO; CLO_0010594
DR Coriell; GM08600
DR dbMHC; 48461
DR ECACC; 85052103
DR IHW; IHW9061
DR IMGT/HLA; 10131
WW http://bioinformatics.hsanmartino.it/ecbr/cl61.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 3134
AC CVCL_H641
DR EFO; EFO_0007069
DR ATCC; CRL-11998
DR ENCODE; ENCBS023ENC
DR ENCODE; ENCBS655OXH
DR GEO; GSM1014196
RX Patent=US7312032;
RX PubMed=10497225;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/3134_Stam_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Characteristics: Contains 200 head to tail copies of a DNA sequence composed of a BPV transforming fragment and a MMTV promoter (LTR containing GR-binding sites) in front of the V-Ha-Ras gene.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Discontinued: ATCC; CRL-11998; probable.
CC Breed/subspecies: RIII.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Z933 ! 904.13
SX Female
CA Cancer cell line
//
ID 31708
AC CVCL_E444
DR dbMHC; 48462
DR ECACC; 94071426
DR IHW; IHW9278
DR IMGT/HLA; 10132
WW http://bioinformatics.hsanmartino.it/ecbr/cl278.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 317G5.C1D3
AC CVCL_J637
SY 317G5; CTCC 0055
DR CLO; CLO_0001289
DR ATCC; HB-8485
DR ATCC; HB-8691
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3197-3
AC CVCL_6764
SY 3T3-MSV
DR CLO; CLO_0001291
DR ATCC; CRL-1568
DR IZSLER; BS CL 155
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Transformed cell line
//
ID 31BY4-1
AC CVCL_DD94
RX PubMed=6840439;
CC Transformant: NCBI_TaxID; 10529; Adenovirus 31 [BamHI-B fragment].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID 31E
AC CVCL_8628
SY IM-2 cl 31E; Line 31E
RX PubMed=2466037;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S548 ! IM-2
SX Female
CA Spontaneously immortalized cell line
//
ID 31E9
AC CVCL_7238
DR CLO; CLO_0001292
DR ATCC; HB-11052
DR CCRID; 3142C0001000000512
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G691 ! BUC
CA Hybridoma
//
ID 31F4L
AC CVCL_4088
DR CLO; CLO_0001293
DR CLDB; cl57
DR ECACC; 87081901
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Sex undetermined
CA Undefined cell line type
//
ID 31GY1-2
AC CVCL_DD95
RX PubMed=6840439;
CC Transformant: NCBI_TaxID; 10529; Adenovirus 31 [HindIII-G fragment].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID 31GY2-5
AC CVCL_DD96
RX PubMed=6840439;
CC Transformant: NCBI_TaxID; 10529; Adenovirus 31 [HindIII-G fragment].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID 31GY3-4
AC CVCL_DD97
RX PubMed=6840439;
CC Transformant: NCBI_TaxID; 10529; Adenovirus 31 [HindIII-G fragment].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID 32-2B
AC CVCL_J717
DR ECACC; 91121237
RX PubMed=3323436;
CC Monoclonal antibody target: UniProtKB; Q03763; Bovine DSG1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 32.2
AC CVCL_J660
DR CLO; CLO_0001294
DR ATCC; HB-9469
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 32.3
AC CVCL_1J86
DR ATCC; CRL-11114
RX Patent=US5698765;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:88335; Cd4.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID 32/32
AC CVCL_E445
DR dbMHC; 48463
DR IHW; IHW9250
DR IMGT/HLA; 10134
WW http://bioinformatics.hsanmartino.it/ecbr/cl250.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 32/37
AC CVCL_E446
DR dbMHC; 48464
DR ECACC; 94022519
DR IHW; IHW9240
DR IMGT/HLA; 10135
WW http://bioinformatics.hsanmartino.it/ecbr/cl240.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94022519; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 3200P
AC CVCL_4Y81
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3201
AC CVCL_X612
OX NCBI_TaxID=9685; ! Felis catus
CA Cancer cell line
//
ID 3201/EECC
AC CVCL_X613
SY 3201-EECC
DR NIH-ARP; 197-133
CC Doubling time: 15-20 hours (NIH-ARP).
OX NCBI_TaxID=9685; ! Felis catus
HI CVCL_X612 ! 3201
CA Cancer cell line
//
ID 3201/61
AC CVCL_X614
DR NIH-ARP; 198-362
CC Doubling time: 15-20 hours (NIH-ARP).
OX NCBI_TaxID=9685; ! Felis catus
HI CVCL_X612 ! 3201
CA Cancer cell line
//
ID 32367
AC CVCL_E447
DR dbMHC; 48465
DR ECACC; 94050335
DR IHW; IHW9257
DR IMGT/HLA; 10136
WW http://bioinformatics.hsanmartino.it/ecbr/cl257.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 325.1
AC CVCL_0I00
DR ATCC; PTA-5120
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 32511
AC CVCL_E448
SY TER81; TER232; TER272; TER284; TER365; TER376
DR dbMHC; 48466
DR ECACC; 94071436
DR IHW; IHW9231
DR IMGT/HLA; 10137
WW http://bioinformatics.hsanmartino.it/ecbr/cl231.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 328/10
AC CVCL_4480
DR ECACC; 08062536
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2135 ! N4TG3
HI CVCL_4114 ! B82
CA Hybrid cell line
//
ID 328/11
AC CVCL_4481
DR ECACC; 08062538
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2135 ! N4TG3
HI CVCL_4114 ! B82
CA Hybrid cell line
//
ID 328/12
AC CVCL_4482
DR ECACC; 08062540
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2135 ! N4TG3
HI CVCL_4114 ! B82
CA Hybrid cell line
//
ID 328/14
AC CVCL_4483
DR ECACC; 08062541
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2135 ! N4TG3
HI CVCL_4114 ! B82
CA Hybrid cell line
//
ID 328/7
AC CVCL_4484
DR ECACC; 08062530
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2135 ! N4TG3
HI CVCL_4114 ! B82
CA Hybrid cell line
//
ID 328/8
AC CVCL_4485
DR ECACC; 08062531
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2135 ! N4TG3
HI CVCL_4114 ! B82
CA Hybrid cell line
//
ID 328/9
AC CVCL_4486
DR ECACC; 08062533
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2135 ! N4TG3
HI CVCL_4114 ! B82
CA Hybrid cell line
//
ID 32B11
AC CVCL_J661
DR CLO; CLO_0001295
DR ATCC; CRL-2559
RX DOI=10.1007/BF00012053;
CC Monoclonal antibody target: UniProtKB; Q0H0L1; Rhizophagus irregularis heat shock protein 60 (Glomalin).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 32D
AC CVCL_0118
DR BTO; BTO:0002882
DR CLO; CLO_0001296
DR CLO; CLO_0051044
DR MCCL; MCC:0000010
DR DSMZ; ACC-411
DR RCB; RCB1145
WW http://www.cells-talk.com/index.php/page/copelibrary?key=32D
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/3/cell-lines-detail-139.html
CC Characteristics: IL3 dependent.
CC Doubling time: ~15 hours (DSMZ).
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID 32D-c-fms
AC CVCL_R769
RX PubMed=2165597;
CC Characteristics: IL3 dependent.
CC Transfected with: HGNC; 2433; CSF1R.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0119 ! 32Dcl3
CA Factor-dependent cell line
//
ID 32Dcl23
AC CVCL_6G54
SY 32D clone 23; 32D cl23; 32D cl 23; 32D cl-23; 32Dc23
RX PubMed=2656885;
RX PubMed=3089920;
RX PubMed=6574462;
CC Characteristics: IL3 dependent.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0118 ! 32D
CA Factor-dependent cell line
//
ID 32Dcl3
AC CVCL_0119
SY 32D clone 3; 32D clone3; 32D-Cl3; 32D.cl3; 32D:cl3; 32D/cl3; 32D CL3; 32D cl3; 32Dc3; 32D.3
DR BTO; BTO:0002883
DR CLO; CLO_0001297
DR CLO; CLO_0051042
DR CLO; CLO_0051043
DR MCCL; MCC:0000011
DR ATCC; CRL-11346
DR BCRC; 60456
DR BCRJ; 0333
DR Lonza; 673
DR RCB; RCB1377
DR RCB; RCB1538
DR TOKU-E; 294
WW http://www.cells-talk.com/index.php/page/copelibrary?key=32D
CC Characteristics: IL3 dependent.
CC Misspelling: Occasionally '32Dc13' or '32D:c13'.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0118 ! 32D
CA Factor-dependent cell line
//
ID 32R1
AC CVCL_DQ51
DR PRIDE; PXD000071
RX PubMed=20660764;
RX PubMed=23210603;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ52 ! 32R2
OI CVCL_DQ53 ! 32R6
SX Female
CA Induced pluripotent stem cell
//
ID 32R2
AC CVCL_DQ52
RX PubMed=20660764;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ51 ! 32R1
OI CVCL_DQ53 ! 32R6
SX Female
CA Induced pluripotent stem cell
//
ID 32R6
AC CVCL_DQ53
RX PubMed=20660764;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ51 ! 32R1
OI CVCL_DQ52 ! 32R2
SX Female
CA Induced pluripotent stem cell
//
ID 33-3D
AC CVCL_J718
DR ECACC; 91121238
CC Monoclonal antibody target: UniProtKB; Q03763; Bovine DSG1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 331.12
AC CVCL_9158
DR CLO; CLO_0001298
DR ATCC; TIB-129
DR BCRJ; 0012
RX PubMed=6165776;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID 337-3
AC CVCL_J873
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 339-1
AC CVCL_J662
DR CLO; CLO_0001299
DR ATCC; HB-186
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 33B
AC CVCL_3982
DR BTO; BTO:0002938
DR CLO; CLO_0001300
DR CLDB; cl58
DR ECACC; 85081901
RX PubMed=1093176;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: Wistar Furth.
DI NCIt; C60461; Rat malignant oligodendroglioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4329 ! TR33B
CA Cancer cell line
//
ID 33D1
AC CVCL_9159
SY 33 D1
DR CLO; CLO_0001301
DR ATCC; TIB-227
DR BCRJ; 0011
DR NCBI_Iran; H135
RX PubMed=6948298;
CC Monoclonal antibody target: Mouse dendritic cell inhibitory receptor 2 (DCIR2).
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 33F8
AC CVCL_J913
SY 33F8.C3D12
DR ATCC; HB-8697
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 33v1-051
AC CVCL_6D21
DR RCB; AES1384
CC Knockout cell: Method=Gene trap; MGI; MGI:106354; Vps25.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 34
AC CVCL_J663
DR CLO; CLO_0001302
DR ATCC; CRL-1889
RX PubMed=6305011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 34-1-2S
AC CVCL_G597
DR CLO; CLO_0001303
DR ATCC; HB-79
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 34-1-4S
AC CVCL_Y309
DR ATCC; HB-74
CC Discontinued: ATCC; HB-74; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 34-2-12S
AC CVCL_G598
DR CLO; CLO_0001304
DR ATCC; HB-87
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 34-4-20S
AC CVCL_G599
DR CLO; CLO_0001305
DR ATCC; HB-75
DR IZSLER; BS Hy 61
CC Discontinued: IZSLER; BS Hy 61; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 34-4-21S
AC CVCL_G600
DR CLO; CLO_0001306
DR ATCC; HB-76
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 34-5-3S
AC CVCL_4487
DR CLO; CLO_0001307
DR ATCC; HB-85
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 34-5-8S
AC CVCL_4488
DR CLO; CLO_0001308
DR CLDB; cl5138
DR ATCC; HB-102
DR IZSLER; BS Hy 40
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 34-7-23S
AC CVCL_4489
DR CLO; CLO_0001309
DR ATCC; HB-101
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 340-RPE-11tv
AC CVCL_W078
DR ATCC; CRL-4002
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-4002; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B365 ! RPE-340
SX Female
CA Telomerase immortalized cell line
//
ID 3402P
AC CVCL_4Y82
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 340529
AC CVCL_0C67
RX PubMed=19147538;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID 3445P
AC CVCL_4Y83
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3446P
AC CVCL_4Y84
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 346D1
AC CVCL_DQ33
DR GEO; GSM2152671
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 346E1
AC CVCL_DQ34
DR GEO; GSM2152672
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 346E2
AC CVCL_DQ35
DR GEO; GSM2152673
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 346F1
AC CVCL_DQ36
DR GEO; GSM2152674
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 347C2
AC CVCL_M027
DR ECACC; 93071515
RX PubMed=2888227;
CC Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fanC.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J051 ! 94A1
CA Hybridoma
//
ID 347C2b/D4
AC CVCL_M028
DR ECACC; 93071503
RX PubMed=2888227;
CC Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fanC.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J051 ! 94A1
CA Hybridoma
//
ID 348617
AC CVCL_0C68
RX PubMed=19147538;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID 348C6
AC CVCL_K116
DR ECACC; 85062511
RX PubMed=2888227;
CC Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fanC.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J051 ! 94A1
CA Hybridoma
//
ID 3498P
AC CVCL_4Y85
RX PubMed=1689712;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 34C9
AC CVCL_IQ40
RX Patent=US7259246;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2296.
CC Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (also reacts with human, mouse and pig).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 34T
AC CVCL_0071
RX PubMed=21518866;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID 35
AC CVCL_4630
DR CLDB; cl59
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID 35 E 10
AC CVCL_D661
DR BCRJ; 0013
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID 35.1
AC CVCL_7239
DR CLO; CLO_0001310
DR ATCC; HB-222
DR CCRID; 3131C0001000600057
RX PubMed=6190907;
CC Monoclonal antibody target: UniProtKB; P20273; Human CD22.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 35.32
AC CVCL_DD40
DR ATCC; CRL-11972
RX Patent=US6051427;
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-11972; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 35.6
AC CVCL_6356
DR CLO; CLO_0001311
DR ATCC; CRL-10052
RX Patent=US5856297;
CC Transfected with: HGNC; 2334; CR1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID 35020
AC CVCL_E449
DR dbMHC; 48467
DR ECACC; 94050321
DR IHW; IHW9232
DR IMGT/HLA; 10145
WW http://bioinformatics.hsanmartino.it/ecbr/cl232.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 3512P
AC CVCL_4Y86
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3513P
AC CVCL_4Y87
RX PubMed=1561323;
RX PubMed=1689712;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3519P
AC CVCL_4Y88
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 351D2/D7
AC CVCL_J664
DR ECACC; 93071501
RX PubMed=2888227;
CC Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fanC.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J051 ! 94A1
CA Hybridoma
//
ID 3528P
AC CVCL_4Y89
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3529P
AC CVCL_4Y90
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3530P
AC CVCL_4Y91
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3535P
AC CVCL_4Y92
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3543P
AC CVCL_4Y93
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3548P
AC CVCL_4Y94
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 356-1
AC CVCL_J665
DR CLO; CLO_0001312
DR ATCC; HB-181
DR IZSLER; BS Hy 37
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 3566P
AC CVCL_4Y95
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 357-101-4
AC CVCL_J666
DR ECACC; 92030603
DR NCBI_Iran; H117
CC Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 357-167-24
AC CVCL_J667
DR ECACC; 92030604
CC Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 3570P
AC CVCL_4Y96
RX PubMed=1689712;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3573P
AC CVCL_4Y97
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 35841
AC CVCL_E450
DR dbMHC; 48468
DR ECACC; 94050322
DR IHW; IHW9235
DR IMGT/HLA; 10146
WW http://bioinformatics.hsanmartino.it/ecbr/cl235.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94050322; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID 3585P
AC CVCL_4Y98
RX PubMed=1689712;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 359-238-8
AC CVCL_J668
DR ECACC; 92030605
CC Monoclonal antibody target: UniProtKB; P01374; Human LTA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 359-81-11
AC CVCL_J669
DR ECACC; 92030606
DR NCBI_Iran; H130
CC Monoclonal antibody target: UniProtKB; P01374; Human LTA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 3590P
AC CVCL_4Y99
RX PubMed=1561323;
RX PubMed=1689712;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 36
AC CVCL_9087
DR CLO; CLO_0001313
DR ATCC; CRL-8193
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0566 ! U266B1
HI CVCL_4032 ! P3X63Ag8.653
CA Hybrid cell line
//
ID 36 BLCL
AC CVCL_E401
DR ECACC; 94031601
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 36.5
AC CVCL_9090
SY 36.5 (CD8+)
DR CLO; CLO_0001314
DR ATCC; CRL-11116
RX Patent=US5530178;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:88346; Cd8a.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID 360-27E06
AC CVCL_J588
DR ATCC; HB-9280
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9280; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 361-31C05
AC CVCL_J589
DR ATCC; HB-9227
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-9227; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 363G1
AC CVCL_DQ37
DR GEO; GSM2152675
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID 3640P
AC CVCL_4Z00
RX PubMed=1689712;
RX PubMed=7539412;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 3677
AC CVCL_H603
DR ChEMBL-Cells; CHEMBL3307809
DR ChEMBL-Targets; CHEMBL612820
RX PubMed=7627964;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 368.1
AC CVCL_0I01
DR ATCC; PTA-4568
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 369F10
AC CVCL_J907
SY 369F10.C3A8
DR ATCC; HB-8682
RX Patent=US4753894;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 36B10
AC CVCL_D602
SY 36B-10; 36 B-10
DR BTO; BTO:0005252
RX PubMed=9635836;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID 36F-18C
AC CVCL_G190
SY 36F
DR CLO; CLO_0001316
DR ATCC; HB-285
DR ECACC; 91060547
CC Monoclonal antibody target: UniProtKB; W5QG93; Sheep CD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 36v-38
AC CVCL_6D22
DR RCB; AES1397
CC Knockout cell: Method=Gene trap; MGI; MGI:2147677; Lpxn.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 37 BLCL
AC CVCL_E402
DR ECACC; 94031602
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 37.04.12
AC CVCL_J670
SY PM 37.04.12
DR CLO; CLO_0001318
DR ATCC; HB-9312
RX Patent=US4818685;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 371M
AC CVCL_W438
RX PubMed=12703547;
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 372
AC CVCL_J538
DR CLO; CLO_0001319
DR ATCC; CRL-1893
RX PubMed=6305011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 37S2.8
AC CVCL_DD41
DR ATCC; CRL-11971
RX Patent=US6051427;
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Discontinued: ATCC; CRL-11971; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID 37v-42
AC CVCL_6D23
DR RCB; AES1421
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 38-1
AC CVCL_J877
DR CLO; CLO_0001321
DR ATCC; HB-182
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 38.1
AC CVCL_J860
DR CLO; CLO_0001320
DR ATCC; HB-231
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 380
AC CVCL_1047
DR CLO; CLO_0001007
DR CLDB; cl63
DR CLDB; cl4977
DR BioSample; SAMN03473573
DR Cosmic; 924101
DR Cosmic; 1012056
DR Cosmic; 1130253
DR Cosmic; 1524787
DR DSMZ; ACC-39
DR GEO; GSM119536
DR GEO; GSM236776
DR GEO; GSM236812
DR ICLC; HTL99019
RX PubMed=6334305;
RX PubMed=16408098;
RX PubMed=16809887;
CC Doubling time: ~80 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 9,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 38C13
AC CVCL_0J29
SY 38C-13
RX PubMed=408154;
RX PubMed=22400032;
CC Breed/subspecies: C3H/eB.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 38E6E7HFK
AC CVCL_0B34
SY 38E6/E7 HFK; 38E6E7 HFK
DR BTO; BTO:0005482
RX PubMed=17898088;
RX PubMed=21482671;
CC Transformant: NCBI_TaxID; 37959; Human papillomavirus type 38 (HPV38) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 38v-29
AC CVCL_6D24
DR RCB; AES1519
CC Knockout cell: Method=Gene trap; MGI; MGI:107194; Shroom2.
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6D29 ! v6.4
SX Male
CA Embryonic stem cell
//
ID 39 BLCL
AC CVCL_E403
DR ECACC; 94031604
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 39-S
AC CVCL_J600
SY 39S
DR CLO; CLO_0001323
DR ATCC; HB-8180
RX PubMed=6277788;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 397-mel
AC CVCL_8050
SY 397-MEL; 397-Mel; 397 mel; 397mel; 397
DR CGH-DB; 9295-4
DR Cosmic; 876699
DR Cosmic; 905209
DR Cosmic; 897736
DR Cosmic; 1295344
RX PubMed=8081556;
RX PubMed=8537970;
RX PubMed=10048982;
RX PubMed=10754339;
RX PubMed=15467732;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 39b
AC CVCL_X725
SY 39b-ALS
RX PubMed=24704492;
WW http://harvard.eagle-i.net/i/00000144-0886-a986-0803-96bd80000000
CC From: Harvard University; Boston; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID 39ER22
AC CVCL_0H89
SY ER 22; ER22
DR ChEMBL-Cells; CHEMBL3308448
RX PubMed=2699431;
CC Transfected with: HGNC; 3236; EGFR.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2886 ! Dede
SX Female
CA Spontaneously immortalized cell line
//
ID 3A sub E
AC CVCL_2287
SY 3A-sub E
DR CLO; CLO_0001324
DR CLO; CLO_0001328
DR CLDB; cl64
DR ATCC; CRL-1584
DR BCRC; 60302
DR ECACC; 90110508
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [ts30].
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2820 ! 3A(tPA-30-1)
CA Transformed cell line
//
ID 3A(tPA-30-1)
AC CVCL_2820
SY TPA30-1
DR CLO; CLO_0001325
DR ATCC; CRL-1583
DR BioSample; SAMN03471399
DR ECACC; 96020926
RX PubMed=206898;
CC Characteristics: Express the transformed phenotype at the permissive temperature (33 Celsius) and the non-transformed phenotype at the restrictive temperature (40 Celsius).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [ts30].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H646 ! TPA30-6
OI CVCL_H645 ! TPWT-2
CA Transformed cell line
//
ID 3A10
AC CVCL_D662
DR BCRJ; 0014
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID 3A2
AC CVCL_J155
DR ATCC; HB-10138
RX Patent=US5011778;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3A21
AC CVCL_J721
DR CLO; CLO_0050301
DR RCB; RCB1285
RX DOI=10.1016/0922-338X(96)88826-X;
CC Monoclonal antibody target: UniProtKB; P61823; Bovine RNASE1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 3A4Bla
AC CVCL_6C47
SY 3A4BLA; 3A4-BLA; CYP3A4-hBLA hES
WW http://www.vistagen.com/pdf_files/SOT-poster-2013.pdf
CC From: VistaGen Therapeutics, Inc.
CC Characteristics: The humanized beta-lactamase reporter gene is inserted in frame in the 3'-UTR region of the CYP3A4 gene.
CC Transfected with: UniProtKB; P62593; E.coli TEM-1 bla (Humanized).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C945 ! K117 [Human ESC]
SX Male
CA Embryonic stem cell
//
ID 3A5
AC CVCL_J881
DR CLO; CLO_0001326
DR ATCC; CRL-2440
CC Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 3A8
AC CVCL_J880
DR CLO; CLO_0001327
DR ATCC; HB-12024
RX Patent=US5677165;
CC Registration: Chiron Master Culture Collection; CMCC 11066 (CMCC #11066).
CC Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3A9
AC CVCL_6239
SY 3 A 9
DR ATCC; CRL-3293
DR Lonza; 702
RX PubMed=6607276;
CC Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3896 ! BW5147
CA Hybridoma
//
ID 3ACFSMEo-
AC CVCL_IN58
RX PubMed=1375758;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3B-11
AC CVCL_5487
DR CLO; CLO_0001330
DR ATCC; CRL-2160
RX PubMed=8496612;
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID 3B11
AC CVCL_5488
DR CLO; CLO_0001329
DR ATCC; CRL-2757
RX PubMed=18824023;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 3B18
AC CVCL_J882
DR CLO; CLO_0001331
DR ATCC; HB-8654
RX Patent=US4628032;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID 3C10
AC CVCL_J000
DR CLO; CLO_0001332
DR ATCC; TIB-228
CC Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 3C11
AC CVCL_G601
DR CLO; CLO_0001333
DR ATCC; HB-8511
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3C5.1
AC CVCL_J722
DR CLO; CLO_0001334
DR ATCC; CRL-2284
RX PubMed=7536191;
CC Monoclonal antibody target: UniProtKB; Q07864; Human POLE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 3C6
AC CVCL_J879
DR ATCC; HB-11340
RX Patent=US5677165;
CC Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3C7.2
AC CVCL_J723
DR CLO; CLO_0001335
DR ATCC; CRL-1959
RX PubMed=2592009;
CC Monoclonal antibody target: Giardia muris trophozoite surface antigens.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 3C9-D11-H11
AC CVCL_4490
SY 3 C9-D11-H11
DR CLO; CLO_0001275
DR CLO; CLO_0001336
DR CLDB; cl5095
DR ATCC; CRL-1745
DR ECACC; 92022115
DR IZSLER; BS Hy 36
RX PubMed=3009510;
CC Monoclonal antibody target: Porcine parvovirus.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3D4
AC CVCL_0F12
RX PubMed=12088830;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Landrace.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Transformed cell line
//
ID 3D4/2
AC CVCL_0F13
DR ATCC; CRL-2845
RX PubMed=12088830;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Landrace.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0F12 ! 3D4
CA Transformed cell line
//
ID 3D4/21
AC CVCL_0F14
DR ATCC; CRL-2843
RX PubMed=12088830;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Landrace.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0F12 ! 3D4
CA Transformed cell line
//
ID 3D4/31
AC CVCL_0F15
DR ATCC; CRL-2844
DR GEO; GSM1967249
DR GEO; GSM1967250
DR GEO; GSM1967251
DR GEO; GSM1967252
DR GEO; GSM1967253
DR GEO; GSM1967254
DR GEO; GSM1967255
DR GEO; GSM1967256
DR GEO; GSM1967257
DR GEO; GSM1967258
DR GEO; GSM1967259
DR GEO; GSM1967260
DR GEO; GSM1967261
DR GEO; GSM1967262
DR GEO; GSM1967263
RX PubMed=12088830;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Landrace.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_0F12 ! 3D4
CA Transformed cell line
//
ID 3D5 [Human B-cell]
AC CVCL_7939
DR BTO; BTO:0004405
RX PubMed=2243835;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 3D5 [Human melanoma]
AC CVCL_Y457
DR Cosmic; 1058336
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 3D8
AC CVCL_U276
DR ATCC; HB-9101
RX Patent=US4904581;
CC Discontinued: ATCC; HB-9101; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3E1
AC CVCL_4491
SY 3 E 1
DR CLO; CLO_0001276
DR CLO; CLO_0001337
DR CLDB; cl5098
DR ATCC; HB-8067
DR IZSLER; BS Hy 8
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 3E9
AC CVCL_J022
DR ATCC; HB-8514
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3F11.3
AC CVCL_N023
DR ATCC; PTA-7312
RX Patent=US7737259;
CC Monoclonal antibody target: UniProtKB; Q9GZX6; Human IL22.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3F4
AC CVCL_X854
DR ATCC; PTA-5590
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3F5
AC CVCL_X855
DR ATCC; PTA-5259
RX Patent=US7091047;
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3F5.4G6
AC CVCL_DN55
RX PubMed=8602402;
CC Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 3F6
AC CVCL_G602
DR CLO; CLO_0001338
DR ATCC; HB-8512
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3F8
AC CVCL_X856
DR ATCC; PTA-5591
RX Patent=US7091047;
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3G1
AC CVCL_V646
RX Patent=WO2013155883A1;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201014.
CC Monoclonal antibody target: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3G12
AC CVCL_U277
DR ATCC; HB-9102
RX Patent=US4904581;
CC Discontinued: ATCC; HB-9102; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3G2
AC CVCL_X857
DR ATCC; PTA-5592
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3G3
AC CVCL_G603
DR CLO; CLO_0001339
DR ATCC; HB-8516
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3G5
AC CVCL_D291
DR CLO; CLO_0001340
DR ATCC; CRL-1814
DR BCRJ; 0015
RX PubMed=6368201;
CC Monoclonal antibody target: O-acetylated gangliosides.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3G8 [Mouse hybridoma against HIV antigens]
AC CVCL_U327
DR ATCC; HB-9114
RX Patent=US4904581;
CC Discontinued: ATCC; HB-9114; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3G8 [Mouse hybridoma against human CD16]
AC CVCL_J227
DR TKG; TKG 0178
CC Monoclonal antibody target: UniProtKB; P08637; Human FCGR3A/CD16.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 3G9F3
AC CVCL_G604
DR CLO; CLO_0001341
DR ATCC; CRL-1843
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 3H5-1
AC CVCL_D292
DR CLO; CLO_0001342
DR ATCC; HB-46
DR BCRJ; 0016
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 3H9
AC CVCL_J228
DR TKG; TKG 0621
RX PubMed=9087970;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 3HTEo-
AC CVCL_U403
SY 3/HTEo-
RX PubMed=1375758;
RX PubMed=2457904;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U404 ! 8HTEo-
OI CVCL_U405 ! 9HTEo-
CA Transformed cell line
//
ID 3J1
AC CVCL_M056
DR KCLB; 60053
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID 3LBLN
AC CVCL_3636
DR CLO; CLO_0001343
DR ATCC; CRL-6048
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6048; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID 3LL
AC CVCL_5653
SY 3-LL; 3 LL; LLC
DR BTO; BTO:0004004
DR ChEMBL-Cells; CHEMBL3307811
DR ChEMBL-Targets; CHEMBL612910
DR JCRB; JCRB1348
CC Caution: Could be identical to LL/2 (LLC1) (CVCL_4358).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 3M
AC CVCL_4J66
DR ATCC; PTA-10481
RX Patent=US9045536;
CC Discontinued: ATCC; PTA-10481; probable.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Transformed cell line
//
ID 3NA12
AC CVCL_M959
RX Patent=US20020048812;
RX PubMed=10804211;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID 3NB12.13
AC CVCL_2H34
DR ATCC; CRL-2354
CC Monoclonal antibody target: C.elegans antigen on pharyngeal cells.
CC Discontinued: ATCC; CRL-2354; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 3Pt12B8
AC CVCL_J724
DR CLO; CLO_0001344
DR ATCC; HB-8136
RX Patent=US4443427;
CC Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 3SB
AC CVCL_E146
DR RCB; RCB0681
RX PubMed=9726009;
CC Discontinued: RCB; RCB0681; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 3T3 MEFs KO
AC CVCL_9091
DR CLO; CLO_0001347
DR ATCC; CRL-2753
RX PubMed=11457855;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID 3T3 MEFs WT
AC CVCL_9092
DR CLO; CLO_0001348
DR ATCC; CRL-2752
RX PubMed=11457855;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID 3T3-C2
AC CVCL_0121
SY 3T3C2
DR MCCL; MCC:0000013
RX PubMed=6698114;
CC Caution: Could be identical to 3T3-M2 (CVCL_4U11).
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3-J2
AC CVCL_W667
SY 3T3 J2; 3T3J2
DR IZSLER; BS CL 153
RX PubMed=1052771;
WW https://www.kerafast.com/product/2285/3t3-j2-cell-line
CC Doubling time: ~18 hours (Kerafast).
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3-L1
AC CVCL_0123
SY 3T3 L1; 3T3L1; 3T3-L1 ad; NIH-3T3-L1; NIH3T3-L1
DR BTO; BTO:0000011
DR CLO; CLO_0001352
DR EFO; EFO_0001084
DR EFO; EFO_0001223
DR MCCL; MCC:0000015
DR CLDB; cl71
DR CLDB; cl72
DR CLDB; cl73
DR ATCC; CL-173
DR ATCC; CCL-92.1
DR BCRC; 60159
DR BCRJ; 0019
DR CCRID; 3111C0001CCC000155
DR CCRID; 3131C0001000300011
DR CCRID; 3142C0001000000148
DR CCRID; 3153C0001000000020
DR ChEMBL-Cells; CHEMBL3307630
DR ChEMBL-Targets; CHEMBL614510
DR ECACC; 86052701
DR ENCODE; ENCBS366WMO
DR ENCODE; ENCBS666CGP
DR IFO; IFO50416
DR IZSLER; BS CL 100
DR JCRB; JCRB9014
DR KCB; KCB 92010YJ
DR KCLB; 10092.1
DR Lonza; 1083
DR MeSH; D041721
DR PRIDE; PXD001063
DR PRIDE; PXD001529
DR PRIDE; PXD003696
DR TOKU-E; 331
DR Wikidata; Q4636414
RX Patent=US4003789;
RX PubMed=165899;
RX PubMed=4426090;
RX PubMed=6698114;
RX PubMed=28176856;
WW https://en.wikipedia.org/wiki/3T3-L1
WW http://www.cells-talk.com/index.php/page/copelibrary?key=3T3-L1%20cells
WW https://www.kerafast.com/product/2284/3t3-preadipose-cell-lines
WW http://www.zen-bio.com/products/cells/3T3L1.php
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-72.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-103.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-334.html
CC Discontinued: ATCC; CCL-92.1; true.
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3-L1 MBX
AC CVCL_0A20
DR ATCC; CRL-3242
WW https://www.researchgate.net/post/Has_anyone_used_3T3-L1_MBX_cell_line_from_ATCC_before
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0123 ! 3T3-L1
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3-M2
AC CVCL_4U11
RX PubMed=165899;
RX PubMed=4426090;
CC Caution: Could be identical to 3T3-C2 (CVCL_0121).
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3-msCD40L
AC CVCL_1H10
SY 3T3-CD40L
DR NIH-ARP; 12535-444
RX PubMed=11691813;
CC Transfected with: MGI; MGI:88337; Cd40lg.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3-MSV
AC CVCL_4578
DR CLO; CLO_0001353
DR CLDB; cl74
DR ECACC; 90092701
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3-Swiss albino
AC CVCL_0120
SY 3T3 Swiss Albino; 3T3; Swiss-3T3; Swiss 3T3; Swiss3T3
DR CLO; CLO_0001345
DR CLO; CLO_0001355
DR MCCL; MCC:0000012
DR CLDB; cl65
DR CLDB; cl66
DR CLDB; cl76
DR CLDB; cl77
DR CLDB; cl78
DR CLDB; cl79
DR CLDB; cl80
DR CLDB; cl81
DR CLDB; cl82
DR CLDB; cl83
DR ATCC; CCL-92
DR BCRC; 60071
DR BCRJ; 0017
DR CCRID; 3111C0001CCC000001
DR CCRID; 3111C0002000000039
DR CCRID; 3131C0001000300009
DR CLS; 400103/p821_3T3-Swiss_albino
DR DSMZ; ACC-173
DR ECACC; 85022108
DR ICLC; ATL95002
DR IFO; IFO50417
DR IZSLER; BS CL 82
DR JCRB; JCRB9019
DR Lonza; 902
DR MeSH; D041701
DR RCB; RCB1642
RX PubMed=13985244;
WW http://www.atcc.org/support/faqs/89140/ATCC%20CCL92%20vs%20ATCC%20CRL1658-453.aspx
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/3t3/3t3cells.html
CC Doubling time: ~40 hours (DSMZ).
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID 3T3.T4
AC CVCL_1E11
DR NIH-ARP; 3945-43
CC Transfected with: HGNC; 1678; CD4.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID 3T3.T4.BOB
AC CVCL_1E12
DR NIH-ARP; 3949-21
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 4469; GPR15.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1E11 ! 3T3.T4
SX Male
CA Transformed cell line
//
ID 3T3.T4.Bonzo
AC CVCL_1E13
DR NIH-ARP; 3950-22
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 16647; CXCR6.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1E11 ! 3T3.T4
SX Male
CA Transformed cell line
//
ID 3T3.T4.CCR3
AC CVCL_1E14
DR NIH-ARP; 3946-25
CC Transfected with: HGNC; 1604; CCR3.
CC Transfected with: HGNC; 1678; CD4.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1E11 ! 3T3.T4
SX Male
CA Transformed cell line
//
ID 3T3.T4.CCR5
AC CVCL_1E15
DR NIH-ARP; 3947-32
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: HGNC; 1678; CD4.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1E11 ! 3T3.T4
SX Male
CA Transformed cell line
//
ID 3T3.T4.CXCR4
AC CVCL_1E16
SY CXCR4-3T3.T4
DR NIH-ARP; 3948-38
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 2561; CXCR4.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1E11 ! 3T3.T4
SX Male
CA Transformed cell line
//
ID 3T3(+3)
AC CVCL_8827
SY 3T3 (+3)
DR CLO; CLO_0001350
DR CLDB; cl69
DR ATCC; CRL-6474
DR ECACC; 89022402
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6474; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID 3T3F442A
AC CVCL_0122
SY 3T3-F442A; 3T3-442A; F442A; F442-A
DR BTO; BTO:0001169
DR EFO; EFO_0002811
DR MCCL; MCC:0000014
DR ECACC; 00070654
WW http://www.cells-talk.com/index.php/page/copelibrary?key=3T3-F442A
WW https://www.kerafast.com/product/2284/3t3-preadipose-cell-lines
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-344.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/3/cell-lines-detail-360.html
CC Doubling time: 18 hours (Kerafast).
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0123 ! 3T3-L1
SX Male
CA Spontaneously immortalized cell line
//
ID 3T6-Swiss albino
AC CVCL_0601
SY 3T6 Swiss Albino; Swiss 3T6; NIH 3T6; 3T6; GM05862
DR BTO; BTO:0000454
DR CLO; CLO_0001356
DR CLO; CLO_0024702
DR CLO; CLO_0050525
DR CLDB; cl86
DR CLDB; cl88
DR CLDB; cl89
DR CLDB; cl90
DR ATCC; CCL-96
DR BCRC; 60070
DR BCRJ; 0020
DR CCRID; 3111C0001CCC000121
DR CCRID; 3111C0002000000040
DR CCRID; 3131C0001000300001
DR CLS; 400104/p766_3T6-Swiss_albino
DR DSMZ; ACC-202
DR ECACC; 86120801
DR Coriell; GM05862
DR IZSLER; BS CL 83
DR JCRB; JCRB9059
DR RCB; RCB0248
RX PubMed=13985244;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-228.html
CC Doubling time: ~15 hours (DSMZ).
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID 3Y1-B cl 1-6-K5-4-2
AC CVCL_J498
DR RCB; RCB0289
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Spontaneously immortalized cell line
//
ID 3Y1-B clone 1
AC CVCL_4563
SY 3Y1B clone 1; 3Y1
DR BTO; BTO:0002368
DR ChEMBL-Cells; CHEMBL3308639
DR ChEMBL-Targets; CHEMBL614741
DR RCB; RCB0290
DR TOKU-E; 4132
RX PubMed=166944;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/3/cell-lines-detail-585.html
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Spontaneously immortalized cell line
//
ID 3Y1-B clone 1-6
AC CVCL_E147
DR JCRB; JCRB0734
DR RCB; RCB0287
DR RCB; RCB0488
RX PubMed=166944;
CC Discontinued: RCB; RCB0287; true.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Spontaneously immortalized cell line
//
ID 3Y1-B clone 1-6-2
AC CVCL_H230
DR RCB; RCB0288
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Spontaneously immortalized cell line
//
ID 3Y1-SB-15
AC CVCL_K105
DR RCB; RCB0323
RX PubMed=4030625;
CC Transformant: ChEBI; CHEBI:64103; Sodium butyrate.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1-SB-16
AC CVCL_K106
DR RCB; RCB0324
RX PubMed=4030625;
CC Transformant: ChEBI; CHEBI:64103; Sodium butyrate.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1BU^(r-1)
AC CVCL_U201
DR RCB; RCB0325
RX CelloPub=CLPUB00012;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID 3Y1BU^(r-2)
AC CVCL_U202
DR RCB; RCB0326
RX CelloPub=CLPUB00012;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID 3Y1BU^(r-3)
AC CVCL_U203
DR RCB; RCB0327
RX CelloPub=CLPUB00012;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID 3Y1ts-101
AC CVCL_L712
DR RCB; RCB0291
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-103
AC CVCL_L713
DR RCB; RCB0293
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-104
AC CVCL_L714
DR RCB; RCB0294
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-105
AC CVCL_L715
DR RCB; RCB0295
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-108
AC CVCL_L716
DR RCB; RCB0298
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-109
AC CVCL_L717
DR RCB; RCB0299
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-111
AC CVCL_L718
DR RCB; RCB0301
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-114
AC CVCL_L719
DR RCB; RCB0304
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-115
AC CVCL_L720
DR RCB; RCB0305
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-117
AC CVCL_L721
DR RCB; RCB0307
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-118
AC CVCL_L722
DR RCB; RCB0308
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-120
AC CVCL_L723
DR RCB; RCB0310
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-122
AC CVCL_L724
DR RCB; RCB0312
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-201
AC CVCL_L725
DR RCB; RCB0317
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1ts-202
AC CVCL_L726
DR RCB; RCB0318
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsA106
AC CVCL_L727
DR RCB; RCB0296
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsB107
AC CVCL_L728
DR RCB; RCB0297
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsC102
AC CVCL_L729
DR RCB; RCB0292
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsC112
AC CVCL_L730
DR RCB; RCB0302
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsC113
AC CVCL_L731
DR RCB; RCB0303
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsC116
AC CVCL_L732
DR RCB; RCB0306
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsC119
AC CVCL_L733
DR RCB; RCB0309
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsC205
AC CVCL_L734
DR RCB; RCB0321
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsD123
AC CVCL_L735
DR RCB; RCB0313
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsD124
AC CVCL_L736
DR RCB; RCB0314
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsD206
AC CVCL_L737
DR RCB; RCB0322
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsE204
AC CVCL_L738
DR RCB; RCB0320
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsF121
AC CVCL_L739
DR RCB; RCB0311
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsF126
AC CVCL_L740
DR RCB; RCB0316
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsG125
AC CVCL_L741
DR RCB; RCB0315
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 3Y1tsH203
AC CVCL_L742
DR RCB; RCB0319
RX PubMed=6583851;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID 4-1.10
AC CVCL_6546
SY 4-1.10''
RX PubMed=8274294;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=4-1.10
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID 4-11
AC CVCL_2821
DR ECACC; 11033103
RX Patent=US7537904;
CC Transfected with: HGNC; 644; AR.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID 4-1st
AC CVCL_L498
SY 4-1ST
RX PubMed=1295442;
RX PubMed=14662023;
RX PubMed=15767549;
CC Part of: JFCR45 cancer cell line panel.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 4-2C11
AC CVCL_J725
DR CLO; CLO_0050361
DR RCB; RCB0868
RX PubMed=3028450;
CC Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4-2D
AC CVCL_J273
DR JCRB; JCRB0084
RX PubMed=2415123;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 4-8H
AC CVCL_J272
DR JCRB; JCRB0083
RX PubMed=2415123;
CC Monoclonal antibody target: UniProtKB; F1NR19; Chicken POLA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 4-HS-MYC
AC CVCL_5A28
RX Patent=EP0232845A2;
RX PubMed=3526329;
CC Transfected with: MGI; MGI:97250; Myc.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID 4.6.5a114K
AC CVCL_J886
SY 4.6.5A 114K
DR ECACC; 93062218
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4/30PRR
AC CVCL_8480
SY MPC 4/30PRR
RX PubMed=15860353;
CC Breed/subspecies: 129S2/SvPas x C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID 4/4 R.M.-4
AC CVCL_4089
SY 4/4 RM-4
DR CLO; CLO_0001357
DR CLDB; cl91
DR ATCC; CCL-216
DR ECACC; 90112711
RX PubMed=7065527;
RX PubMed=7216240;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Spontaneously immortalized cell line
//
ID 40 BLCL
AC CVCL_E404
DR ECACC; 94031605
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 40.10.09
AC CVCL_J671
SY PM 40.10.09
DR CLO; CLO_0001358
DR ATCC; HB-9311
RX Patent=US4818685;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 402-91
AC CVCL_S813
SY 402/91; MLS 402-91; MLS402
DR Cosmic; 1105011
DR Cosmic; 1672267
DR Cosmic; 2307719
RX PubMed=1283316;
RX PubMed=16651630;
RX PubMed=20515481;
RX PubMed=24726063;
RX PubMed=25393000;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 402-91/ET
AC CVCL_S814
RX PubMed=21805478;
CC Selected for resistance to: ChEBI; CHEBI:84050; Trabectedin (Ecteinascidin-743; ET-743).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S813 ! 402-91
SX Male
CA Transformed cell line
//
ID 404C2
AC CVCL_DP92
SY 404C-2
DR GEO; GSM1040274
DR GEO; GSM1040344
DR GEO; GSM1489194
DR GEO; GSM1489223
DR GEO; GSM1489252
DR GEO; GSM1489427
RX PubMed=21460823;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 409B2
AC CVCL_K092
SY 409-B2; 409B-2
DR GEO; GSM1040275
DR GEO; GSM1040345
DR GEO; GSM1489195
DR GEO; GSM1489224
DR GEO; GSM1489251
DR GEO; GSM1489428
DR RCB; HPS0076
DR SKIP; SKIP000218
RX PubMed=21460823;
RX PubMed=22802639;
RX PubMed=24259714;
RX PubMed=25665923;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=21460823
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,13
ST D16S539: 11,13
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 8,10
ST FGA: 20,22
ST Penta D: 9,11
ST Penta E: 7,19
ST TH01: 6
ST TPOX: 8,9
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 41-2
AC CVCL_G693
SY mAb 41-2
DR CLO; CLO_0001360
DR ATCC; CRL-2695
DR ATCC; PTA-226
RX Patent=US6245898;
CC Monoclonal antibody target: UniProtKB; Q9H5V8; Human CDCDP1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 41-3.48
AC CVCL_J727
DR CLO; CLO_0001361
DR ATCC; HB-130
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 410.4
AC CVCL_W343
RX PubMed=2790822;
RX PubMed=3940214;
RX PubMed=6677618;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0I84 ! 168
OI CVCL_9722 ! 66 [Mouse mammary tumor]
OI CVCL_0I87 ! 67 [Mouse mammary tumor]
SX Female
CA Cancer cell line
//
ID 410.4H
AC CVCL_W344
SY 410.4-H
RX PubMed=10457219;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W343 ! 410.4
SX Female
CA Cancer cell line
//
ID 411-14E10
AC CVCL_J726
DR CLO; CLO_0001359
DR ATCC; CRL-2663
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 413-15D12
AC CVCL_J618
DR CLO; CLO_0001362
DR ATCC; CRL-2653
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4143
AC CVCL_IV49
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6935474;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 414C2
AC CVCL_DP60
SY 414C-2
DR GEO; GSM1040276
DR GEO; GSM1040346
DR GEO; GSM1899767
RX PubMed=21460823;
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=21460823
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,13
ST D16S539: 11,13
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 8,10
ST FGA: 20,22
ST Penta D: 9,11
ST Penta E: 7,19
ST TH01: 6
ST TPOX: 8,9
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP59 ! HDF1388
SX Female
CA Induced pluripotent stem cell
//
ID 416-20E10
AC CVCL_0F03
DR ATCC; CRL-2664
CC Discontinued: ATCC; CRL-2664; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 416B
AC CVCL_3983
DR BTO; BTO:0002884
DR CLO; CLO_0001363
DR EFO; EFO_0005482
DR CLDB; cl92
DR ECACC; 85061103
DR ENCODE; ENCBS024ENC
DR ENCODE; ENCBS107JSU
DR GEO; GSM1014163
DR GEO; GSM1499158
DR GEO; GSM1499159
RX PubMed=763330;
RX PubMed=6821513;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/416B_Stam_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Discontinued: ECACC; 85061103; probable.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID 418C1
AC CVCL_DP93
SY 418C-1
DR GEO; GSM1489289
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3199 ! TIG-114
SX Male
CA Induced pluripotent stem cell
//
ID 41M
AC CVCL_4993
SY 41-M; OAW41M; 041M; 41 M
DR BTO; BTO:0003998
DR BioSample; SAMN03151866
DR ChEMBL-Cells; CHEMBL3307631
DR ChEMBL-Targets; CHEMBL614511
DR ECACC; 93061002
DR GEO; GSM313659
DR GEO; GSM851922
RX PubMed=1423261;
RX PubMed=1617660;
RX PubMed=1892748;
RX PubMed=2653399;
RX PubMed=8795574;
RX PubMed=15677628;
RX PubMed=20143388;
RX PubMed=22710073;
RX PubMed=23415752;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OAW28 derivative (PubMed=20143388).
CC Omics: Transcriptome analysis.
CC Misspelling: 'M41' in GEO GSM851922.
CC Discontinued: ECACC; 93061002; probable.
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1614 ! OAW28
SX Female
CA Cancer cell line
//
ID 41M-cisR
AC CVCL_N788
SY 41M/cisR; 41McisR
DR Cosmic; 1609533
DR GEO; GSM851923
RX PubMed=1617660;
CC Problematic cell line: Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Transcriptome analysis.
CC Misspelling: 'M41CisR' in GEO GSM851923.
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4993 ! 41M
SX Female
CA Cancer cell line
//
ID 41M:RD1694
AC CVCL_Y427
RX PubMed=7537518;
CC Problematic cell line: Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
CC Selected for resistance to: ChEBI; CHEBI:5847; ICI D1694 (Tomudex; ZD1694).
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4993 ! 41M
SX Female
CA Cancer cell line
//
ID 41M47
AC CVCL_Y037
SY 41m/47
DR Cosmic; 688088
DR Cosmic; 1609530
RX PubMed=12068308;
CC Problematic cell line: Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4993 ! 41M
SX Female
CA Cancer cell line
//
ID 42-MG-BA
AC CVCL_1798
SY 42MGBA
DR CLO; CLO_0001367
DR BioSample; SAMN03473596
DR CCLE; 42MGBA_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 687561
DR Cosmic; 1746946
DR Cosmic; 1995325
DR Cosmic; 2060804
DR Cosmic; 2302328
DR Cosmic-CLP; 687561
DR DSMZ; ACC-431
DR GDSC; 687561
DR GEO; GSM326214
DR GEO; GSM886839
DR GEO; GSM887902
DR GEO; GSM1669567
RX PubMed=9604998;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 42.08.07
AC CVCL_J672
SY PM 42.08.07
DR CLO; CLO_0001364
DR ATCC; HB-9313
RX Patent=US4818685;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 421C1
AC CVCL_DP94
SY 421C-1
DR GEO; GSM1899765
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3192 ! TIG-107
SX Female
CA Induced pluripotent stem cell
//
ID 424GC
AC CVCL_X064
RX PubMed=16536871;
DI NCIt; C24227; Mouse gastric adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID 426C2
AC CVCL_DP95
SY 426C-2
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP67 ! HDF1554
SX Female
CA Induced pluripotent stem cell
//
ID 427.1
AC CVCL_L904
RX PubMed=8500519;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 427.1.86
AC CVCL_L905
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L904 ! 427.1
CA Transformed cell line
//
ID 427D4
AC CVCL_DP96
SY 427D-4
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP66 ! HDF1437
SX Male
CA Induced pluripotent stem cell
//
ID 427F1
AC CVCL_DQ31
DR GEO; GSM1489196
DR GEO; GSM1489225
DR GEO; GSM1489431
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP66 ! HDF1437
SX Male
CA Induced pluripotent stem cell
//
ID 428C2
AC CVCL_DP97
SY 428C-2
DR GEO; GSM1899766
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3202 ! TIG-120
SX Female
CA Induced pluripotent stem cell
//
ID 42GPA9
AC CVCL_U464
RX PubMed=9475418;
RX PubMed=15541572;
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID 42TA
AC CVCL_5489
DR CLO; CLO_0001368
DR ATCC; CRL-2759
RX PubMed=8988857;
RX PubMed=18824023;
CC Group: Fish cell line.
OX NCBI_TaxID=7998; ! Ictalurus punctatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 430F
AC CVCL_J229
DR TKG; TKG 0179
CC Monoclonal antibody target: Sheep red blood cells (SRBC).
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 435.eB
AC CVCL_0124
DR MCCL; MCC:0000016
CC Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC Transfected with: HGNC; 3430; ERBB2.
CC Derived from metastatic site: Subcutaneous; right buttock.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0417 ! MDA-MB-435
SX Male
CA Cancer cell line
//
ID 43L
AC CVCL_3356
DR CLO; CLO_0050280
DR RCB; RCB2843
DR TKG; TKG 0381
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID 44-2
AC CVCL_A597
SY rMTC 44-2
RX PubMed=6353060;
RX PubMed=6832044;
RX PubMed=7736432;
CC Breed/subspecies: WAG/Rij.
DI NCIt; C60369; Rat C-cell carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID 44-22-1
AC CVCL_D663
SY 44.22.1
DR BCRJ; 0021
RX PubMed=2459713;
RX PubMed=2578398;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID 44-3
AC CVCL_4U24
SY rMTC 44-3
RX PubMed=6353060;
CC Breed/subspecies: WAG/Rij.
DI NCIt; C60369; Rat C-cell carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_A597 ! 44-2
CA Cancer cell line
//
ID 44-3C1
AC CVCL_A598
SY rMTC 44-3C1; 44-3 clone 1
RX PubMed=6353060;
CC Breed/subspecies: WAG/Rij.
DI NCIt; C60369; Rat C-cell carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U24 ! 44-3
CA Cancer cell line
//
ID 44-6-1
AC CVCL_0E32
DR ATCC; CRL-2491
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 44-6-2
AC CVCL_0E33
DR ATCC; CRL-2492
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 443-15D3-2F12
AC CVCL_F772
SY 15D3
DR CLO; CLO_0001369
DR ATCC; HB-11342
RX Patent=US6143873;
CC Registration: Chiron Master Culture Collection; CMCC 10748 (CMCC #10748).
CC Monoclonal antibody target: UniProtKB; P08183; Human ABCB1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 443-17F9-1C6
AC CVCL_J963
SY 17F9
DR ATCC; CRL-2694
DR ATCC; PTA-354
RX Patent=US6143873;
CC Registration: Chiron Master Culture Collection; CMCC 10747 (CMCC #10747).
CC Monoclonal antibody target: UniProtKB; P08183; Human ABCB1.
CC Discontinued: ATCC; CRL-2694; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 446.1
AC CVCL_0I02
DR ATCC; PTA-5549
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4470
AC CVCL_9669
DR EFO; EFO_0002807
RX PubMed=18329371;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 4475
AC CVCL_9670
DR EFO; EFO_0002808
RX PubMed=18329371;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 448-D 100, 10, 1
AC CVCL_8940
SY 448-D
DR CLO; CLO_0001370
DR ATCC; HB-10895
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3419 ! SHM-D33
CA Hybridoma
//
ID 4483
AC CVCL_9671
DR EFO; EFO_0002809
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID 44aacb
AC CVCL_J601
DR CLO; CLO_0001371
DR ATCC; HB-249
CC Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 44FT0
AC CVCL_0I83
RX PubMed=3426919;
RX PubMed=3940214;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W343 ! 410.4
SX Female
CA Cancer cell line
//
ID 45.6
AC CVCL_1D02
SY MPC-11 45.6
RX PubMed=805428;
RX PubMed=4139712;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3857 ! MPC-11
SX Female
CA Cancer cell line
//
ID 45.6.2.4
AC CVCL_1D03
SY MPC-11.45.6.2.4
RX PubMed=805428;
RX PubMed=4139712;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1D02 ! 45.6
SX Female
CA Cancer cell line
//
ID 45.6.3.1
AC CVCL_1D04
RX PubMed=805428;
RX PubMed=4139712;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1D02 ! 45.6
SX Female
CA Cancer cell line
//
ID 45.6.TG1.7
AC CVCL_4090
SY 45,6TG1.7; 45.6TG1.7; MPC11-45.6TG1.7; MPC11-45.6 TG1.7; MPC11 TG1.7; GM03572
DR CLO; CLO_0001372
DR CLO; CLO_0017235
DR CLDB; cl96
DR ATCC; CRL-1608
DR Coriell; GM03572
DR ECACC; 90110506
RX PubMed=605383;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1D02 ! 45.6
SX Female
CA Cancer cell line
//
ID 451F3
AC CVCL_DP98
SY 451F-3
DR GEO; GSM1040277
DR GEO; GSM1040347
DR GEO; GSM1489197
DR GEO; GSM1489241
DR GEO; GSM1489432
RX PubMed=21460823;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 451Lu
AC CVCL_6357
SY 451LU; 451-LU; WM 451-Lu; WM-451Lu; WM-451LU; WM451Lu; WM451; WC00059; LU451; EST81
DR BTO; BTO:0003710
DR CLO; CLO_0001373
DR ATCC; CRL-2813
DR BioSample; SAMN03471798
DR Coriell; WC00059
DR Cosmic; 686411
DR Cosmic; 1047656
DR Cosmic; 1155281
DR Cosmic; 1155568
DR Cosmic; 1187587
DR Cosmic; 1303027
DR Cosmic; 2163808
DR Cosmic; 2230114
DR Cosmic-CLP; 1287706
DR ESTDAB; ESTDAB-081
DR GDSC; 1287706
DR GEO; GSM156019
DR GEO; GSM188238
DR GEO; GSM188268
DR GEO; GSM188327
DR GEO; GSM555187
DR GEO; GSM952579
DR GEO; GSM1199178
DR GEO; GSM1669568
RX PubMed=2068080;
RX PubMed=2156614;
RX PubMed=2918552;
RX PubMed=8342600;
RX PubMed=17260012;
RX PubMed=24055054;
RX PubMed=27397505;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=51606
CC Part of: Wistar Institute melanoma cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; CRL-2813; true.
CC Discontinued: Coriell; WC00059; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 12 (ATCC; Cosmic-CLP; ESTDAB)
ST CSF1PO: 11,12 (Wistar)
ST D13S317: 11
ST D16S539: 13
ST D18S51: 10
ST D19S433: 13
ST D21S11: 28,31.2
ST D2S1338: 18,19
ST D3S1358: 18
ST D5S818: 12 (ATCC; Cosmic-CLP; ESTDAB)
ST D5S818: 11,12 (Wistar)
ST D7S820: 9,10 (ATCC; ESTDAB; Wistar)
ST D7S820: 10 (Cosmic-CLP)
ST D8S1179: 13,14
ST FGA: 21,25 (ESTDAB)
ST FGA: 21 (Wistar)
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14,15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7928 ! WM164
SX Male
CA Cancer cell line
//
ID 451Lu-BR
AC CVCL_AP83
SY 451Lu BR; 451LU BR; 451LuBR; 451Lu-R
RX PubMed=21156289;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51612
CC Part of: Wistar Institute melanoma cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:131882; SB-590885.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6357 ! 451Lu
SX Male
CA Cancer cell line
//
ID 451Lu-MR
AC CVCL_DG54
DR GEO; GSM1199179
RX PubMed=24055054;
CC Selected for resistance to: ChEBI; CHEBI:75998; Trametinib (Mekinist; GSK1120212).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6357 ! 451Lu
SX Male
CA Cancer cell line
//
ID 452F2-1B2
AC CVCL_N287
SY 452F2
DR ATCC; HB-10811
RX Patent=US5169774;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 453C2
AC CVCL_DR12
DR GEO; GSM1899762
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DQ50 ! DP94
SX Female
CA Induced pluripotent stem cell
//
ID 453F2
AC CVCL_DP99
SY 453F-2
DR GEO; GSM1899759
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DQ50 ! DP94
SX Female
CA Induced pluripotent stem cell
//
ID 454B1
AC CVCL_DQ01
SY 454B-1
DR GEO; GSM1899760
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 454C11
AC CVCL_G605
DR CLO; CLO_0001374
DR ATCC; HB-8484
RX Patent=US4753894;
RX Patent=US5169774;
RX Patent=US5629197;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 454C2
AC CVCL_DQ02
SY 454C-2
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 454D1
AC CVCL_DQ03
SY 454D-1
DR GEO; GSM1899761
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 454E2
AC CVCL_T791
SY 454-E2; 454 E2; 454E-2
DR GEO; GSM1040278
DR GEO; GSM1040348
DR GEO; GSM1489198
DR GEO; GSM1489242
DR GEO; GSM1489433
DR RCB; HPS0077
DR SKIP; SKIP000219
RX PubMed=21460823;
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=21460823
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 10,14
ST D16S539: 9,10
ST D18S51: 13,19
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 11,12
ST FGA: 21,24
ST Penta D: 10,13
ST Penta E: 5,15
ST TH01: 7
ST TPOX: 8
ST vWA: 17,21
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 454F1
AC CVCL_DQ04
SY 454F-1
RX PubMed=21460823;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 455
AC CVCL_G191
DR CLO; CLO_0001375
DR ATCC; HB-8507
DR ECACC; 92090408
RX Patent=US4943533;
CC Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J593 ! NS-1-503
CA Hybridoma
//
ID 457C1
AC CVCL_DQ05
SY 457C-1
DR GEO; GSM1489199
DR GEO; GSM1489243
DR GEO; GSM1489255
DR GEO; GSM1489434
RX PubMed=21460823;
RX PubMed=22802639;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
ST Source(s): PubMed=21460823
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 10,14
ST D16S539: 9,10
ST D18S51: 13,19
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 11,12
ST FGA: 21,24
ST Penta D: 10,13
ST Penta E: 5,15
ST TH01: 7
ST TPOX: 8
ST vWA: 17,21
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP68 ! DP74
SX Female
CA Induced pluripotent stem cell
//
ID 46-2
AC CVCL_G606
DR CLO; CLO_0001377
DR ATCC; CRL-2186
RX PubMed=7590785;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 46-3
AC CVCL_0E85
DR ATCC; CRL-2191
RX PubMed=7590785;
CC Discontinued: ATCC; CRL-2191; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 46-4
AC CVCL_G608
DR CLO; CLO_0001378
DR ATCC; CRL-2178
RX PubMed=7590785;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 46-5
AC CVCL_G609
DR CLO; CLO_0001379
DR ATCC; CRL-2184
RX PubMed=7590785;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 46-6B5
AC CVCL_HA21
RX PubMed=2459713;
RX PubMed=2578398;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID 46/4
AC CVCL_G607
DR CLO; CLO_0001376
DR ATCC; HB-67
DR IZSLER; BS Hy 51
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4647
AC CVCL_4075
SY Continuous kidney cell line No. 4647
DR CLO; CLO_0001013
DR CLDB; cl97
DR CLDB; cl98
DR CCRID; 3131C0001000400027
DR ECACC; 90091902
DR IZSLER; BS CL 223
RX PubMed=6495709;
RX PubMed=17500238;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=60710; ! Chlorocebus pygerythrus
CA Spontaneously immortalized cell line
//
ID 46BR
AC CVCL_L943
RX PubMed=2973075;
RX PubMed=3180052;
RX PubMed=3856882;
RX PubMed=6600729;
DI NCIt; C26931; Hypogammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 46BR.1G1
AC CVCL_2288
SY 46Br.1G1; 46BR 1G1; 46BR-1G1
DR BTO; BTO:0005012
DR CLO; CLO_0001380
DR CLDB; cl100
DR ECACC; 92091814
RX PubMed=2903889;
RX PubMed=3002824;
RX PubMed=3180052;
RX PubMed=7683758;
RX PubMed=22222975;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-gpt].
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C26931; Hypogammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L943 ! 46BR
SX Female
CA Transformed cell line
//
ID 46BR.1N
AC CVCL_2289
SY 46BR-1N; 46BR.NEO
DR CLO; CLO_0001381
DR CLDB; cl101
DR ECACC; 92100623
RX PubMed=2903889;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
DI NCIt; C26931; Hypogammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L943 ! 46BR
SX Female
CA Transformed cell line
//
ID 46BRLigI
AC CVCL_L950
DR BTO; BTO:0005013
RX PubMed=19628465;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-gpt].
DI NCIt; C26931; Hypogammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2288 ! 46BR.1G1
SX Female
CA Transformed cell line
//
ID 46C
AC CVCL_Y482
SY ES-46C; 46C ES
DR EFO; EFO_0005484
DR ENCODE; ENCBS122ENC
DR GEO; GSM450272
DR GEO; GSM450283
RX PubMed=12524553;
CC Part of: ENCODE project mouse cell lines.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y481 ! ES-E14TG2a.4
SX Male
CA Embryonic stem cell
//
ID 47 BLCL
AC CVCL_E405
DR ECACC; 94031606
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 47.10
AC CVCL_6820
RX PubMed=9923447;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=47.10
CC Characteristics: Produced in a transgenic mouse expressing human CSF1R.
CC Characteristics: CSF1 or CSF2 or IL3 dependent.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Factor-dependent cell line
//
ID 47BR
AC CVCL_4T38
RX PubMed=2973075;
RX PubMed=6600729;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 48
AC CVCL_J728
DR CLO; CLO_0001382
DR ATCC; CRL-1913
RX PubMed=6305011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 48 BLCL
AC CVCL_E406
DR ECACC; 94031607
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 48-4
AC CVCL_0C66
SY Clone 48-4
RX PubMed=19147538;
RX PubMed=19754807;
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID 486P
AC CVCL_7940
SY 486-P
RX PubMed=66978;
RX PubMed=944089;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=6935474;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 48BR
AC CVCL_4T39
RX PubMed=2903889;
RX PubMed=2973075;
RX PubMed=6600729;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID 49 BLCL
AC CVCL_E407
DR ECACC; 94031608
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 49-15
AC CVCL_DC77
DR ATCC; CRL-8011
RX Patent=EP0008092B1;
RX PubMed=6153172;
CC Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl (DNP).
CC Discontinued: ATCC; CRL-8011; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 49B2
AC CVCL_S156
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 49Z
AC CVCL_0Q74
SY 49-Z; Z49
RX PubMed=11696444;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3014; Endometriosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 4a-2
AC CVCL_Z620
SY 4A-2; 4a2
RX PubMed=10681436;
RX PubMed=23382679;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-917.aspx
WW https://www.vectorbase.org/data/anopheles-gambiae-4a-2-cell-line-avcl
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: 4a r/r.
OX NCBI_TaxID=7165; ! Anopheles gambiae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 4a-2s4
AC CVCL_Z621
DR BTO; BTO:0002633
RX PubMed=12626708;
WW http://hawaii.eagle-i.net/i/0000012b-5662-f5f5-2f73-b43980000000
CC Group: Insect cell line.
CC Breed/subspecies: 4a r/r.
OX NCBI_TaxID=7165; ! Anopheles gambiae
HI CVCL_Z620 ! 4a-2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 4a-3A
AC CVCL_Z622
SY 4A-3A; 4a3A
RX PubMed=10206988;
RX PubMed=23382679;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-918.aspx
WW https://www.vectorbase.org/data/anopheles-gambiae-4a-3a-cell-line-avcl
CC Group: Insect cell line.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-918.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: 4a r/r.
OX NCBI_TaxID=7165; ! Anopheles gambiae
OI CVCL_Z623 ! 4a-3B
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 4a-3B
AC CVCL_Z623
SY 4A-3B; 4a3B
RX PubMed=10206988;
RX PubMed=23382679;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-919.aspx
WW https://www.vectorbase.org/data/anopheles-gambiae-4a-3b-cell-line-avcl
CC Group: Insect cell line.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-919.
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: 4a r/r.
OX NCBI_TaxID=7165; ! Anopheles gambiae
OI CVCL_Z622 ! 4a-3A
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 4A4B11
AC CVCL_G610
DR CLO; CLO_0001383
DR ATCC; HB-8327
RX Patent=US4595654;
CC Monoclonal antibody target: UniProtKB; P02745; Human C1QA.
CC Monoclonal antibody target: UniProtKB; P02746; Human C1QB.
CC Monoclonal antibody target: UniProtKB; P02747; Human C1QC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4A6
AC CVCL_J639
DR CLO; CLO_0001384
DR ATCC; CRL-1928
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4B2
AC CVCL_J048
DR CLO; CLO_0001385
DR ATCC; HB-196
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 4B2-6C3-1C9
AC CVCL_J638
SY 1C9
DR CLO; CLO_0001386
DR ATCC; HB-12466
RX Patent=US5861241;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4BG
AC CVCL_M614
RX PubMed=8689637;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 4C
AC CVCL_J640
SY SKI 300 4C; mAb 4C; moAb 4C
DR CLO; CLO_0001387
DR ATCC; HB-8311
RX Patent=US4710457;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 4C11
AC CVCL_0E08
DR ATCC; CRL-2436
RX PubMed=7889418;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 4C2.4A7.5H11
AC CVCL_J641
SY 4C2
DR CLO; CLO_0001388
DR ATCC; CRL-2744
DR ATCC; JHU-28
CC Discontinued: ATCC; CRL-2744; true.
CC Discontinued: ATCC; JHU-28; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 4C4
AC CVCL_9160
DR CLO; CLO_0001389
DR ATCC; HB-327
DR NCBI_Iran; H110
RX PubMed=9531266;
CC Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4C5G
AC CVCL_J642
DR CLO; CLO_0001390
DR ATCC; CRL-2538
RX PubMed=1846531;
CC Monoclonal antibody target: UniProtKB; A6QLN5; Bovine PI4K2A (also reacts with human and other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4C7.2.1
AC CVCL_J987
DR ATCC; PTA-4999
RX Patent=US20080171036;
CC Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
CC Discontinued: ATCC; PTA-4999; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 4C8
AC CVCL_CW40
DR NCBI_Iran; H146
RX CelloPub=CLPUB00331;
CC Monoclonal antibody target: UniProtKB; P23223; Leishmania donovani gp63 (also reacts with other Leishmania species gp63).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 4C9
AC CVCL_D150
DR CLO; CLO_0001391
DR ATCC; CRL-2437
RX PubMed=7889418;
CC Monoclonal antibody target: UniProtKB; P07151; Rat B2m.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D145 ! HL-1 Friendly Myeloma-653
CA Hybridoma
//
ID 4D1
AC CVCL_X858
DR ATCC; PTA-5593
RX Patent=US7091047;
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 4D1.5.7
AC CVCL_J001
SY 4D1
DR CLO; CLO_0001392
DR ATCC; HB-11495
RX Patent=US5440021;
CC Monoclonal antibody target: UniProtKB; P25025; Human CXCR2/IL8RB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 4D11
AC CVCL_9161
DR CLO; CLO_0001393
DR ATCC; HB-240
DR NCBI_Iran; H134
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 4D12
AC CVCL_J813
DR CLO; CLO_0001394
DR ATCC; HB-178
RX PubMed=6181035;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 4D3
AC CVCL_J023
DR ATCC; HB-8517
RX Patent=US4596769;
CC Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4D4
AC CVCL_J230
DR TKG; TKG 0619
RX PubMed=17543284;
CC Monoclonal antibody target: UniProtKB; O95498; Human VNN2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 4D9D4
AC CVCL_J729
DR CLO; CLO_0001395
DR ATCC; CRL-1818
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 4DE4
AC CVCL_U623
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/4/cell-lines-detail-440.html
CC From: Staudt L.M.; National Cancer Institute; Bethesda; USA.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 4E11
AC CVCL_J730
DR CLO; CLO_0001396
DR ATCC; HB-9259
RX Patent=US4851341;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 4E7
AC CVCL_0I03
DR ATCC; PTA-5109
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4E8C12
AC CVCL_G611
DR CLO; CLO_0001397
DR ATCC; HB-10452
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4F10
AC CVCL_X859
DR ATCC; PTA-8763
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 4F2C13
AC CVCL_G092
DR CLO; CLO_0001398
DR ATCC; HB-22
DR CCRID; 3131C0001000600003
RX PubMed=6153676;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 4G12
AC CVCL_C560
DR IFO; IFO50090
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 4G5(PGM1) Clone B7
AC CVCL_U074
DR ECACC; 02043023
CC Monoclonal antibody target: UniProtKB; P36871; Human PGM1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4H1-A7
AC CVCL_1934
DR CLO; CLO_0001399
DR CLDB; cl102
DR ATCC; CRL-1813
DR DSMZ; ACC-28
RX PubMed=3281371;
CC Monoclonal antibody target: Canine adenovirus serotype 2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4H8(GC) Clone 4D4
AC CVCL_U075
DR ECACC; 02043019
CC Monoclonal antibody target: UniProtKB; P02774; Human GC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 4MBr-5
AC CVCL_4492
SY 4MBR-5
DR CLO; CLO_0001400
DR ATCC; CCL-208
DR IZSLER; BS CL 222
RX CelloPub=CLPUB00288;
RX PubMed=7065527;
CC Group: Non-human primate cell line.
CC Characteristics: EGF dependent.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Factor-dependent cell line
//
ID 4nH1
AC CVCL_N544
RX PubMed=17531078;
CC Characteristics: Has a tetraploid karyotype.
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_N541 ! H-1
SX Male
CA Embryonic stem cell
//
ID 4SB3
AC CVCL_J887
SY 4S.B3
DR ECACC; 92030610
DR NCBI_Iran; H113
RX PubMed=6438252;
CC Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 4T
AC CVCL_L857
RX PubMed=6081590;
DI NCIt; C3829; Benign synovial neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 4T07
AC CVCL_B383
SY 4TO7
DR BTO; BTO:0004026
RX PubMed=1540948;
RX PubMed=1993557;
RX PubMed=3426919;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0I83 ! 44FT0
SX Female
CA Cancer cell line
//
ID 4T1
AC CVCL_0125
SY 4T1-A
DR BTO; BTO:0004311
DR CLO; CLO_0001401
DR EFO; EFO_0002037
DR MCCL; MCC:0000017
DR ATCC; CRL-2539
DR BCRJ; 0022
DR CCRID; 3131C0001000800032
DR ChEMBL-Cells; CHEMBL3307995
DR ChEMBL-Targets; CHEMBL612589
DR KCB; KCB 200967YJ
DR Lonza; 481
DR NCBI_Iran; C604
RX PubMed=10411109;
WW http://www.addexbio.com/productdetail?pid=13
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/4/cell-lines-detail-66.html
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W343 ! 410.4
SX Female
CA Cancer cell line
//
ID 4T1-Luc
AC CVCL_J239
DR JCRB; JCRB1447
DR JCRB; NIHS0696
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0696; true.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1-luc2
AC CVCL_L899
RX PubMed=19404236;
WW http://web.archive.org/web/20150520035101/http://www.perkinelmer.com/catalog/product/id/124087
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124087.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1-luc2-GFP
AC CVCL_5J28
SY 4T1-luc2/GFP
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transfected with: UniProtKB; P42212; GFP.
CC Discontinued: PerkinElmer; Catalog number 129090.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1-luc2-tdTomato
AC CVCL_5J46
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transfected with: tdTomato; a bright red fluorescent protein derived from drFP583 (DsRed).
CC Discontinued: PerkinElmer; Catalog number 125669.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1-Red-FLuc
AC CVCL_5I84
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124087
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1-Red-FLuc-GFP
AC CVCL_5I85
WW http://www.perkinelmer.com/Catalog/Product/ID/BW128090
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1-S
AC CVCL_HE47
SY 4T1-Sapporo
RX PubMed=26857856;
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1-tdTomato
AC CVCL_5J45
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transfected with: tdTomato; a bright red fluorescent protein derived from drFP583 (DsRed).
CC Discontinued: PerkinElmer; Catalog number 125668.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1.13
AC CVCL_GR31
RX PubMed=15671244;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 4T1.2
AC CVCL_GR32
RX PubMed=10411109;
RX PubMed=15671244;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0125 ! 4T1
SX Female
CA Cancer cell line
//
ID 5-2
AC CVCL_W172
SY GMI-M5-2
RX Patent=US6673605;
RX PubMed=11054807;
CC Characteristics: CSF2 dependent.
CC Breed/subspecies: C57BL/6J(H-2b).
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID 5-8F
AC CVCL_C528
SY 58F
DR Cosmic; 1322951
DR Cosmic; 1459415
DR GEO; GSM375842
RX PubMed=12485491;
CC Omics: Transcriptome analysis.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6946 ! SUNE1
CA Cancer cell line
//
ID 5-8F/Erbitux
AC CVCL_S665
SY 5-8F-Erbitux
DR Cosmic; 1459416
RX PubMed=21122407;
CC Selected for resistance to: Cetuximab (Erbitux).
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C528 ! 5-8F
CA Cancer cell line
//
ID 5/9 m a3-18
AC CVCL_6358
SY 5/9 M alpha 3-18; CHO 5/9 M alpha3-18
DR CLO; CLO_0001403
DR ATCC; CRL-10154
DR BCRC; 60185
CC Transfected with: HGNC; 2432; CSF1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID 50 AZA SEL
AC CVCL_J884
DR ECACC; 85062505
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=9940; ! Ovis aries
HI CVCL_J883 ! GA4
CA Hybrid cell line
//
ID 50-11-10
AC CVCL_J888
SY 50.11.10
DR ECACC; 94020814
CC Monoclonal antibody target: UniProtKB; P06127; Human CD5.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 50-6
AC CVCL_G694
SY mAb 50-6
DR CLO; CLO_0001404
DR ATCC; CRL-2696
DR ATCC; PTA-227
RX Patent=US6245898;
CC Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID 50-69
AC CVCL_9V04
RX Patent=US5731189;
RX PubMed=2922401;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 501-mel
AC CVCL_4633
AS CVCL_C608
SY 501-MEL; 501 mel; 501 Mel; 501Mel; 501mel; 501; Mel 501; Mel501; MEL501; Me 501; Me-501; Me501
DR BTO; BTO:0002956
DR CGH-DB; 9296-4
DR Cosmic; 686481
DR Cosmic; 876680
DR Cosmic; 905210
DR Cosmic; 1197392
DR Cosmic; 1238106
DR Cosmic; 1458962
DR Cosmic; 1559440
DR Cosmic; 2159451
DR Cosmic; 2163827
DR Cosmic; 2440478
DR ESTDAB; ESTDAB-120
DR GEO; GSM188239
DR GEO; GSM188269
DR GEO; GSM188328
DR GEO; GSM433918
DR GEO; GSM555174
DR IGRhCellID; 501Mel
RX PubMed=10048982;
RX PubMed=15467732;
RX PubMed=20149136;
RX PubMed=23671654;
CC Microsatellite instability: Stable (MSS) (PubMed=23671654).
CC Derived from metastatic site: Not specified.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12
ST FGA: 22,23
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 501.1
AC CVCL_0I04
DR ATCC; PTA-4569
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 505-05-01
AC CVCL_E059
DR CLO; CLO_0050202
DR RCB; RCB0761
RX PubMed=7050499;
CC Breed/subspecies: C57BL/Ka x C3H/He.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID 50B11
AC CVCL_M745
RX PubMed=17565537;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID 51 BLCL
AC CVCL_E408
DR ECACC; 94031609
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 51.1
AC CVCL_7240
DR CLO; CLO_0001405
DR ATCC; HB-230
DR CCRID; 3131C0001000600010
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 514
AC CVCL_J926
DR CLO; CLO_0001406
DR ATCC; CRL-1914
RX PubMed=6305011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 5175
AC CVCL_EQ44
DR GEO; GSM666034
DR GEO; GSM666035
RX PubMed=22033105;
CC Omics: Transcriptome analysis.
DI NCIt; C98994; NADH dehydrogenase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID 51B
AC CVCL_D232
RX PubMed=3028609;
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 51B LiM-1
AC CVCL_D233
RX PubMed=3028609;
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D232 ! 51B
CA Cancer cell line
//
ID 51B LiM-2
AC CVCL_D234
RX PubMed=3028609;
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D233 ! 51B LiM-1
CA Cancer cell line
//
ID 51B LiM-3
AC CVCL_D235
RX PubMed=3028609;
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D234 ! 51B LiM-2
CA Cancer cell line
//
ID 51B LiM-4
AC CVCL_D236
RX PubMed=3028609;
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D235 ! 51B LiM-3
CA Cancer cell line
//
ID 51B LiM-5
AC CVCL_D237
SY 51B LiM 5; 51BLiM5
RX PubMed=3028609;
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D236 ! 51B LiM-4
CA Cancer cell line
//
ID 51B LiM-6
AC CVCL_D238
SY 51B LiM 6; 51BLiM6
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D237 ! 51B LiM-5
CA Cancer cell line
//
ID 52
AC CVCL_J927
SY Anti PDGF hybridoma #52
DR CLO; CLO_0001407
DR ATCC; HB-9361
RX Patent=US5175255;
CC Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 52-3D
AC CVCL_K117
DR ECACC; 91121235
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 52-S
AC CVCL_J597
SY 52S
DR CLO; CLO_0001410
DR ATCC; HB-8181
DR IZSLER; BS Hy 50
RX PubMed=6277788;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 520C9
AC CVCL_G612
SY 520C9.C3B10T
DR CLO; CLO_0001408
DR ATCC; HB-8696
RX Patent=US4753894;
RX Patent=US5169774;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 526-mel
AC CVCL_8051
SY 526-MEL; 526 mel; 526mel; 526MEL; 526; MEL-526; Mel526; MEL526
DR CGH-DB; 9297-4
DR Cosmic; 905211
DR Cosmic; 1303043
DR GEO; GSM206440
DR GEO; GSM218052
RX PubMed=8081556;
RX PubMed=8537970;
RX PubMed=10048982;
RX PubMed=15467732;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Misspelling: '527MEL' in GEO GSM206440.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 528
AC CVCL_J596
DR CLO; CLO_0001409
DR ATCC; HB-8509
RX Patent=US4943533;
CC Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 52iALS-n1
AC CVCL_W561
DR SKIP; SKIP000323
RX PubMed=24154603;
CC Characteristics: Has a hexanucleotide expansion in the 1st intron of C9orf72.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID 53-569
AC CVCL_DC78
DR ATCC; CRL-8010
RX Patent=EP0008092B1;
RX PubMed=6153172;
CC Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl (DNP).
CC Discontinued: ATCC; CRL-8010; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 53-6.72
AC CVCL_9162
SY 53-6.7
DR CLO; CLO_0001411
DR ATCC; TIB-105
DR BCRC; 60319
DR BCRJ; 0023
RX PubMed=398327;
CC Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 53-7.313
AC CVCL_9163
SY 53-7.3
DR CLO; CLO_0001412
DR ATCC; TIB-104
DR BCRJ; 0025
RX PubMed=398327;
CC Monoclonal antibody target: UniProtKB; P13379; Mouse Cd5.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 53-S
AC CVCL_J598
SY 53S
DR CLO; CLO_0001413
DR ATCC; HB-8182
RX PubMed=6277788;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 530
AC CVCL_W282
RX PubMed=1918136;
RX PubMed=2060184;
RX PubMed=3402430;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 537-B1-1
AC CVCL_K118
DR ECACC; 93102701
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 537-mel
AC CVCL_8052
SY 537-MEL; 537 mel; 537 MEL; 537mel; 537; Mel537
DR EFO; EFO_0006357
DR BioSample; SAMN03471452
DR CGH-DB; 9298-4
DR Cosmic; 876685
DR Cosmic; 905212
DR Cosmic; 1507618
DR Cosmic; 2233664
RX PubMed=8081556;
RX PubMed=10048982;
RX PubMed=10754339;
RX PubMed=15467732;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Not specified.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 11,15
ST D21S11: 29,31.2
ST D3S1358: 15,16
ST D5S818: 13
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 22,24
ST Penta D: 9
ST Penta E: 7,17
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 53B3
AC CVCL_J061
DR ECACC; 85062501
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybrid cell line
//
ID 548
AC CVCL_K119
DR CLO; CLO_0001414
DR ATCC; CRL-1890
RX PubMed=6305011;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 54B3
AC CVCL_J062
DR ECACC; 93071512
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybrid cell line
//
ID 54SCC2
AC CVCL_4091
DR ECACC; 08062560
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1970 ! C6-BU-1
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID 54SCC3
AC CVCL_4092
DR ECACC; 08062561
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1970 ! C6-BU-1
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID 54SCC7
AC CVCL_4093
DR ECACC; 08062518
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1970 ! C6-BU-1
HI CVCL_3984 ! A-9
CA Hybrid cell line
//
ID 55-100
AC CVCL_0E86
DR ATCC; CRL-2157
RX PubMed=7590785;
CC Discontinued: ATCC; CRL-2157; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 55-2
AC CVCL_G613
DR CLO; CLO_0001415
DR ATCC; CRL-2155
RX PubMed=7590785;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 55-36
AC CVCL_G614
DR CLO; CLO_0001416
DR ATCC; CRL-2153
RX PubMed=7590785;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 55-6
AC CVCL_G615
DR CLO; CLO_0001417
DR ATCC; CRL-2156
DR ECACC; 97040308
RX PubMed=7590785;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 55-83
AC CVCL_G616
DR CLO; CLO_0001418
DR ATCC; CRL-2185
RX PubMed=7590785;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 551-iPS8
AC CVCL_C248
SY 551-IPS8
DR ISCR; 10
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2434 ! Detroit 551
SX Female
CA Induced pluripotent stem cell
//
ID 553-mel
AC CVCL_8053
SY 553-MEL; 553 mel; 553mel; 553
RX PubMed=8027550;
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 553B-mel
AC CVCL_W285
SY 553B mel; 553Bmel
DR CGH-DB; 9299-4
DR Cosmic; 905213
RX PubMed=10048982;
RX PubMed=15467732;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 558-D 100, 10, 1
AC CVCL_8941
SY 558-D
DR CLO; CLO_0001419
DR ATCC; HB-10894
OX NCBI_TaxID=9606; ! Homo sapiens
CA Hybridoma
//
ID 559/64-D 100, 10, 1
AC CVCL_8942
SY 559/64-D
DR CLO; CLO_0001420
DR ATCC; HB-10893
OX NCBI_TaxID=9606; ! Homo sapiens
CA Hybridoma
//
ID 56/10 A1
AC CVCL_F758
RX PubMed=1662315;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 5637
AC CVCL_0126
DR BTO; BTO:0003137
DR CLO; CLO_0001421
DR CLO; CLO_0050845
DR EFO; EFO_0002096
DR MCCL; MCC:0000018
DR CLDB; cl1
DR CLDB; cl105
DR CLDB; cl7118
DR ATCC; HTB-9
DR BCRC; 60061
DR BCRJ; 0026
DR BioSample; SAMN01821610
DR BioSample; SAMN03472760
DR BioSample; SAMN03473359
DR CCLE; 5637_URINARY_TRACT
DR CCRID; 3131C0001000700001
DR ChEMBL-Cells; CHEMBL3308352
DR ChEMBL-Targets; CHEMBL612565
DR CLS; 300105/p667_5637
DR Cosmic; 687452
DR Cosmic; 715695
DR Cosmic; 760484
DR Cosmic; 845565
DR Cosmic; 846281
DR Cosmic; 928819
DR Cosmic; 943732
DR Cosmic; 1016892
DR Cosmic; 1046675
DR Cosmic; 1093983
DR Cosmic; 1285103
DR Cosmic; 1285998
DR Cosmic; 1927307
DR Cosmic; 2050427
DR Cosmic; 2057434
DR Cosmic; 2301520
DR Cosmic; 2444227
DR Cosmic-CLP; 687452
DR DSMZ; ACC-35
DR GDSC; 687452
DR GEO; GSM142303
DR GEO; GSM142309
DR GEO; GSM886840
DR GEO; GSM887903
DR GEO; GSM1374370
DR GEO; GSM1574578
DR GEO; GSM1669563
DR ICLC; HTL01017
DR IGRhCellID; 5637
DR KCLB; 30009
DR LINCS; 50001
DR NCBI_Iran; C450
DR PRIDE; PXD003105
DR RCB; RCB1191
DR RCB; RCB3676
DR SKY/M-FISH/CGH; 17
DR TKG; TKG 0605
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=7459858;
RX PubMed=8873383;
RX PubMed=12127398;
RX PubMed=16885334;
RX PubMed=17254797;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=5637
WW http://www.addexbio.com/productdetail?pid=8
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/5/cell-lines-detail-354.html
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~24 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'HTB9' (based on the ATCC catalog number).
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=11416159; PubMed=17254797; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9
ST D18S51: 16,18
ST D21S11: 36
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 10,16
ST FGA: 22
ST Penta D: 11
ST Penta E: 10,12
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16,18 (ATCC; Cosmic-CLP; TKG)
ST vWA: 18 (CLS; DSMZ; KCLB; PubMed=11416159; PubMed=17254797; RCB)
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 56B3
AC CVCL_6765
SY 56b3
DR CLO; CLO_0001422
DR ATCC; CRL-2542
DR ATCC; CRL-11117
RX Patent=US5625122;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:96756; Lck.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID 56FHTE8o-
AC CVCL_IN61
RX PubMed=1375758;
RX PubMed=10498856;
RX PubMed=15463957;
WW http://www.dartmouth.edu/~cysfib/cell-lines.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 575A
AC CVCL_7941
DR Cosmic; 1016885
DR GEO; GSM1574575
RX PubMed=66978;
RX PubMed=6244232;
RX PubMed=6935474;
RX PubMed=16885334;
RX PubMed=25997541;
RX PubMed=26621286;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 577MF
AC CVCL_2290
DR ECACC; 06011802
RX PubMed=6169654;
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C509 ! 577ML
OI CVCL_C510 ! 577MR
SX Male
CA Cancer cell line
//
ID 577ML
AC CVCL_C509
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2290 ! 577MF
OI CVCL_C510 ! 577MR
SX Male
CA Cancer cell line
//
ID 577MR
AC CVCL_C510
RX PubMed=7471097;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2290 ! 577MF
OI CVCL_C509 ! 577ML
SX Male
CA Cancer cell line
//
ID 579
AC CVCL_J595
DR CLO; CLO_0001423
DR ATCC; HB-8506
RX Patent=US4943533;
CC Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 58-S
AC CVCL_J599
SY 58S
DR CLO; CLO_0001426
DR ATCC; HB-8183
RX PubMed=6277788;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 585A1
AC CVCL_DQ06
DR GEO; GSM1040279
DR GEO; GSM1040349
DR GEO; GSM1489230
DR GEO; GSM1489447
DR GEO; GSM2152683
DR GEO; GSM2152684
DR GEO; GSM2152685
DR GEO; GSM2152686
DR GEO; GSM2152687
DR GEO; GSM2152688
DR GEO; GSM2152689
DR GEO; GSM2152690
DR PRIDE; PXD000071
RX PubMed=22802639;
RX PubMed=23210603;
RX PubMed=24259714;
RX PubMed=25665923;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ07 ! 585B1
OI CVCL_DQ20 ! 692D2
OI CVCL_DQ21 ! 703A1
OI CVCL_DQ22 ! 703B1
SX Male
CA Induced pluripotent stem cell
//
ID 585B1
AC CVCL_DQ07
DR GEO; GSM1040280
DR GEO; GSM1040350
DR GEO; GSM1489231
DR GEO; GSM1489448
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ06 ! 585A1
OI CVCL_DQ20 ! 692D2
OI CVCL_DQ21 ! 703A1
OI CVCL_DQ22 ! 703B1
SX Male
CA Induced pluripotent stem cell
//
ID 586-EBV
AC CVCL_GR76
RX PubMed=8027550;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z021 ! 586-mel
SX Female
CA Transformed cell line
//
ID 586-mel
AC CVCL_Z021
SY 586-MEL; 586 MEL; 586 Mel; 586 mel
DR Cosmic; 876700
RX PubMed=8027550;
RX PubMed=8081556;
RX PubMed=10048982;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GR76 ! 586-EBV
SX Female
CA Cancer cell line
//
ID 58967 NRK
AC CVCL_7241
SY NRK cell line No. 58967; TR-NRK-P
DR CLO; CLO_0001424
DR CLDB; cl107
RX PubMed=170369;
CC Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Transformed cell line
//
ID 58B2C
AC CVCL_S157
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 58D3C9
AC CVCL_V062
DR CLO; CLO_0001425
DR CLDB; cl108
DR IHW; IHW8007
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID 59-3
AC CVCL_J874
RX PubMed=6183593;
CC Monoclonal antibody target: Coxsackievirus B4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 591
AC CVCL_E451
DR dbMHC; 48469
DR ECACC; 94050343
DR IHW; IHW9230
DR IMGT/HLA; 10166
WW http://bioinformatics.hsanmartino.it/ecbr/cl230.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID 598RCC
AC CVCL_B384
SY 598-RCC
DR BTO; BTO:0003734
RX PubMed=17284252;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 59B5
AC CVCL_N779
DR ATCC; CRL-11115
RX Patent=US5625122;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:96756; Lck.
CC Misspelling: '5gb5' in patent US5625122.
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4378 ! ES-D3
SX Male
CA Embryonic stem cell
//
ID 59M
AC CVCL_2291
SY OAW59M; OAW 59M; 59 M
DR CLO; CLO_0001428
DR EFO; EFO_0006358
DR CLDB; cl110
DR BioSample; SAMN03472466
DR CCLE; 59M_OVARY
DR ECACC; 89081802
DR GEO; GSM313717
DR GEO; GSM887904
DR GEO; GSM1374376
RX PubMed=2653399;
RX PubMed=8795574;
RX PubMed=15677628;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=22460905;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 9
ST D18S51: 12
ST D19S433: 14,16
ST D21S11: 31
ST D2S1338: 19,20
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 10,14
ST FGA: 22.2
ST Penta D: 8
ST Penta E: 15
ST TH01: 7
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 59M13
AC CVCL_6E55
SY 59m/13
DR Cosmic; 1609532
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2291 ! 59M
SX Female
CA Cancer cell line
//
ID 5A-HS-MYC
AC CVCL_4586
SY 5A HS MYC
DR CLO; CLO_0002845
DR ATCC; CRL-9010
RX Patent=EP0232845A2;
RX PubMed=3526329;
CC Transfected with: MGI; MGI:97250; Myc.
CC Caution: ATCC CRL-9010 use DUKX B1 as the name of the cell line which is a misspelling of the parent cell line from the Patent EP0232845A2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID 5A1
AC CVCL_8943
DR CLO; CLO_0001429
DR ATCC; CRL-2702
RX PubMed=2454994;
CC Monoclonal antibody target: UniProtKB; P07141; Mouse Csf1.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID 5A5-WASP
AC CVCL_B990
DR CLO; CLO_0050380
DR RCB; RCB2740
DR TKG; TKG 0631
CC Monoclonal antibody target: UniProtKB; P42768; Human WAS.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5B-HS-MYC
AC CVCL_5A29
RX Patent=EP0232845A2;
RX PubMed=3526329;
CC Transfected with: MGI; MGI:97250; Myc.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID 5B4
AC CVCL_X860
DR ATCC; PTA-5260
RX Patent=US7091047;
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 5B6.3.10
AC CVCL_J988
DR ATCC; PTA-4298
RX Patent=US20080171036;
CC Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
CC Discontinued: ATCC; PTA-4298; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 5C2
AC CVCL_S158
RX DOI=10.1577/1548-8667(1998)010<0075:doltcl>2.0.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=8022; ! Oncorhynchus mykiss
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID 5C5
AC CVCL_CW39
DR NCBI_Iran; H145
RX CelloPub=CLPUB00331;
CC Monoclonal antibody target: UniProtKB; P23223; Leishmania donovani gp63 (also reacts with other Leishmania species gp63).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 5C6 Clone 1
AC CVCL_8828
DR CLO; CLO_0001430
DR ATCC; CRL-1969
RX PubMed=2445894;
CC Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID 5C6.10.4
AC CVCL_J929
DR ATCC; HB-9572
RX Patent=US5194593;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID 5c8
AC CVCL_J906
DR CLO; CLO_0001431
DR ATCC; HB-10916
RX Patent=US5474771;
CC Monoclonal antibody target: UniProtKB; P29965; Human CD40LG/CD154.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5C9
AC CVCL_4493
SY 5 C 9
DR CLO; CLO_0001402
DR CLO; CLO_0001432
DR CLDB; cl5099
DR ATCC; HB-8371
DR IZSLER; BS Hy 38
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5D12
AC CVCL_J878
DR ATCC; HB-11339
RX Patent=US5677165;
CC Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5D4-11
AC CVCL_J928
DR CLO; CLO_0001433
DR ATCC; HB-49
RX PubMed=6285749;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID 5D5.11.6
AC CVCL_J002
SY 5D5
DR CLO; CLO_0001434
DR ATCC; HB-11895
RX Patent=US5646036;
RX Patent=US5686292;
CC Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID 5E10
AC CVCL_U333
DR ATCC; CRL-2698
DR ATCC; PTA-865
RX PubMed=9851244;
CC Discontinued: ATCC; PTA-865; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 5E4
AC CVCL_G617
DR CLO; CLO_0001435
DR ATCC; CRL-2635
RX PubMed=11401970;
CC Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5E9 TLK-2
AC CVCL_Y108
DR BCRC; 60524
CC Monoclonal antibody target: UniProtKB; Q86UE8; Human TLK2.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 5F12 AD3
AC CVCL_C552
SY 5 F12 AD 3
DR CLO; CLO_0001437
DR ATCC; HB-8209
DR CCRID; 3142C0001000000494
RX Patent=US4558006;
RX Patent=US5106760;
CC Monoclonal antibody target: UniProtKB; P01588; Human EPO.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5G2
AC CVCL_L105
DR ATCC; CRL-8797
RX Patent=US4834975;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-8797; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 5G3
AC CVCL_4494
SY 5g3
DR CLO; CLO_0001438
DR CLDB; cl5108
DR IZSLER; BS Hy 47
RX DOI=10.1080/09540109609354898;
CC Monoclonal antibody target: ChEBI; CHEBI:174690; Clenbuterol.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 5G5
AC CVCL_G618
DR CLO; CLO_0001439
DR ATCC; CRL-2633
RX PubMed=11401970;
CC Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5G6
AC CVCL_X861
DR ATCC; PTA-5595
RX Patent=US7368428;
RX Patent=US7674460;
CC Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 5H6
AC CVCL_K226
RX PubMed=9495512;
CC Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID 5H7
AC CVCL_0P39
RX PubMed=20410930;
WW https://www.kerafast.com/product/1278/diphtheria-toxin-resistant-hek293t-cell-line-5h7
CC Transfected with: HGNC; 3214; EEF2 (with R-717).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID 5H8
AC CVCL_G619
DR CLO; CLO_0001440
DR ATCC; CRL-2646
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 5HL2
AC CVCL_Y459
RX PubMed=2591959;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4599 ! UV5
CA Hybrid cell line
//
ID 5HL2-B
AC CVCL_Y461
SY 5HL2 B; GM10792
DR CLO; CLO_0023670
DR Coriell; GM10792
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y459 ! 5HL2
CA Hybrid cell line
//
ID 5HL9
AC CVCL_Y460
RX PubMed=1967982;
RX PubMed=2591959;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4599 ! UV5
CA Hybrid cell line
//
ID 5HL9-4
AC CVCL_Y462
SY GM10449
DR CLO; CLO_0028515
DR Coriell; GM10449
RX PubMed=2276735;
RX PubMed=2591959;
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y460 ! 5HL9
CA Hybrid cell line
//
ID 5L
AC CVCL_F951
SY 5-L
RX PubMed=7085765;
RX PubMed=16548065;
RX PubMed=23639626;
CC Omics: Proteome analysis.
CC Breed/subspecies: AxC.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0269 ! Fao
SX Male
CA Cancer cell line
//
ID 5LBLN
AC CVCL_3637
DR CLO; CLO_0001441
DR ATCC; CRL-6049
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6049; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Finite cell line
//
ID 5RP7
AC CVCL_5490
DR IFO; IFO50277
CC Transfected with: HGNC; 5173; HRAS.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID 5T33
AC CVCL_G080
SY 5T33MM
DR EFO; EFO_0006530
RX PubMed=1457349;
CC Breed/subspecies: C57BL/KaLwRij.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID 6-1
AC CVCL_W173
SY GMI-M6-1
RX Patent=US6673605;
RX PubMed=11054807;
CC Characteristics: CSF2 dependent.
CC Breed/subspecies: C57BL/6J(H-2b).
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID 6-10B
AC CVCL_C529
DR Cosmic; 2366878
DR GEO; GSM375843
RX PubMed=12485491;
CC Omics: Transcriptome analysis.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6946 ! SUNE1
CA Cancer cell line
//
ID 6-23
AC CVCL_A599
SY rMTC-6-23; rMTC 6-23
RX PubMed=6353060;
RX PubMed=6248326;
RX PubMed=6932046;
RX PubMed=7389665;
CC Breed/subspecies: WAG/Rij.
DI NCIt; C60369; Rat C-cell carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID 6-23C6
AC CVCL_4495
SY rMTC 6-23C6; 6-23 clone 6; 6-23 (Clone 6); 6-23 (clone 6)
DR CLO; CLO_0001446
DR CLO; CLO_0001447
DR CLDB; cl111
DR CLDB; cl5109
DR ATCC; CRL-1607
DR ECACC; 87042206
DR IZSLER; BS TCL 130
DR IFO; IFO50270
RX PubMed=6353060;
RX PubMed=7736432;
CC Breed/subspecies: WAG/Rij.
DI NCIt; C60369; Rat C-cell carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_A599 ! 6-23
CA Cancer cell line
//
ID 6-3
AC CVCL_W174
SY GMI-M6-3
RX Patent=US6673605;
RX PubMed=11054807;
CC Characteristics: CSF2 dependent.
CC Breed/subspecies: C57BL/6J(H-2b).
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID 6.1.1
AC CVCL_L906
RX PubMed=8500519;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_L908 ! 6.1.7
OI CVCL_L907 ! 6.1.11
CA Transformed cell line
//
ID 6.1.11
AC CVCL_L907
RX PubMed=8500519;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_L906 ! 6.1.1
OI CVCL_L908 ! 6.1.7
CA Transformed cell line
//
ID 6.1.7
AC CVCL_L908
RX PubMed=8500519;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_L906 ! 6.1.1
OI CVCL_L907 ! 6.1.11
CA Transformed cell line
//
ID 6.12
AC CVCL_6766
DR CLO; CLO_0001442
DR ATCC; CRL-13006
DR ATCC; PTA-3344
RX Patent=US6365157;
RX Patent=US6448077;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 6.23.58K
AC CVCL_K134
DR ECACC; 93062219
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 60
AC CVCL_C917
DR ISCR; 330
RX PubMed=19252478;
CC From: Samuel Lunenfeld Research Institute; Toronto; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID 6005
AC CVCL_6G42
RX PubMed=833871;
RX PubMed=7459858;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID 600MPE
AC CVCL_9875
AS CVCL_8287
SY 600 MPE; 600-MPE; MPE-600; MPE 600; MPE600; 600PE; 600-PEI
DR CLO; CLO_0009908
DR EFO; EFO_0001085
DR Cosmic; 997932
DR Cosmic; 1000128
DR Cosmic; 1046948
DR Cosmic; 1091346
DR Cosmic; 1136351
DR Cosmic; 1176628
DR Cosmic; 1287907
DR Cosmic; 1289403
DR Cosmic; 2301521
DR GEO; GSM814
DR GEO; GSM320174
DR GEO; GSM1661985
DR LINCS; 51092
RX PubMed=3470538;
RX PubMed=10862037;
RX PubMed=17157791;
RX PubMed=23601657;
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
CC Misspelling: 'MPE699' in Cosmic 1287907.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 601
AC CVCL_U662
SY Line 601
RX PubMed=10590124;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U656 ! AE1-2a
SX Male
CA Cancer cell line
//
ID 604A1
AC CVCL_DQ08
DR GEO; GSM1040281
DR GEO; GSM1040351
DR GEO; GSM1489290
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ09 ! 604A3
OI CVCL_DQ10 ! 604B1
OI CVCL_DQ32 ! 622C1
OI CVCL_DQ15 ! 622E1
OI CVCL_DQ16 ! 622G1
OI CVCL_DQ30 ! 648A1
OI CVCL_DQ17 ! 648B1
SX Male
CA Induced pluripotent stem cell
//
ID 604A3
AC CVCL_DQ09
DR GEO; GSM1040282
DR GEO; GSM1040352
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ08 ! 604A1
OI CVCL_DQ10 ! 604B1
OI CVCL_DQ32 ! 622C1
OI CVCL_DQ15 ! 622E1
OI CVCL_DQ16 ! 622G1
OI CVCL_DQ30 ! 648A1
OI CVCL_DQ17 ! 648B1
SX Male
CA Induced pluripotent stem cell
//
ID 604B1
AC CVCL_DQ10
DR GEO; GSM1040283
DR GEO; GSM1040353
RX PubMed=22802639;
RX PubMed=24259714;
RX PubMed=25665923;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ08 ! 604A1
OI CVCL_DQ09 ! 604A3
OI CVCL_DQ32 ! 622C1
OI CVCL_DQ15 ! 622E1
OI CVCL_DQ16 ! 622G1
OI CVCL_DQ30 ! 648A1
OI CVCL_DQ17 ! 648B1
SX Male
CA Induced pluripotent stem cell
//
ID 606A1
AC CVCL_DQ11
DR GEO; GSM1040284
DR GEO; GSM1040354
DR GEO; GSM1489239
DR GEO; GSM1489442
DR PRIDE; PXD000071
RX PubMed=22802639;
RX PubMed=23210603;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ12 ! 606B1
OI CVCL_DQ23 ! 711A1
OI CVCL_DR11 ! 711A5
OI CVCL_DQ24 ! 711A6
OI CVCL_DQ25 ! 711C1
SX Female
CA Induced pluripotent stem cell
//
ID 606B1
AC CVCL_DQ12
DR GEO; GSM1040285
DR GEO; GSM1040355
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ11 ! 606A1
OI CVCL_DQ23 ! 711A1
OI CVCL_DR11 ! 711A5
OI CVCL_DQ24 ! 711A6
OI CVCL_DQ25 ! 711C1
SX Female
CA Induced pluripotent stem cell
//
ID 609050M
AC CVCL_4065
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=609050M
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 60bca
AC CVCL_J905
DR CLO; CLO_0001443
DR ATCC; HB-247
CC Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 60H9(9)D10.E6
AC CVCL_2822
SY D10.E6
DR CLO; CLO_0001444
DR CLDB; cl112
DR ECACC; 94111519
DR NCBI_Iran; C157
DR NIH-ARP; 8132-4
RX PubMed=1717573;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3098; Hepatitis C infection
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID 61
AC CVCL_C918
DR ISCR; 329
RX PubMed=19252478;
CC From: Samuel Lunenfeld Research Institute; Toronto; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID 61/7
AC CVCL_J643
DR CLO; CLO_0001445
DR ATCC; HB-8154
RX Patent=US4521510;
RX Patent=US4524025;
CC Monoclonal antibody target: ChEBI; CHEBI:28177; Theophylline.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID 610A2
AC CVCL_DQ13
DR GEO; GSM1040286
DR GEO; GSM1040356
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ14 ! 610B1
OI CVCL_DQ18 ! 665A1
OI CVCL_DQ19 ! 665A7
SX Male
CA Induced pluripotent stem cell
//
ID 610B1
AC CVCL_DQ14
DR GEO; GSM1040287
DR GEO; GSM1040357
DR GEO; GSM1489240
DR GEO; GSM1489258
DR GEO; GSM1489443
DR GEO; GSM1942571
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ13 ! 610A2
OI CVCL_DQ18 ! 665A1
OI CVCL_DQ19 ! 665A7
SX Male
CA Induced pluripotent stem cell
//
ID 62.1E6
AC CVCL_J619
DR BCRJ; 0027
WW http://dshb.biology.uiowa.edu/Slug
CC Monoclonal antibody target: UniProtKB; E1C375; Chicken SNAI2.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID 621-101
AC CVCL_S879
RX PubMed=12922981;
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID 621.1
AC CVCL_0I05
DR ATCC; PTA-5121
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 621NST
AC CVCL_S880
RX DOI=10.1158/1055-9965.DISP-11-A64;
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S879 ! 621-101
SX Female
CA Cancer cell line
//
ID 622C1
AC CVCL_DQ32
DR GEO; GSM2152676
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ08 ! 604A1
OI CVCL_DQ09 ! 604A3
OI CVCL_DQ10 ! 604B1
OI CVCL_DQ15 ! 622E1
OI CVCL_DQ16 ! 622G1
OI CVCL_DQ30 ! 648A1
OI CVCL_DQ17 ! 648B1
SX Male
CA Induced pluripotent stem cell
//
ID 622E1
AC CVCL_DQ15
DR GEO; GSM1040288
DR GEO; GSM1040358
DR GEO; GSM2152677
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ08 ! 604A1
OI CVCL_DQ09 ! 604A3
OI CVCL_DQ10 ! 604B1
OI CVCL_DQ32 ! 622C1
OI CVCL_DQ16 ! 622G1
OI CVCL_DQ30 ! 648A1
OI CVCL_DQ17 ! 648B1
SX Male
CA Induced pluripotent stem cell
//
ID 622G1
AC CVCL_DQ16
DR GEO; GSM1040359
DR GEO; GSM1040289
RX PubMed=22802639;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ08 ! 604A1
OI CVCL_DQ09 ! 604A3
OI CVCL_DQ10 ! 604B1
OI CVCL_DQ32 ! 622C1
OI CVCL_DQ15 ! 622E1
OI CVCL_DQ30 ! 648A1
OI CVCL_DQ17 ! 648B1
SX Male
CA Induced pluripotent stem cell
//
ID 624-mel
AC CVCL_8054
SY 624-MEL; 624 MEL; 624 Mel; 624 mel; 624mel; 624; Mel-624; Mel624; MEL624
DR BTO; BTO:0002951
DR EFO; EFO_0006359
DR BioSample; SAMN03471309
DR CGH-DB; 9301-4
DR Cosmic; 876683
DR Cosmic; 905214
DR Cosmic; 1303044
DR Cosmic; 1559441
DR Cosmic; 2163793
DR ESTDAB; ESTDAB-049
DR GEO; GSM206438
RX PubMed=8027550;
RX PubMed=8081556;
RX PubMed=8537970;
RX PubMed=10048982;
RX PubMed=10754339;
RX PubMed=15467732;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
ST Source(s): ESTDAB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10,13
ST D16S539: 14
ST D18S51: 16
ST D21S11: 29
ST D3S1358: 14,16
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 12
ST FGA: 24
ST Penta D: 9
ST Penta E: 7,13
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 624.28 Mel
AC CVCL_C586
SY 624.28-MEL; Mel-624.28; Me 624.28; 624.28; 624-28
DR ESTDAB; ESTDAB-121
DR GEO; GSM218053
DR GEO; GSM1092560
RX PubMed=10754339;
RX PubMed=11924911;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10,13
ST D3S1358: 14,16
ST D5S818: 12
ST D7S820: 10,12
ST FGA: 24
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8054 ! 624-mel
SX Male
CA Cancer cell line
//
ID 624.38 Mel
AC CVCL_C588
SY 624.38-MEL; Mel-624.38; Me624.38; Mel624.38; 624.38; 624-38
DR ESTDAB; ESTDAB-113
DR GEO; GSM218056
RX PubMed=10754339;
RX PubMed=11924911;
RX PubMed=18172304;
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10,13
ST D3S1358: 14,16
ST D5S818: 12
ST D7S820: 10
ST FGA: 24
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8054 ! 624-mel
SX Male
CA Cancer cell line
//
ID 63 BLCL
AC CVCL_E409
DR ECACC; 94031610
RX PubMed=8588125;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3201; Systemic lupus erythematosus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID 633
AC CVCL_E066
SY Line 633
DR CLO; CLO_0050068
DR BioSample; SAMN03471969
DR RCB; RCB2352
RX PubMed=10590124;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U656 ! AE1-2a
SX Male
CA Cancer cell line
//
ID 633.1
AC CVCL_0I06
DR ATCC; PTA-5122
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 639V
AC CVCL_1048
SY 639-V; 639 V
DR CLO; CLO_0001448
DR EFO; EFO_0002097
DR BioSample; SAMN03473587
DR CCLE; 639V_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3308703
DR ChEMBL-Targets; CHEMBL1075383
DR Cosmic; 906798
DR Cosmic; 923375
DR Cosmic; 928821
DR Cosmic; 1285104
DR Cosmic; 1927315
DR Cosmic; 2050428
DR Cosmic-CLP; 906798
DR DSMZ; ACC-413
DR GDSC; 906798
DR GEO; GSM827155
DR GEO; GSM886841
DR GEO; GSM887905
DR GEO; GSM1574552
DR GEO; GSM1574584
DR GEO; GSM1669569
DR IGRhCellID; 639V
RX PubMed=66978;
RX PubMed=944089;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=6935474;
RX PubMed=8873383;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=26621286;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 11,14
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 9.3
ST TPOX: 9,12
ST vWA: 16,19
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 63D3
AC CVCL_G620
DR CLO; CLO_0001449
DR ATCC; HB-44
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 647V
AC CVCL_1049
SY 647-V; 647 V
DR CLO; CLO_0001450
DR EFO; EFO_0002098
DR BioSample; SAMN03473588
DR CCLE; 647V_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3308704
DR ChEMBL-Targets; CHEMBL1075384
DR Cosmic; 906797
DR Cosmic; 928822
DR Cosmic; 1046676
DR Cosmic; 1285105
DR Cosmic; 1286005
DR Cosmic; 1927309
DR Cosmic; 2050429
DR Cosmic; 2057435
DR Cosmic; 2444239
DR Cosmic-CLP; 906797
DR DSMZ; ACC-414
DR GDSC; 906797
DR GEO; GSM827156
DR GEO; GSM886842
DR GEO; GSM887906
DR GEO; GSM1374377
DR GEO; GSM1669570
DR IGRhCellID; 647V
DR LINCS; 50002
RX PubMed=66978;
RX PubMed=944089;
RX PubMed=6244232;
RX PubMed=7459858;
RX PubMed=8873383;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8
ST vWA: 18,21
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID 648A1
AC CVCL_DQ30
DR GEO; GSM1489207
DR GEO; GSM1489233
DR GEO; GSM1489257
DR GEO; GSM1489445
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ08 ! 604A1
OI CVCL_DQ09 ! 604A3
OI CVCL_DQ10 ! 604B1
OI CVCL_DQ32 ! 622C1
OI CVCL_DQ15 ! 622E1
OI CVCL_DQ16 ! 622G1
OI CVCL_DQ17 ! 648B1
SX Male
CA Induced pluripotent stem cell
//
ID 648B1
AC CVCL_DQ17
DR GEO; GSM1489208
DR GEO; GSM1489234
DR GEO; GSM1489446
RX PubMed=25665923;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ08 ! 604A1
OI CVCL_DQ09 ! 604A3
OI CVCL_DQ10 ! 604B1
OI CVCL_DQ32 ! 622C1
OI CVCL_DQ15 ! 622E1
OI CVCL_DQ16 ! 622G1
OI CVCL_DQ30 ! 648A1
SX Male
CA Induced pluripotent stem cell
//
ID 64CP
AC CVCL_1B36
RX CelloPub=CLPUB00240;
RX PubMed=9772905;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Abdomen.
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2292 ! 833K-E
SX Male
CA Cancer cell line
//
ID 650E2-2B12
AC CVCL_J903
SY 650E2; IVI 10083
DR CLO; CLO_0001451
DR ATCC; HB-10812
RX Patent=US5629197;
CC Registration: Chiron Master Culture Collection; CMCC 10121 (CMCC #10121).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID 654.1
AC CVCL_0I07
DR ATCC; PTA-5247
RX Patent=US7429382;
CC Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
** -----------------------------------------------------------------------
** CALIPHO group at the SIB - Swiss Institute of Bioinformatics
** Geneva, Switzerland
** -----------------------------------------------------------------------
**
** Description: References file for the Cellosaurus
** Version: 24.0
** Last update: 15-November-2017
**
** -----------------------------------------------------------------------
您正在向 biovector.net 发送关于产品 细胞株1-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
免费订购电话: 400-800-2947